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Abstract
The ability of a cell to recognise and respond to external stimuli is essential for cell survival and
growth. Type-I cytokine receptors regulate many inflammatory, homeostatic, and growth and de-
velopment signalling pathways. For example, the erythropoietin receptor is the main driver of red
blood cell production from stem cells. All type-I cytokine receptors consist of an extracellular ligand-
binding domain, a single helical transmembrane domain and an intracellular domain that associates
with kinase/transcription factor signalling pathway, for example the JAK2/STAT5 pathway. Despite
being extensively studied and structures of the extracellular domains of many of these receptors be-
ing known, the precise mechanism by which these receptors couple the event of ligand-binding to
intracellular activation is not known. Indeed, multiple mechanisms have been proposed from exper-
imental and crystallographic data for different receptors. For example, the activation of the growth
hormone receptor is proposed to involve a relative rotation of two receptor chains, while in the case
of the erythropoietin receptor the chains were suggested to separate in a scissor-like mechanism. In
part, this is due to the limits of resolution achievable by experimental approaches as well as a lack
of appreciation for the dynamical properties of the receptor proteins and the membrane environment.
This thesis focuses on the use of fully atomistic molecular dynamics simulations to investigate the
mechanism of activation for the type-I cytokine receptors. In particular MD simulations are used
to probe whether conformations of the receptors observed crystallographically are representative of
physiological conformations. Further to this, the quality of the X-ray crystal structures is tested by
recreation of the crystal lattice inMD simulations. The effect of membrane composition is investigated
by comparing the behaviour of the transmembrane domain in bulk and cholesterol-enriched raft-like
bilayers. Finally, receptor dimers are examined for active and inactive conformations in raft-like bi-
layers containing sphingomyelin. Force field parameters for the lipid sphingomyelin that were used
to build raft-like bilayers were also generated and validated. The work draws into question several
of the mechanistic models proposed for the type-I cytokine receptors and demonstrates the difficulty
in proposing a detailed mechanism of action based on limited sets of structural data. In particular,
they highlight the limitations of the use of structural data in proposing a model when only a part of
the receptor is considered. Results from the simulations also suggest that the lipid composition can
influence the structure and behaviour of the receptors. Taken together the work shows the importance
of considering not only the ligand-binding domain of the receptor but also the restrictions imposed
by the transmembrane domain and structural influences caused by the membrane when proposing a
mechanism of activation for this important class of cell surface receptor.
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Chapter 1
Introduction
1.1 Signalling Through the Cell Plasma Membrane
1.1.1 Type-I cytokine receptors
A cell requires the ability to sense and monitor its surroundings to respond to and survive environmen-
tal changes. In cell communities, for example microbial biofilms and higher order organisms, such
as humans, cells are required to work in concert and it is necessary for an individual cell to recognise
and respond to signals released into the environment from other cells. Cytokines are a large family
of proteins that act as chemical messengers to coordinate the function of cells during inflammation,
immune responses, foetal and neonatal growth and development, and to maintain homeostasis. Cells
perceive cytokines through protein receptors that are embedded in the plasma membrane. These re-
ceptors are able to selectively recognise and bind specific cytokines and elicit a cellular response.
The signal of the cytokine binding is transferred via the receptor through the plasma membrane into
the cytoplasm. Intracellular secondary chemical messengers are then activated, for example protein
kinases, and continue the signalling pathway that in many cases ultimately results in changes in gene
expression. An example of this process is the binding of the cytokine erythropoietin (EPO) to the
erythropoietin receptor (EPOR) on the surface of stem cells in the bone marrow to regulate the forma-
tion of erythroblasts during erythropoiesis [2, 3]. Understanding how cytokine receptors transfer the
activation signal into the cell could help explain how these receptors become dysregulated in diseases,
such as chronic inflammation and cancer, and aid in the development of drugs designed to activate or
inactivate specific signalling pathways.
Type-I cytokine receptors are a large family of cytokine receptors that comprise interleukin re-
ceptors, growth factor receptors and haematopoietic cytokine receptors (Figure 1.1). A sub-family
of the haematopoietic cytokine receptors, referred to as the growth hormone receptor (GHR) family,
consists of the growth hormone (GH), prolactin (PRL), EPO and thrombopoietin (TPO) receptors.
The proteins of the GHR family are, in general, the smallest of the type-I cytokine receptors, but still
contain all the features of a typical type-I cytokine receptor. These are: (i) an extracellular ligand-
binding domain, (ii) a single-pass transmembrane domain, and (iii) an intracellular domain associated
with a Janus kinase (JAK) coupled to a signal transducer and activator of transcription (STAT) sig-
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Fං඀ඎඋൾ 1.1: Representative members of the type-I cytokine receptor family. The ligand-binding extracellular domain of
these receptors comprises a cytokine receptor homology domain, which itself is consists of two fibronectin type-III
sub-domains with an immunoglobulin-like fold. The extracellular domain may also comprise additional fibotrnectin
type-III or immunoglobulin domains. The receptors all have a single pass transmembrane domain that continues into
the cytosolic domain. Conserved motifs amongst the receptors are the structurally important WSXWS motif in the
extracellular domain and the Box 1 and 2 motifs in the cytosolic domain required for JAK binding [13].
nalling pathway. The GHR family also differ from other members of the type-I cytokine receptors,
in that they are active as homodimers, whereas, for example, the interleukin-6 receptor is active as a
heterodimer with gp-130 [4]. Currently, there is no atomic-resolution structure of a full-length type-I
cytokine receptor. Instead, as in the case of the EPOR, only X-ray crystallographic structures of the
soluble extracellular domains (referred to as soluble erythropoietin receptor (sEPOR), residues 1-226)
[5, 6, 7, 8, 9] and an NMR structure of the transmembrane domain in a micelle [10, 11] have been re-
ported. To date only the prolactin receptor (PRLR) has been been modelled as full-length receptor by
piecing together X-ray crystal data for the extracellular domain and NMR data for the transmembrane
and intracellular domains [12]. However, the use of this model either as a single chain or in a dimer
complex to study the motions involved in the activation of the receptor has not been performed.
As first shown in 1991 in relation to the GHR, in this receptor family a single cytokine interacts
2
Fං඀ඎඋൾ 1.2: A Corey, Pauling and Koltun (CPK)-ball presentation of the X-ray crystal structure of the growth hormone
cytokine (pink) bound in between two extracellular domains of the growth hormone receptor (green and blue). Protein
Data Bank entry 3HHR.
with two independent receptor chains (Figure 1.2) to form an activated complex [14, 15]. The forma-
tion of such an activated complex results in the transphosphorylation of the receptor cytosolic domains
at key tyrosine residues by the JAK and initiates one of the STAT pathways -- in the case of the GHR
and EPOR, JAK2 and the STAT5 pathway. This transphosphorylation is in contrast to the members of
the tyrosine kinase receptor family, e. g. the epidermal growth factor receptor, that auto-phosphorylate
upon activation. Despite these similarities in the structure of the type-I cytokine receptors, the nature
of ligand binding and the fact that all type-I cytokine receptors activate a JAK/STAT pathway, multiple
mechanisms of activation have been proposed for the type-I cytokine receptors. These models include
ligand-induced dimerisation [16], a relative rotation of the receptor chains [17, 18] and a cross-action
scissor-like motion of the receptor chains [8] (Figure 1.3). It is not currently feasible to directly ob-
serve the movements of these receptors on the cell surface to elucidate the mechanism of action. In
order to be able to observe the dynamical behaviour and properties of these receptors and to study
the initial steps in receptor activation in atomic detail computational techniques, such as molecular
dynamics (MD) simulations, will need to be employed.
As an example of a prototypical type-I cytokine receptor, Figure 1.4A shows the crystal structure
of the complex between EPO (red) and two sEPOR protomers (green and blue). As can be seen, each
soluble erythropoietin receptor (sEPOR) consists of two fibronectin type-III domains, labelled D1
(residues 1-117) and D2 (residues 122-226), represented in light and dark blue and green respectively.
These are joined by a four-residue linker region depicted as yellow and magenta spheres (residues
118-121) [5, 6, 7, 8]. The cytokine EPO is a member of the interleukin-2 cytokine family with the
typical coiled-coil four-helix bundle tertiary structure. To date, two alternative X-ray crystal structures
of sEPOR bound to EPO (sEPOR2-EPO) have been solved (Protein Data Bank (PDB) entries 1EER
and 1CN4) [7]. In both cases the overall arrangement of the molecules and the binding interfaces
between EPO and the two sEPOR molecules are similar [7]. As evident from Figure 1.4A, there are
two EPO:EPOR interfaces, referred to as site 1 and site 2 (S1 and S2 respectively) [7]. For the sEPOR,
the affinity at S1 is 1000 fold greater than at S2 (dissociation constants of 1 nආ and 1 μආ respectively)
[19]. Nevertheless, occupation of both the S1 and S2 sites is required for receptor activation. For
example, the mutation R103A in EPO abolishes binding at S2 resulting in an antagonistic ligand
[16]. The mechanism by which the binding of EPO to the EPOR forms an activated complex has
3
Fං඀ඎඋൾ 1.3: Proposed mechanisms of activation for the type-I cytokine receptors: (A) ligand-induced dimerisation, (B)
relative rotation of the receptor chains and (C) cross-action scissor-like motion. (D) Proposed rotation-based mecha-
nism of activation of the related growth hormone receptor [18]. The receptor chains A and B are coloured green and
blue respectively, and the cytokine is coloured red. The orange spheres represent the protein kinase domain of the JAK
protein associated with the cytosolic domains of the receptor that require the correct alignment of two domains in order
to transphosphorylate.
been the subject of continuing debate with a number of alternative models having been proposed
[16, 8, 20, 21, 22]. The main models of activation are ligand-induced dimerisation (Figure 1.3A)
[16], a change in the relative orientation of the receptor chains (Figure 1.3B) [21], and cross-action
scissor-like motion of the receptor chains (Figure 1.3C) [8, 20, 22].
The involvement of two receptor chains interacting with a single cytokinemolecule in the activated
type-I cytokine receptor complexes led initially to the widespread assumption that receptor activation
was the result of ligand-induced dimerisation (Figure 1.3A). Indeed, EPO has been observed to induce
the dimerisation of the sEPOR in solution [19]. The proposal that dimerisation was key to activation
was supported by the fact that antibodies generated against the extracellular domains of the GHR
and EPOR could activate the respective receptors [23, 24], and mutagenesis studies of the EPOR that
showed certain cysteine mutants capable of forming intermolecular disulphide bridges were constitu-
tively active [25]. However, other studies have shown that in the absence of cytokine, the receptors
could be found in the form of inactive dimers and oligomers on the cell surface [26, 27, 17]. The extent
to which the receptor exists as a preformed dimer continues to be debated. Recent single-molecule
fluorescence measurements suggest the EPOR may be primarily monomeric on the cell surface in
the absence of EPO [9]. That the receptors can exist as preformed dimers on the cell surface has led
some to suggest that the activation of the receptor is triggered by difference in the structure of the
dimer between the apo (unbound) and the holo dimer (cytokine-bound) rather than by the process of
dimerisation itself [20, 27, 17, 28, 29].
Experimentally, the activation of the EPOR dimer after EPO binding would appear to involve a
reorientation of the receptor molecules. Isothermal titration calorimetry and circular dichroism data
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Fං඀ඎඋൾ 1.4: Crystal structures of the soluble EPOR extracellular domain dimers. The extracellular domain is shown
bound to EPO (A), in the apo form (B), bound to an agonistic mimetic peptide EMP1 (C) and bound to an anagonist
mimetic peptide EMP33 (D) (PDB entries 1EER, 1ERN, 1EBP and 1EBA, respectively)[5, 6, 7, 8]. (A-D) Chains A
and B are shown in green and blue, respectively, and the ligand is shown in (A) red, (C) orange and (D) purple. The four
residues in the hinge region connecting the N-terminal D1 domain and the C-terminal D2 domain within a chain are
represented as yellow and magenta spheres in chain A and chain B respectively. Note, the extracellular juxtamembrane
region and the transmembrane and cytosolic domains are depicted schematically in (A). (E) Top view (looking down
onto the surface of the plasma membrane) of the two D1 domains in the EPOR dimer from the crystal structures of the
EPOR bound to EPO (blue), EMP1 (red), EMP33 (green) and in the apo state (magenta). The structures in (B-E) have
been aligned on the receptor chain A of (A) as a reference.
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of the EPO binding to a chimeric construct consisting of an sEPOR2 dimer fused to an antibody Fc do-
main suggest a conformational change within the dimer [30]. Furthermore, studies that were designed
to induce a relative rotation between the two transmembrane helices within the EPOR dimer [21],
and similar chimeric constructs with the GHR [18], could generate constitutively active or inactive
dimers. This suggests regulation of the activity of the dimer occurs through particular orientations of
the two receptor chains rather than merely bringing the two chains into close proximity. However,
the precise nature of the structural transition that leads to receptor activation upon ligand binding in
the case of the type-I cytokine receptors is not known. In the GHR, ligand binding is hypothesised
to result in the rotation and reorientation of the two extracellular domains with respect to each other
within the dimer, leading to the partial separation of the cytosolic domains that brings together the
protein kinase domains of JAK2 [18] (Figure 1.3D). This model is based on mutagenesis and Förster
resonance energy transfer (FRET) studies using fluorophore-labelled cytosolic domains. This model
is also supported by simulation studies of the holo and apo forms of the GHR extracellular domains
[31], which showed a spontaneous rotation of the extracellular domains on removal of the cytokine, in
line with experiment. Similar results were also obtained in the case of the prolactin receptor (PRLR)
[32].
The rotation between the GHRmolecules was proposed to bemediated in part via contacts between
the two D2 domains of the extracellular domains [17]. Whether a similar mechanism occurs in the
case of the EPOR is unclear. In the EPO-bound crystal structures of the sEPOR dimer, the two D2
domains do not form extensive contacts (Figure 1.4A). In fact, contacts in this region only occur
in one of the alternative crystal forms. For example, in the PDB entry 1EER the two D2 domains
form hydrogen-bonding interactions between Ser135 and Glu134, while in PDB entry 1CN4 the two
domains do not make contact [7]. This is in contrast to the extensive contacts observed in the crystal
structures of the homodimeric GHR bound to the growth hormone [33] and the prolactin receptor
bound to the placental lactogen or prolactin [34, 35]. It is all the more puzzling that the sEPOR chains
are arranged in a similar manner to the receptor chains in other structures of cytokine-bound type-I
cytokine receptors. Intriguingly, based on the crystal structure of the apo dimer of the sEPOR (Figure
1.4B), dimerisation was suggested to occur via the EPO-binding sites in the extracellular domains with
the termini of the D2 domains remaining separated in the inactive dimer [8]. A similar arrangement
of the receptor chains dimerising via the cytokine binding cite was observed for the apo dimer of the
interleukin-7 receptor subunit  (IL-7R) [29]. However, if these apo dimers are truly representative
of the inactive dimer on the cell surface it is unclear how the cytokine would initially bind and drive
the dissociation of the receptor chains to allow binding to the cytokine binding sites to then drive a
rearrangement between the two receptor chains.
Two further crystal structures of the sEPOR in complex with an erythropoietin mimetic peptide
(EMP) have been solved (Figures 1.4C and D) [5, 6]. Specifically, the agonist EMP1 and antagonist
EMP33. These EMPs are a part of a series of peptides that are 18-20 amino acids in length and
are unrelated to EPO. In these EMP-bound complexes precise differences in the arrangement of the
receptor chains were suggested to account for the activity of the ligands. To illustrate these different
arrangements an overlay of the positions of the D1 domains of all the structures is shown in Figure
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1.4E. The second sEPOR chain in the EMP33-bound dimer was calculated to be rotated 15° with
respect to the second chain in the EMP1-bound dimer when first fitted on a single sEPOR chain [6].
In the EPO-bound structure, there is a greater asymmetry with the two chains at an angle of about
120° [7], and in the cross-like structure of the apo the D1 domains are almost parallel but inverted [8].
These differences in the arrangement of the receptor chains in these X-ray crystal structures have not
only been suggested to account for the differences in the activity of the bound ligands but have also
been interpreted as inactive and active conformations of the receptor dimer (in particular the apo and
EMP1-bound EPOR dimers respectively) along a single trajectory involving a cross-action scissor-like
motion (Figure 1.3C) [8]. The cross-action scissor-like motion would require the two D1 domains to
move apart resulting in the two D2 domains (separated in the structure Figure 1.4B) being brought
closer together (as seen in Figures 1.4A, C and D) and allowing the interaction of the two cytoplasmic
domains [8, 20]. This would imply that EPOR operated via a fundamentally different mechanism
to that proposed for the widely studied GHR [18]. Interestingly, it was recently inferred from the
crystal structures of the sEPOR bound to three alternative diabodies that an activated complex of the
sEPOR could be formed with the D2 C-termini separated by over 13 nm [9]. Such an arrangement
would be in stark contrast to the active dimers proposed based on both the EPO and EMP1 complexes
and challenge the proposal that the separation of the D2 domains in the apo dimer was significant
in the regulation of the inactive dimer. The use of MD simulations to study these receptors can help
resolve any doubt as to whether the differences in the structures observed crystallographically are truly
significant differences that exist beyond the crystalline environment.
It is important to know whether these conformations of the receptors observed in the crystal struc-
tures are unique conformations in the presence and absence of agonistic and antagonistic ligands as
they have been given physiological significance when proposing mechanisms of activation such as
the cross-action scissor-like model for the EPOR. This becomes even more important when exper-
imental data are interpreted in light of these models. For example, the cross-action scissor model
was compatible with in vivo enzyme complementation experiments [20]. Specifically, chimeric con-
structs consisting of the EPOR extracellular and transmembrane domains linked to complementary
fragments of dihydrofolate reductase (DHFR) by a flexible linker of 5, 10, or 30 amino acids were
used to probe the activation of the receptor by fluorescence techniques. It was found that in the absence
of EPO or EMP1, the DHFR fragments did not associate when linked to the EPOR by 5 amino acids
whereas the longest 30-amino-acid linker was associated with functional DHFR. Addition of EPO
or EMP1 was able to generate a functional DHFR with the 5-amino-acid linker. From this, it was
claimed that only the cross-action scissor-like motion could account for the difference in activation of
EPOR. Intriguingly, a similar protein fragmentation complementation assay, in which the full-length
EPOR was fused to alternative -galactosidase fragments, suggested little to no EPOR dimerisation
in the absence of EPO or ligand [9]. It also suggested EMP33 could act as an agonist at sufficiently
high concentrations. It is unclear however, if this later study captured the event of activation via
ligand-induced dimerisation or the activation of a preformed dimer. In these assays detection of the
threshold of -galactosidase complementation is only detected at concentrations of EPO above 100 pආ
whereas phosphorylation of the EPOR could already be detected at concentrations of EPO as low as
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10 pආ (see fig. 1 of Ref. [9]). Together these data indicate that considering the mechanism of acti-
vation to be solely ligand-induced dimerisation is overly simplistic. The validity of the cross-action
scissor-like mechanism has also been brought into question by immunofluorescence experiments us-
ing EPOR-PRLR heterodimers which suggest that interactions between the transmembrane domains
play an important role in the dimerisation of the apo receptor [27], and studies of the self-association
of the EPOR transmembrane domains in isolation [36, 37]. The diverse range of dimer configurations
proposed to be active or inactive conformations and conflicting experimental data used to support
these models raises an important question of whether it is valid to interpret these structures observed
crystallographically as physiologically meaningful. Given the conflicting reports in the literature it
is unclear which mechanism is likely in the case of the EPOR and whether the type-I cytokine re-
ceptors do indeed have a similar mechanism of activation across the family. In order to understand
the dynamics involved in receptor activation MD will need to be employed. The EPOR provides a
novel opportunity to study the effects of ligands with varying activities on receptor activation as the
extracellular domain has been crystallised with several different agonistic and antagonistic ligands.
Further complexity in the activation of the type-I cytokine receptors arises when the effects of
the membrane are considered. As noted above, although only one model of a full length receptor
has been generated based on experimental data, attempts at linking the extracellular domain obtained
from X-ray crystal data to a modelled transmembrane domain have been done for the GHR and PRLR
[18, 32]. In this case, only the PRLR system has been studied by MD simulations [32]. In both in-
stances however, the transmembrane domain was only considered in a pure phosphatidylcholine (PC)
lipid bilayer. It has been observed for the EPOR that upon stimulation with EPO, the receptor colo-
calises with membrane rafts and that rafts are required for signalling [38]. It is therefore necessary to
examine and compare the structure and behaviour of these receptor complexes in alternativemembrane
environments including a raft environment. MD simulations is a method of choice to yield exquisite
details on the structure and dynamics of these receptors in different membrane environments. This
however requires the development and validation of lipid force field parameters prior to investigating
the properties of raft-like model membranes and protein behaviour in raft-like membranes.
1.1.2 Membrane rafts and sphingomyelins
The type-I cytokine receptors transfer the activation signal through the plasma membrane of the cell.
The plasma membrane consists of a lipid matrix in which cell-surface proteins along with a wide va-
riety of other proteins are embedded or associated. Within the membrane are patches of ordered lipids
ranging between 20-200 nm in diameter and referred to as membrane rafts. Rafts organise and com-
partmentalise cellular processes and potentially regulate protein activity [39, 40]. These membrane
rafts are generally richer in sphingolipids and cholesterol compared to the bulk membrane composed
predominantly of PCs. The higher degree of order in these rafts is suggested to result from the intrinsic
features of the sphingolipids compared to the PCs, as well as favourable interactions between sphin-
golipids and cholesterol. Initially recognised for having important roles in membrane trafficking [39],
membrane rafts have been implicated as essential to the functioning of numerous receptor and trans-
porter proteins, for example the T-cell antigen receptor and CD20 [41, 42]. Indeed, the EPOR, which
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co-localises with membrane rafts upon cytokine binding, loses the ability to signal when cholesterol
is depleted from the cell [38]. This suggests involvement of the membrane environment in modulat-
ing type-I cytokine receptor structure and function during activation. While potential differences in
the conformation of the receptor complex in different lipid environments may be observable via tech-
niques such as cryo-electron microscopy, the use of MD provides a unique opportunity to study the
dynamics and interactions of the receptor and lipid components in atomic detail. Of particular interest
is how these receptors behave in the presence of an order-enhancing lipid such as the sphingolipid
sphingomyelin.
A major component of membrane rafts is the sphingolipid family of lipids that is based on the
molecule sphingosine. Sphingomyelins are the predominant phospholipid in this family and are gen-
erated by the addition of a phosphocholine group and an acyl chain to the sphingosine backbone
(Figure 1.5). Within the sphingomyelins the length of the acyl chain varies with tissue type, for ex-
ample the acyl chains palmitoyl and stearoyl are predominantly found in erythrocytes and nervous
tissue respectively [43, 44, 45]. The major chemical differences between a typical sphingomyelin,
such as N-palmitoyl-ൽ-erythro-sphingomyelin (PSM) (Figure 1.5), and a glycerophospholipid, such
as 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) (Figure 1.5B), are the degree of acyl
chain saturation, configuration of the carbon-carbon double bond and the number of H-bond donor
and acceptor groups (for completeness the structure of the sterol cholesterol is also shown in Figure
1.5C). Sphingomyelins tend to have a higher degree of saturation in the acyl chain, and the double
bond in the sphingosine is in the trans configuration. In contrast POPC has an unsaturated carbon
chain with the double bond in the cis configuration. Sphingomyelins also have both both H-bond
donor (hydroxyl and amide hydrogens) and H-bond acceptor (amide carbonyl oxygen) group, while
glycerophospholipids only have the H-bond acceptor (carbonyl oxygen) groups. These properties
promote tighter packing of the lipids and result in a higher gel-to-liquid-crystalline melting tempera-
ture allowing the lipids to phase-separate at physiological temperatures with the bulk membrane and
form the rafts. As well as having a higher degree of order than the bulk membrane, rafts tend also
to be thicker. What remains unclear is whether membrane proteins, in particular the type-I cytokine
receptors, require the presence of a particular lipid molecule or the general structural properties of
membrane rafts (e. g. ordering and thickness) in order to function. Studying the type-I cytokine recep-
tors by MD simulations in bulk and raft-like membrane is essential to elucidate the critical regulatory
properties of the membrane environment on the receptors in atomic detail.
1.2 Molecular Modelling and Dynamics
1.2.1 Molecular dynamics
Despite extensive research into the activation of the type-I cytokine receptors the precise structural
changes in the receptor complex after ligand binding that lead to activation have not been determined.
This is due in part to the limits of resolution achievable by experimental approaches. To understand
the activation of these receptors as a mechanical process requires the use of computational tools, in
9
Fං඀ඎඋൾ 1.5: Molecular structure of a sphingomyelin (A), a phosphatidylcholine (B) and cholesterol (C). Highlighted are
the phosphocholine headgroup (orange), sphingosine backbone (blue), glycerol backbone (red) and acyl chains (green
and purple).
particular molecular dynamics (MD) simulations techniques. MD essentially treats a protein as a
series of interconnected soft spheres with empirically derived and theoretical functions to describe the
interactions between the particles. By assigning all the atoms in the system initial velocities, Newton's
Equations of motion are solved by finite difference methods to propagate the system through time,
which generates a trajectory that describes how the system changes with time. The receptors can
therefore be modelled in a range of different environments, e. g. solution, crystalline or membrane-
embedded, to examine their dynamical behaviour and how the environment influences the receptor
complex. This section will provide an overview of MD theory [46, 47] beginning with Newton's Laws
of Motion:
1. When viewed in an initial reference frame, an object either remains at rest or continues to move
at a constant velocity, unless acted upon by an external force.
2. The vector sum of the external forces F on an object is equal to the mass m of that object
multiplied by the acceleration vector a of the object: F = ma.
3. When a body exerts a force on a second body, the second body simultaneously exerts a force
equal in magnitude and opposite in direction on the first body.
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From the second law it can be shown the rate of change in the position of a particle with mass mi
along the coordinate xi will have the directional force Fxi .
d2xi
dt2
=
Fxi
mi
(1.1)
The total force acting on the particle changes with its position and the positions of any interacting
particles. The interactions between particles during MD are described by a force field. Classical force
fields use empirically derived and theoretical functions to calculate the forces from bonded and non-
bonded interactions between atoms in the electronic ground state. Using the GROMOS forcefield
[48] as an example, the total potential energy (Vtotal) for a system is calculated as the sum of bonded
and non-bonded terms, represented schematically in Figure 1.6. The bonded terms consist of covalent
bonds (Vb), bond angles (Va), dihedral angles (Vd) and improper dihedral angles (Vi). Non-bonded
terms consist of van der Waals interactions, which are the short-range repulsion and long-range dis-
persion interactions approximated using the Lennard-Jones potential (VLJ ), and Coulomb interactions
(VC) between charges or partial charges on atoms.
Fං඀ඎඋൾ 1.6: Illustration of the bonded and non-bonded terms used in the GROMOS forcefield.
Vtotal = Vb + Va + Vd + Vi + VLJ + VC (1.2)
Vb has a harmonic potential of the form:
Vb(ri; rj) =
1
2
kb(r   b0)2 (1.3)
where kb is the bond stretching force constant, b0 is the bond length at equilibrium and r is the distance
between the two atoms (i; j) with the coordinates ri and rj:
r = jri   rjj (1.4)
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Va has a harmonic potential of the form:
Va(ri; rj; rk) =
1
2
k(   0)2 (1.5)
where k is the bond angle force constant, 0 is the bond angle at equillibrium and  is the angle
between atoms (i; j; k) with the coordinates ri, rj and rk calculated from the dot product:
 = arccos rij  rjkkrijkkrjkk (1.6)
Vd maintains the torsional angle between the atoms (i; j; k; l) and is given by the periodic function:
Vd() = k(1 + cos(n  0)) (1.7)
where k is the dihedral force constant, 0 is the dihedral angle at equilibrium, n is the periodicity
(number of maxima and minima) of the potential between 0 and 2, and  is the angle between the
two planes (i; j; k) and (j; k; l) is calculated from the dot product:
 = arccos oijk  pjklkoijkkkpjklk (1.8)
where oijk and pjkl are the normals to the planes.
Vi maintains chirality and planarity of groups of four atoms i; j; k; l and has the harmonic form:
Vi =
1
2
k(   0)2 (1.9)
where  is the angle between the planes (i; j; k) and (j; k; l), 0 is the improper dihedral force constant
and 0 is the dihedral angle at equilibrium. The angle  is calculated using the dot product in Equation
(1.8)
The van de Waals interactions between two atoms i; j are approximated using a Lennard-Jones
potential of the form:
VLJ(r) = 4
h
r
12
 

r
6i
(1.10)
where  is the measure of attraction between the two atoms i and j,  is the distance at which the inter-
molecular potential between atoms i and j is zero, and r is the distance between the atoms (Equation
(1.4)).
The Coulomb potential between two atoms i; j has the form:
VC(r) = fel
qiqj
"rr
(1.11)
where qi and qj are the charges on the atoms, fel = (4"0) 1, "0 is the physical constant of the dielectric
permittivity in vacuum, "r is the relative dielectric permittivity and r is the distance between the atoms
(Equation (1.4)).
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To begin the simulation, the atoms in the system are assigned initial velocities using a Maxwell-
Boltzmann distribution centered around the temperature (T ) of reference:
p(vix) =
 mi
2kBT
 1
2 exp
"
  1
2
miv
2
ix
kBT
#
(1.12)
where p(vix) is the probability that an atom i with massmi has a velocity vix in the x direction. kB is
the Boltzmann constant.
The system is then propagated through time by using a discrete time step (t). The total force on
each particle in the system at time t is calculated as the vector sum of its interactions with all other
particles. The calculated forces are used to determine the acceleration of the particles. Combining the
new accelerations with the known positions and velocities at time t the new positions and velocities
at t + t are calculated. The forces at time t + t are then used to calculate the new positions and
velocities at time t+ 2t ad infinitum [46].
The MD simulation software package GROMACS [49, 50] implements the leap-frog algorithm
[51], a variant of the Verlet algorithm [52] for integrating the equations of motion. The underlying
assumption of these algorithms is the positions, velocities and accelerations can be approximated by
Taylor series expansions:
r(t+ t) = r(t) + tv(t) + 1
2
t2a(t) + 1
6
t3b(t) : : : (1.13)
v(t+ t) = v(t) + ta(t) + 1
2
t2b(t) : : : (1.14)
a(t+ t) = a(t) + tb(t) : : : (1.15)
v is the velocity (first derivative of the positions with respect to time), a is the acceleration (second
derivative) and b the third derivative. The Verlet algorithm obtains the new positions r(t + t) by
adding the positions and accelerations at time t and the previous positions and accelerations at time
t  t:
r(t+ t) = r(t) + tv(t) + 1
2
t2a(t) + 1
6
t3b(t) +O(t4) (1.16)
r(t  t) = r(t)  tv(t) + 1
2
t2a(t)  1
6
t3b(t) +O(t4) (1.17)
r(t+ t) = 2r(t)  r(t  t) + t2a(t) +O(t4) (1.18)
The velocities are obtained from the Verlet algorithm by dividing the difference in positions at t+ t
and t  t by t (Equation (1.19)), or estimated during the half-step t+ 1
2
t (Equation (1.20)):
v(t) = [r(t+ t)  r(t  t)]
2t
(1.19)
v(t+ 1
2
t) =
[r(t+ t)  r(t)]
t
(1.20)
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A major limitation of the Verlet algorithm is that the velocities are not used in the propagation of the
positions and as a consequence it is not possible to regulate the temperature of the system during a
simulation. To address this issue a number of other algorithms have been proposed. For example,
the leap-frog algorithm uses the velocities at time t   1
2
t and accelerations at time t to calculate the
velocities at time t+ 1
2
t which are used to update the positions r(t+ t):
v(t+ 1
2
t) = v(t  1
2
t) + ta(t) (1.21)
r(t+ t) = r(t) + tv(t+ 1
2
t) (1.22)
Many biophysical properties are dependent on the temperature and pressure, for example phase
transitions in lipid bilayers. Several algorithms can be implemented to maintain the temperature and
pressure in molecular dynamics simulation. The Berendsen thermostat uses the concept of an external
heat bath that can provide or remove heat as required [53]. The velocities are scaled by a factor  such
that the rate of change is proportional to the difference between temperature of the bath (Tbath) and
the temperature of the system (T ).
2 = 1 +
t
T
Tbath
T (t)
  1

(1.23)
Similarly, the Berendsen barostat couples the pressure to a pressure bath by scaling the atomic coor-
dinates which is effectively scaling the volume of the system [53]. The pressure scaling factor is:
 = 1   t
P
(P   Pbath) (1.24)
where  is the isothermal compressibility, usually of water ( 4:5  10 5atm 1). T and P are
coupling constants that determine how strong the coupling is between the scaling factor and the time
step.
Fං඀ඎඋൾ 1.7: Periodic boundary conditions are created by surrounding a system (red box) with translated copies (dashed
boxes) of itself in all directions. Any movement of a molecule outside the box is translated to the other side of the box
as indicated by the arrows.
To eliminate edge of a box artefacts in molecular dynamics simulations themolecules are subjected
to periodic boundary conditions. The system is placed within a space-filling unit cell or box and then
surrounded by translated copies of itself, which in effect mimics an infinitely large system (Figure
1.7). This removes the effect of molecules hitting artificial boundaries or walls in the system and
is not only beneficial but essential in simulations of environments such as lipid bilayers and protein
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crystals. A cost of using periodic boundary conditions is the system must be sufficiently large enough
to prevent a molecule from seeing or interacting with its periodic image.
By careful and thoughtful construction of a molecular system, MD simulations provide a tool
to study biological process in atomic detail. For example, by exploiting the effects of the periodic
boundary conditions in two dimensions one can transform a small patch of a lipid bilayer into what
can essentially be considered a membrane. Furthermore, a crystal lattice can be created by simply
simulating a single unit cell under periodic conditions in three dimensions. MD is therefore an ap-
propriate and powerful tool to use to probe some of the questions that arise from the literature on
the type-I cytokine receptors: (i) are crystal structures of the EPOR appropriate models for active and
inactive conformations of the receptor? (ii) does the membrane environment influence the receptor be-
haviour? (iii) how do the receptors mechanically send a signal from the extracellular domain through
a membrane via the transmembrane region?
1.2.2 X-ray crystallography
Molecular modelling aims to provide a (relatively) simple atomic description of a molecular system
that can be used for behaviour and structure prediction. While MD simulations can investigate the
dynamics of a protein, it is heavily reliant on the initial coordinates of the models for the molecules
used to build the system. By far the most common technique for generating a model of a protein
structure is X-ray crystallography, which has been used to generate over 90% of the more than 100,000
structures in the Protein Data Bank. To obtain a model of a protein by X-ray crystallography, the
protein must first be purified and concentrated into a supersaturated solution that can be forced to
phase separate into a protein-rich phase (the protein crystal) and a saturated protein solution. This
separation can be caused, for example, by gradually evaporating the solvent. The protein crystal
is comprised of the protein molecule periodically arranged in space with, on average, 50% solvent in
large channels between the stacked protein molecules. Structural information about the atom positions
within the crystal is generated from exposure of the crystal to intense X-ray radiation from multiple
angles with the scattered reflections detected (Figure 1.8) [54]. The X-ray diffraction pattern can be
described using Bragg's law (Equation (1.25)):
n = 2d sin  (1.25)
At a particular incidence angle () of a radiation beam with a wavelength , two reflecting planes
within the crystal will produce constructive interference when separated by a certain distance (d)
resulting in intense peaks of reflected radiation. In Equation (1.25) n is an integer.
Each reflection is indexed according to the number of times a set of reflecting planes intersects the
respective a, b or c axis of the unit cell ((hkl) where h, k and l are all integers). The unit cell being the
smallest number of asymmetric units that can reproduce the crystal lattice by only using translational
operations (Figure 1.9). Also measured is the intensity of the reflection, which is proportional to the
square of the structure factor for the reflection. The structure factor (Fhkl) for a given reflection is a
summation of the scattering factor (fj) over all atoms j with their x; y; z fractional coordinates (Equa-
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Fං඀ඎඋൾ 1.8: Bragg diffraction giving rise to an X-ray diffraction pattern. Image of X-ray diffraction from RPP1 NdA TIR
domain, courtesy of Adam Bentham.
tion (1.26)). fj is the scattering factor for atom j and is dependent on the atom type and diffraction
angle of the reflection hkl.
Fhkl =
atomsX
j=1
fje
2i(hxj+kyj+lzj) (1.26)
Fං඀ඎඋൾ 1.9: A unit cell of a crystal of the erythropoietin receptor in complex with erythropoietin (PDB entry 1EER)
[7]. The crystal lattice is generated by translational operations of the unit cell. The unit cell itself is generated by
translational and rotational operations (symmetry operations) performed on the asymmetric unit. The four asymmetric
units coloured red, blue, green and yellow each contain two receptor chains and one erythropoietin molecule.
The structure factors are thus dependent on the local electron density at a given point in space.
It becomes evident from Equation (1.26) that if the structure is known the structure factors can be
calculated. X-ray crystallography deals with the inverse problem of determining the structure (or
electron density ()) from the structure factors. By applying a Fourier transformation to Equation
(1.26) the following formula is obtained:
(x; y; z) =
1
V
X
h
X
k
X
l
Fhkle
 2i(hx+ky+lz) (1.27)
This provides the electron density () as the sum of the structure factor (Fhkl) in electrons di-
vided by the volume (V ) of the unit cell. However, Equation (1.27) is expressed in terms of complex
structure factors and the experimental data only provides the magnitude of the structure factors jFhklj.
16
Alternatively, this problem can be expressed by noting the absolute value of the complex vector Fhkl
can be determined experimentally but not its phase hkl. The phase is determined by the distance
between the crest of the emitted wave and a point of reference common to all the emitted X-rays. If
the phases can be estimated, for example by proposing a given structure of the protein, they can be
combined with the magnitudes to generate the electron density (Equation (1.27)):
(x; y; z) =
1
V
X
h
X
k
X
l
jFhklje 2i(hx+ky+lz hkl) (1.28)
Fං඀ඎඋൾ 1.10: Electron density map generated during refinement. Image courtesy of Shane Horsefield.
One method for estimating the phases is multiple isomorphous replacement where there are two
crystals of the same protein, except in one a specific atom within the protein has been replaced by a
heavier atom, for example mercury. This method exploits the fact that the heavy metal dominates the
observed diffraction pattern and thus the location of the heavy atoms can be obtained directly. These
can then be used to solve the rest of the structure using Equation (1.29).
FH+Phkl = F
P
hkl + F
H
hkl (1.29)
Where FH+Phkl is the reflection from a crystal containing a heavy metal, F Phkl is the same reflection
from a crystal without the heavy metal and FHhkl is a theoretical reflection of a crystal containing only
the heavy metal atoms and at the same locations as in theH +P crystal. By determining the location
of the heavy metal atoms in the unit cell from multiple isomorphous crystals, the structure factor
amplitude and phases can be calculated for FHhkl. These in turn can be used to determine the phases
for the FH+Phkl and F Phkl using vector addition.
Once the electron density map has been generated a crystallographic model is made by building the
known protein sequence into the electron density (Figure 1.10). Subsequent rounds of refinement can
be carried out by systematically adjusting the atomic positions and the amplitudes of the reflections
by comparing the theoretical reflections calculated from the model to the experimental data. X-ray
crystal structure of a protein can then be presented as stylised traces of the backbone atoms to illustrate
protein folding or as a space filling model such as the Corey, Pauling and Koltun (CPK) model that
reveals information about the surface of the protein (Figure 1.11).
Unlike crystals of, for example, sodium chloride (NaCl) where each sodium and chloride ion in
the unit cells are essentially identical, each protein molecule in the unit cell varies slightly. This
variation is a result of static disorder, in which the protein molecules have a different conformation
or arrangement in each unit cell, and dynamic disorder as a result of thermal motion. These slightly
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Fං඀ඎඋൾ 1.11: Representation of the crystal structure of EPO as (A) a cartoon highlighting secondary structure elements,
or (B) a CPK model revealing a surface of the protein. Both (A) and (B) are taken from the same view of EPO from
the Protein Data Bank entry 1EER [7].
alternative arrangement of atoms affect the scattering of the waves emanating from the crystal. To
limit the effect of thermal motion the protein crystal is usually kept under liquid nitrogen during data
collection, however flexible regions of the protein are frozen in multiple configurations and have a
higher degree of uncertainty compared to more rigid regions. This means that the model structure will
not only be an average structure of the unit cell over time during X-ray diffraction but also spatially
within the crystal. To give a relative measurement of the atomic displacement of each heavy atom in
the protein crystal, aB-factor is calculated for each atom. TheB-factor is often interpreted as indicating
increased areas of flexibility or dynamics. However, whilst X-ray crystallography is a powerful tool
for determining protein structure, it only provides very limited information about protein dynamics. In
fact analysis of multiple crystal structures indicated that atoms involved in crystal contacts had lower
B-factors than those without contacts indicating that the assignment of B-factors is heavily dependent
on the packing within the crystal [55]. This makes it difficult to discern in some cases if a region of a
protein is more flexible than another by considering the X-ray structure alone.
A commonmethod that has been believed to yield details of the dynamicswithin proteins is to solve
multiple crystal structures of the same protein in different conditions. Indeed the structure of hen egg
white lysozyme has been know for over 50 years, yet more recent structures produced under high-
pressure have revealed novel conformations of the catalytic residues [56]. In the case of the EPOR
alternative conformations of the receptor dimer solved under different conditions have been considered
by some to be snapshots of the receptor complex along a single action pathway and used to propose a
mechanism of action for the EPOR [8]. This assumes all the conformations of the protein within the
crystal are not only of physiological significance but that straight (non-physical) linear interpolations
between two crystal structures can be taken as dynamical processes. Specifically, the sEPOR-EMP1
complex involves two large receptor molecules and two small ligand molecules arranged within a
crystalline environment. The individual contributions of the ligand molecules and the crystal packing
forces to the overall arrangement of the complex are not known and whether the complex has a similar
arrangement outside of a crystal has not yet been determined. While there are many metrics that can
be used during the generation of a model structure from X-ray data to increase the reliability of the
structure, such as Ramachandran plots, clash scores andR-values, these do not provide information on
the biological significance of an X-ray crystal structure. To study the dynamics of proteins in atomic
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detail and determine physiologically significant conformations the use of computational techniques
such as MD simulations are required.
1.3 Aims and Objectives of this Thesis
The overarching aim of this thesis is to better understand how the type-I cytokine receptors mechani-
cally couple the event of a ligand binding to the extracellular domain to activation of the intracellular
domains through a cell membrane.
Specific aims and objectives:
1. The first aim of the thesis is to determine whether the X-ray crystal structures of only the extra-
cellular domain from the EPOR are appropriate models of the active and inactive conformations
of the receptor complex. This will be achieved through a re-examination of the crystal struc-
tures and MD simulations of the receptor complex in solution bound to a series of agonistic and
antagonistic ligands.
2. The second aim of the thesis to to ensure the models of the X-ray crystal structures of the EPOR
have been modelled appropriately and that the force field is suitable for simulating these pro-
teins. This will be achieved by recreating the crystal lattice of the models containing the EPOR
as well as a high resolution crystal structure of bovine pancreatic trypsin inhibitor (BPTI).
3. The third aim of the thesis is to understand the influences of the membrane and lipid composition
has on the behaviour of the type-I cytokine receptors. This will be achieved by simulation of
the transmembrane domain in a variety of lipid bilayers. This will also require the generation
and validation of parameters for sphingomyelin to be used in the raft-like bilayers.
4. The final aim of the thesis is to determine how the transmembrane domains are orientated in
a dimer complex and how they are coupled to the extracellular domain. This will be exam-
ined by modelling the transmembrane domains in chimeric constructs such as the Jun and Put3
dimers. The linkage between the two domains will be studied by modelling the linker as a loop
or continuation of the transmembrane domain helix.
1.4 Thesis Outline
Chapter 1: Introduction.
Chapter 2: Revisiting the Scissor-Like Mechanism of Activation for the Erythropoietin Receptor. This
chapter reviews the support for the scissor-like mechanism and re-examines the crystal structures upon
which the model was originally based.
Chapter 3: Do X-ray Crystal Structures of Protein Complexes with Agonistic and Antagonistic Lig-
ands Truly Represent Active and Inactive Conformations? The Erythropoietin Receptor a Case Study.
In this chapter the X-ray crystal structures of the EPOR are examined free in solution.
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Chapter 4: Can the Models of the X-ray Crystal Structures for the Erythropoietin Receptor Repro-
duce the Crystal Lattice? In this chapter the X-ray crystal structure containing the EPOR are used to
recreate the crystal lattice the stability of which is tested using MD simulations.
Chapter 5: Does the Membrane Environment Affect the Structural Properties of the Type-I Cytokine
Receptor Transmembrane Domains? In this chapter the influence of cholesterol in the membrane on
the transmembrane domain from several type-I cytokine receptors is examined.
Chapter 6: Generation and Validation of Palmitoyl Sphingomyelin Parameters and Lipid Raft-Like
Bilayers. This chapter is dedicated to generating and validating parameters for sphingomyelin that are
to be used in raft-like bilayer for MD simulations.
Chapter 7: What are Active Conformations of a Type-I Cytokine Receptor Transmembrane Domain
Dimer? This chapter examines transmembrane domain dimers of the IL-7R, GHR and EPOR.
Chapter 8: Conclusions and perspectives
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Chapter 2
Revisiting the Scissor-Like Mechanism of
Activation for the Erythropoietin Receptor
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2.1 Does the Erythropoietin Receptor Activate via a Scissor-like
Mechanism?
2.1.1 History of the scissor-like model
In 1999, an article published in Science by Livnah et al. [8] proposed a potential mechanism for the
activation of the erythropoietin receptor (EPOR) in which it was suggested that the binding of the
cytokine induced a scissor-like motion of the two receptor domains within the receptor dimer. This
model was based on an interpretation of differences between crystal structures of the EPOR dimer with
and without the agonist erythropoietin mimetic peptide 1 (EMP1) (Figure 2.1). The article was also
published back-to-back with an experimental study by Remy et al. [20] who used a protein fragment
complementation assay to suggest the unliganded receptor could exist as a preformed dimer on the
cell surface in a conformation in which the associated Janus kinase (JAK)2 molecules did not become
transphosphorylated (activated). It was one of the first models to be proposed that could account for
how the binding of a cytokine to a preformed receptor dimer might lead to activation. At the time,
it was novel and attracted considerable attention and, according to the Web of Science, the work of
Livnah et al. [8] has been cited over 430 times. This scissor-like model continues to be propagated.
Not only is it still being reproduced in literature reviews [57] and cited to describe the intracellular
domains of the receptor dimer moving into proximity of each other upon erythropoietin binding [58],
but has in recent years also been used to interpret data on bacterial two-component systems [59] and
even on T cell receptors [60]. For example, McElroy et al. [29] used the work of Livnah et al. [8]
on EPOR to propose a scissor-like model to interpret crystal structures for the interleukin-7 receptor
subunit  (IL-7R) (a related type-I cytokine receptor) with direct parallels being drawn between the
two systems. This is concerning as the scissor-like model appears to be being invoked without proper
consideration as to whether the proposed model is physiologically reasonable, or whether the model
as originally proposed by Livnah et al. [8] is even compatible with what is currently known regarding
the EPOR and other type-I cytokine receptors.
The scissor-like model of activation was proposed following a suggestion that preformed receptor
dimers of the surface of the cell would be required to explain why erythropoietin binding to both the
high- and low-affinity sites was required for activation [19]. At the time it was widely believed that
signalling was initiated by the bringing together of the intracellular JAK2 molecules associated with
the receptor cytosolic domains, and that these would need to be separated in the apo (unliganded)
state. The structural basis on which the scissor-like model was proposed is illustrated in Figure 2.1,
which is a recreation of fig. 1 of Livnah et al. [8]. On the left of Figure 2.1A is a backbone trace of
the X-ray crystal structure of the apo dimer showing that the extracellular domains of two receptor
molecules (chains A and B) adopt a cross-shaped arrangement in which the membrane-proximal D2
subdomains (D2A and D2B) are widely splayed. In this arrangement the two equivalent C-terminal
residues (Thr220) from each chain, to which the transmembrane helices are connected, are separated
by 7.3 nm. In the left panel of Figure 2.1B, is the backbone trace of the X-ray crystal structure of the
EPOR dimer bound to the agonist EMP1. In this structure the D2A and D2B subdomains lie close
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Fං඀ඎඋൾ 2.1: The projection of the crystal structure as presented in fig.1 1 from Livnah et al. [8] of (A) the apo EPOR
dimer and (B) the EMP1-bound EPOR dimer illustrating the proposed scissor-like motion. Chain A is coloured orange
in both (A) and (B) while chain B is coloured blue in (A) and green in (B). The black arrows indicate the membrane-
proximal C-terminal ends of the D2 subdomains in each EPOR molecule. The distances between these two residues
were calculated as 7.3 and 3.9 nm for the apo and EMP1-bound dimer respectively [8].
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together with the C-terminal residues (Thr220) separated by just 3.9 nm [8]. On the right of Figure
2.1A and B is a recreation of the schematic from fig. 1 of Livnah et al. [8] of the receptor complex in
relation to the membrane surface. As presented, it is easy to imagine the intracellular region and the
associated JAK molecules being held apart by the extracellular domain of the receptor, and that the
binding of ligand would lead to a reorganisation of the receptor molecules bringing the D2A and D2B
subdomains closer together via a scissor-type motion. This could allow the transphosphorylation of
the JAK2 molecules and subsequent signalling via the signal transducer and activator of transcription
(STAT)5 pathway [8].
2.1.2 Experimental data conflicting with the scissor-like model
However, there are several difficulties with the scissor-like model for the EPOR. The model is based
primarily on the differences between the structure of the apo dimer and the structure of the agonist
EMP1. When the model was proposed, the structure of the EPOR bound to erythropoietin and also
the structure of the EPOR bound to the antagonist EMP33 were also known. In the EMP33-bound
structure, the EPOR chains are aligned in a manner more similar to the EMP1-bound structure than to
the apo dimer. Despite the EMP33 complex being inactive, the D2 subdomains do not have the wide
separation observed in the apo form. In fact, the distance between the C-terminal residues (Thr220)
in the EMP33-bound structure is also 3.9 nm. The explanation offered by Livnah et al. [8] to account
for the fact the EMP33-bound complex was inactive was that this complex is not as symmetric as
that of EMP1. This explanation is difficult to reconcile with the fact that at the time it was known
that in the EPO-bound EPOR structure the two receptor chains are asymmetrically arranged in the
complex [7]. The authors also mentioned that the receptor-receptor contacts in the apo dimer were
very similar to those used to bind EMP1, EMP33 and erythropoietin [8]. Atanasova and Whitty [61]
noted this receptor-receptor contact surface occludes the binding site making it difficult to understand
how erythropoietin or the EMPs bind to the preformed dimer in such a state.
Further difficulties with the scissor-like model for the EPOR have emerged over the last decade.
First, the model assumes that it is the bringing together of the JAKs which leads to activation, while
extensive studies on the closely related growth hormone receptor (GHR) have demonstrated that
transphosphorylation is associated with the partial separation of the JAK2s which form a tight com-
plex in the inactive state of the receptor [18]. Given the structural similarity between the extracellular
domains of these two receptors and that signalling occurs through JAK2 in both cases, it is unlikely
that inhibition and activation of the JAK2 is occurring through fundamentally different mechanisms.
Indeed, Waters et al. [62] have created chimeras where the GHR extracellular domain has been re-
placed with the extracellular domain of the EPOR. These chimeras could activate GHR signaling
in response to the agonist EMP1 but not the antagonist EMP33. This would suggest the transmem-
brane and intracellular regions of the type-I cytokine receptors are being activated by a conserved
mechanism.
Second, in the structure of the apo dimer the D2 subdomains are widely splayed. This implies
that the extracellular domains of the EPOR must self-associate strongly to maintain both this con-
formation and drive the formation of the inactive dimer on the surface of the cell. Experimentally it
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has been shown that the extracellular domains interact weakly and that the formation of the preformed
dimers appears to be driven primarily by the interactions between the transmembrane domains [27]. In
addition, mutagenesis studies in which cysteine residues were introduced into the transmembrane do-
mains in order to crosslink the receptors by inducing disulfide bridges, have demonstrated that simply
bringing the D2 subdomains together is insufficient for receptor activation [63].
2.1.3 Re-examination of the erythropoietin receptor crystal structures
A final difficulty with the scissor-like model for EPOR also becomes apparent if one re-examines the
original structures on which the model was based. The projections of the two crystal structures shown
in Figure 2.1, and in fig. 1 from Livnah et al. [8] give the impression that the transition between the
two alternative arrangements of the receptor extracellular domains is associated with a motion of the
transmembrane domains of approximately 3 to 4 nm. This was reinforced by the simple 2D schematic
of the mechanism provided by Livnah et al. [8]. What is not captured in either of the projections or
the original schematic is that the C-terminus of chain B lies on alternative sides of the chain A in the
two structures. The differences between the arrangements of the receptors in the two structures can
be readily seen in the alternative projections shown in Figure 2.2. From the side projections in Figure
2.2A it can be seen that in the proposed inactive apo dimer, the D2B subdomain projects behind and
away from the D2A subdomain. In contrast, the same projection of the proposed active EMP1-bound
dimer, shown in Figure 2.2B, has the D2B subdomain projecting to the front of the D2A subdomain.
Furthermore, the D2B subdomain is not in direct contact with the D2A subdomain as suggested in the
projection shown in Figure 2.1B. The significance of D2B subdomains lying on opposite sides of chain
A is that these two alternative arrangements of the EPOR molecules cannot be generated by simply
changing the distance between the D2 subdomains by just 3 to 4 nm through a scissor-like motion.
This can be clearly seen in Figure 2.2C, which shows an overlay of the two structures fitted on chain
A. As shown in Figure 2C the linear distance between the C-terminal residues (Thr220) of the D2B
subdomains from the apo and EMP1-bound dimers is 8.3 nm. Assuming that the receptor complex
could undergo a scissor-like motion, following the associated radial path required on the surface of the
membrane would mean the transmembrane domains attached to the C-termini of the D2 subdomains
would have to move a combined distance of over 13 nm through a membrane environment (Figure
2.3). Considering the relative size of the EMP1 to the EPOR extracellular domain and the attached
cytosolic region and JAK2 molecules this scissor-like motion seems impossibly large.
2.2 Conclusions
When the scissor-like model for the activation of the EPORwas initially proposed over 15 years ago, it
was novel and could explain much of the experimental data available at the time. Its rapid acceptance
reflected the fact that it could reconcile the widely held assumption that transphosphorylation required
the JAKs to be brought together and the suggestion that the receptors could reside on the surface of cells
as inactive, preformed dimers. The crystallographic studies on which the model was based represented
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Fං඀ඎඋൾ 2.2: Front and side projections of (A) the apo EPOR dimer and (B) the EMP1-bound EPOR dimer after super-
imposition of the two structures onto chain A. The third panels of (A) and (B) are schematics of the rear and forwards
projection of the D2B subdomain relative to chain A in the apo and EMP1-bound crystal structures respectively. (C)
The overlay of the two structures shown in (A) and (B). The calculated linear distance between the -carbon of Thr220
in the apo (blue) and EMP1-bound EPOR (green) chain Bs is 8.3 nm. The arrows indicate the membrane-proximal
C-terminal ends of the D2 subdomains in each EPORmolecule. In (B) and (C) the EMP1 molecules have been omitted
for clarity.
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Fං඀ඎඋൾ 2.3: A 3D schematic of (A) the apo dimer transitioning via a scissor-like motion to (B) the EMP1-bound dimer in
a membrane. The combined radial distance between the C-termini of the two structures is over 13 nm. The two planes
indicate the surface of the membrane.
amajor scientific advance and a unique source of high-resolution structural data. However, at the same
time the model was highly idealised. As shown in Figure 2.2, the motions proposed do not directly
account for the differences between the two crystal structures on which the model was based. In
addition, one might question whether it should even be expected that the structures of the extracellular
domains with and without cytokine truly represent active and inactive conformations of the receptor.
Such an assumption not only implies that the transmembrane domains and the membrane itself play
only a minor role in the organisation of the extracellular domains but also neglect the possible effects
of crystal packing. The problem illustrated here is not in the proposal of the original model or the
presentation of overly simplistic schematics. The problem is that despite an accumulation of evidence
against the scissor-like model for the activation of the EPOR over the last decade [18, 27, 63], it has
not been critically evaluated and revised in light of new findings and observations and continues to be
propagated and used as a basis to interpret other systems [29]. We hope that by presenting the evidence
above it can be seen that it is highly unlikely that the activation of EPOR by binding of cytokine
occurs via a scissor-like model, and that this interpretation of the EPOR structures should not be used
to justify proposing this model in respect to other receptor systems. More generally, our analysis of
the EPOR system illustrates the potential pitfalls when proposing detailed mechanistic models based
on the selective interpretation of crystal structures, especially in cases of protein complexes such as
the EPOR, where only part of the protein is considered and the systems are not in a representative
(membrane) environment.
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Chapter 3
Do X-ray Crystal Structures of Protein
Complexes with Agonistic and Antagonistic
Ligands Truly Represent Active and Inactive
Conformations? The Erythropoietin
Receptor a Case Study.
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3.1 Introduction
The erythropoietin receptor (EPOR) is a cell-surface protein receptor and a member of the type-I cy-
tokine receptor family. This family also includes the growth hormone, prolactin, thrombopoietin and
some interleukin receptors. As first shown in 1991 in relation to the growth hormone receptor (GHR),
the activated complex for a type-I cytokine receptor is formed from the interaction of two independent
receptor chains with a single cytokine (Figure 1.2) [14, 15, 33]. The formation of such an activated
complex results in the phosphorylation of the receptor cytosolic domains at key tyrosine residues by a
Janus kinase (JAK) and initiates one of the Signal Transducer and Activator of Transcription (STAT)
pathways -- in the case of the EPOR, JAK2 and the STAT5 pathway. The full-length EPOR molecule
comprises: (i) a ligand-binding extracellular domain (residues 1-226), (ii) a single-pass transmem-
brane domain (residues 227-249), and (iii) a cytosolic domain (residues 250-484). Currently, there
are no atomic-resolution structures of the full-length EPOR. Instead, onlyX-ray crystallographic struc-
tures of the soluble EPOR extracellular domain (referred to as sEPOR, residues 1-226) in unbound [8]
and ligand-bound states [5, 6, 7, 9], and NMR structures of the transmembrane domain in a micelle
[10, 11] have been reported. Figure 1.4 shows the crystal structure of the EPO-bound (Figure 1.4A)
and apo sEPOR dimers (Figure 1.4B). As can been seen, each sEPOR consists of two fibronectin type-
III domains, labelled D1 (residues 1-117) and D2 (residues 122-226), that are joined by a four-residue
linker region (residues 118-121) [5, 6, 7, 8].
Owing to the medical importance of erythropoiesis, the EPOR has been the target of considerable
pharmaceutical development. A wide range of mimetic peptides with agonistic and antagonistic ac-
tivity have been identified, some of which are in widespread use in the clinic. In contrast to EPO,
which has a coiled-coil four-helix bundle structure, these EPO mimetic peptides (EMPs) are only 18-
20 amino acids in length and adopt a hairpin structure consisting of two short antiparallel -strands
connected by a disulfide bridge close to the termini [5, 6]. The sEPOR dimer has been crystallised
in the presence of two EMPs: the agonist EMP1 [5] and the antagonist EMP33 [6]. In both cases
the crystal complex contains two EMP molecules that form a dimer, which in turn binds two sE-
POR chains arranged as a quasisymmetric dimer (Figure 1.4C and D). Like EPO, the EMPs bind in
between the two sEPOR protomers. Overall, the structures of the two EMP-bound complexes are sim-
ilar. However, if the structures are superimposed using a single receptor D2 domain as a reference,
there is a rotation of 15° of the second sEPOR protomer in EMP33-bound sEPOR complex relative to
the EMP1-bound sEPOR [6]. An overlay of D1 domains from the EPO, EMP1, EMP33-bound and
apo crystal structures after superimposition onto a single D1 domain is shown in Figure 1.4E. This
variation in the orientation between the two EMP-bound sEPOR complexes is important to note as it
was suggested that the difference in dimer configuration accounted for the difference in proliferative
properties [6].
Based on the crystal structures of the apo dimer of sEPOR, dimerisation of the EPOR chains was
suggested to occur via the EPO-binding sites in the extracellular domains with the termini of the
D2 domains remaining separated (Figure 1.4B), thereby keeping the transmembrane and cytosolic
domains apart [8]. Furthermore, based on differences in the relative arrangement between the two
protomers and the distance between the two D2 domains between the apo and EMP1-bound sEPOR
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dimers, it was proposed that the activation of EPOR involved a cross-action scissor-likemotion (Figure
1.3C) [8]. In this case, the two D1 domains move apart resulting in the two D2 domains being brought
closer together (as seen in Figures 1.4A, C and D), allowing the interaction between cytoplasmic
domains [8, 20]. However, our reanalysis in Chapter 2 of the scissor-like mechanism in the light of
the differences between the apo and EMP1-bound sEPOR dimers has questioned whether this model
is physiologically possible on the cell surface [1]. Specifically, the motions proposed do not directly
account for the differences between the two crystal structures and lead to an unrealistic rearrangement
within the EPOR dimer that neglects the role of the transmembrane domains and the membrane itself.
This leads to the more general question of whether the relative arrangement of the extracellular
domains within the sEPOR dimer as observed crystallographically are truly representative of the com-
plexes with agonists and antagonists free in solution, and indeed whether they are representative of
active and inactive complexes more generally. To address this, atomistic molecular dynamics simu-
lations have been used to examine the structure of the sEPOR dimer in the apo state, bound to EPO
and bound to a range of agonistic and antagonistic EMPs in the absence of crystal packing effects.
3.2 Materials and Methods
3.2.1 Systems simulated
The sEPOR dimer (sEPOR2) was simulated: (i) in presence of the wild-type erythropoietin (EPO)
cytokine, (ii) in the absence of EPO, (iii) in a complex with a series of six EPO mimetic peptides
(EMPs), and (iv) in the presence of the EPOmutant R103A. The coordinates of sEPOR2 in the presence
of EPO were taken from the crystal structure of the EPO-bound human sEPOR dimer (Protein Data
Bank (PDB) entry 1EER) [7]. The structure of the apo form of the sEPOR dimer was derived in two
ways. First, directly from the crystal structure of the apo sEPOR2 (PDB entry 1ERN) and second
from the sEPOR2-EPO complex by removing EPO either from the initial crystal structure (PDB entry
1EER) or after 20 ns of simulation. These apo dimers are referred to as apo-sEPOR2, apo-sEPOR2-0
and apo-sEPOR2-20, respectively. Coordinates of the sEPOR2 with the mutant EPO R103A were also
based on the PDB entry 1EER. The EPO R103A mutant was obtained by deleting the supernumerary
side-chain atoms of residue 103 in the EPO molecule. The structures of the sEPOR2 bound to two
copies of the EMPs 1, 6, 7, 8 and 16 were derived from the crystal structure of sEPOR2-EMP12 (PDB
entry 1EBP) [5]. The coordinates of the structure of sEPOR2 complexedwith two EMP33 ligandswere
taken from the crystal structure of sEPOR2-EMP332 (PDB entry 1EBA) [6]. Residues within the EMP
ligands that were not observed crystallographically (residues G1, G2, G19 and G20 in EMP1, and G1,
G2, G19 and G20 in EMP33) were modelled using PyMOL [64]. Residue 4 in EMP6, EMP7 and
EMP8 (A4, T4 and F4, respectively) was substituted for Y4 in EMP1 using PyMOL. The sequences
of the EMPs used in this study are provided in Table 3.1. The sEPOR chains in all systems simulated
included all residues from D8 to P226 with the N- and C-termini acetylated or amidated respectively.
Side chains or residues not observed crystallographically were modelled using PyMOL. Force field
parameters for the 3,5-dibromotyrosine in EMP33 were obtained using the ATB [65]. Side chains and
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Tൺൻඅൾ 3.1: Amino acid sequence of the EMPs used in this study.
EMP Sequence Activity
1 GGTYSCHFGPLTWVCKPQGG Agonist
6 GGTASCHFGPLTWVCKPQGG Antagonist
7 GGTTSCHFGPLTWVCKPQGG Agonist
8 GGTFSCHFGPLTWVCKPQGG Agonist
16 GGTYSCHFGPLTWVCKPQ Agonist
33 GGTXSCHFGPLTWVCKPQGG Antagonist
X is 3,5-dibromotyrosine.
Sequence and activity data obtained from Liv-
nah et al. (1998) [6].
Tൺൻඅൾ 3.2: Overview of the systems simulated.
System Receptor:ligand ratio Initial PDB structure Repeats Simulation time (ns)
Crystal structures
sEPOR2-EPO 2:1 1EER 5 80
apo-sEPOR2 2:0 1ERN 3 50
sEPOR2-EMP1 2:2 1EBP 3 50
sEPOR2-EMP33 2:2 1EBA 3 50
Derived structures
apo-sEPOR2-0 2:0 1EER 3 50
apo-sEPOR2-20 2:0 a 3 50
sEPOR2-EPO R103A 2:1 1EER 3 80
sEPOR2-EMP6 2:2 1EBP 3 50
sEPOR2-EMP7 2:2 1EBP 3 50
sEPOR2-EMP8 2:2 1EBP 3 50
sEPOR2-EMP16 2:2 1EBP 3 50
a The initial coordinates for the sEPOR2-20 system were derived from the configuration of the sEPOR2-
EPO simulation 2 at 20 ns.
the N- and C-termini of the ligands (EPO and EMPs) were protonated as appropriate for pH 7. Each
system was then placed in a box of water and sufficient Na+ and Cl  ions were added to neutralise
the system and achieve a physiological salt concentration (150mආ). The ions were added by selecting
water molecules at random and replacing them by either Na+ or Cl  ions. The systems examined in
this work are summarised in Table 3.2.
3.2.2 Simulation parameters
All simulations of the receptor complex in solution were performed using the GROMACS simulation
package 3.3.3 [49] in conjunction with the GROMOS 54A7 united-atom force field [48]. Each sys-
tem was simulated under periodic conditions in a truncated octahedral box. The pressure was coupled
to an isotropic pressure bath and maintained at 1 bar by weakly coupling the system to a pressure
bath [53] using an isothermal compressibility of 4.610 5 bar 1 and a coupling constant P = 1 ps.
The temperature of the system was maintained by independently coupling the protein and water to-
gether with ions to an external temperature bath at 298K with a coupling constant T = 0:1 ps using
a Berendsen thermostat [53]. All bond lengths within the protein were constrained using the LINCS
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algorithm [66]. Water was included explicitly in the simulations using the Simple-Point Charge (SPC)
model [67] and constrained using the SETTLE algorithm [68]. Nonbonded interactions were evalu-
ated using a twin-range cutoff scheme: interactions falling within the 0.8-nm short range cutoff were
calculated every step whereas interactions within the 1.4-nm long cutoff were updated every three
steps, together with the pair list. A reaction-field correction was applied to the electrostatic interac-
tions beyond the long-range cutoff [69], using a relative dielectric permittivity constant of RF = 62
as appropriate for SPC water [70]. Polar hydrogen atoms in the protein were replaced by virtual in-
teraction sites, the positions of which were constructed at each step from the coordinates of the heavy
atoms to which they are attached as described by Feenstra et al. [71]. This allowed a 4-fs time step to
be used without affecting the thermodynamic properties of the system significantly. All systems were
energy-minimised. The temperature of each system was then gradually increased from 50K to 298K
in 50-K steps over 120 ps to further relax the system and obtain the starting configurations used in the
simulations. All systems were simulated three times starting from different initial velocities, except
sEPOR2-EPO which was simulated 5 times.
3.2.3 Analysis
3.2.3.1 Root mean square deviation
The root mean square deviation (RMSD) of the coordinates of the backbone with respect to a reference
structure was calculated after performing a least-squares fit of the backbone atoms to the reference
structure. Due to the extended nature of the N-terminal region of the sEPOR protomers in the initial
EMP-bound structures, only residues 27-220 were used for the RMSD calculation for these structures.
3.2.3.2 Conformations of the apo and ligand-bound sEPOR dimers
The overall relative arrangement of the sEPOR protomers within the sEPOR2 was characterised by the
angle  between the sEPOR protomers and the distance d between the D2 domains.  was calculated
as the angle between the normals of the planes representing each of the sEPOR protomers. The planes
were defined by the centres of mass of the backbone atoms in D1 and D2 domains and the four-amino
acid-hinge region (amino acids Val118-Leu121) at each time point. d was calculated as the distance
between the centres of mass of the backbone atoms in D2 domains at each time point.
3.3 Results
3.3.1 Structure of EPOR in the apo and bound dimers
Changes within the structure of the individual receptor chains in the sEPOR2 dimers bound to EPO,
EMP1, EMP33 and in its apo form were examined by calculating the root mean square deviation
(RMSD) of the atomic positions of the backbone atoms with respect to their corresponding initial
crystal structure. An overlay of the backbone trace of the chain A and chain B structures from the
simulations for each of these systems superimposed onto the four-residue linker is shown in Figure
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Fං඀ඎඋൾ 3.1: Overlays of the individual sEPOR chain conformations obtained from all simulations of sEPOR2-EPO (A),
apo-sEPOR2 (B), sEPOR2-EMP1 (C) and sEPOR2-EMP33 (D). In each case the chain has been superimposed onto
the backbone atoms of the hinge residues Val118-Leu121.
3.1. Overall, the structure of the individual sEPOR chains underwent little change during any of the
simulations indicating that the structure of the D1 and D2 domains and their relative arrangement were
stable and relatively rigid. The average RMSD values for chains A and B for each simulation are listed
in Table 3.3. Regardless of the presence or absence of a ligand, or the nature of the ligand, the RMSDof
the backbone typically ranged between 0.26 and 0.41 nm. Such variation is not unexpected considering
the individual chains are elongated and consist of two sub-domains, and that the exposed termini are
flexible. Note, in one replicate of the EMP33-bound dimer chain B displayed greater fluctuations
within the chain in part because of the N-terminal region not folding under the D1 domain as in all
other simulations, leading to a poorer superimposition of the chain conformations (Figure 3.1D) and
a higher average RMSD of 0.61 nm.
Changes in the structure of the sEPOR2 dimers were investigated by calculating the RMSDover the
entire receptor dimer backbone after first superimposing onto chain A in the respective initial crystal
structure as a reference. The time evolution of the overall RMSD for the dimer in each simulation
is shown in Figure 3.2. The RMSD varied between 1.0 and to 3.0 nm. These larger values arose
from changes in the relative orientations of the receptor chains. There were also marked differences
between the four systems. Whereas the apo dimer (Figure 3.2B) remained close to the starting crystal
structure, the ligand-bound sEPOR2 dimers varied substantially between the different runs, especially
in the case of the EPO-bound dimer (Figure 3.2A). The sharp increase in the RMSD of up to 3.0 nm
at around 30-40 ns in a simulation of the EMP1-bound system (Figure 3.2C) was caused by a relative
rotation of the chain B around the chain A that eventually rotated back leading to a relative orientation
of the two chains that produced RMSD values similar to those observed in the two other simulations.
As noted earlier for the individual chains, in one of the replicates involving the EMP33-bound system
(Figure 3.2D), fluctuations of the N-terminal region caused fluctuations within the chain which in turn
33
Tൺൻඅൾ 3.3: Atomic position root mean squared deviation (RMSD) values of the individual chains in the sEPOR2.
RMSD (nm)
Chain A Chain B
sEPOR2-EPO 1 0.41 0.37
2 0.41 0.32
3 0.41 0.35
4 0.41 0.34
5 0.40 0.30
average 0.410.06 0.340.05
apo-sEPOR2 1 0.28 0.28
2 0.29 0.31
3 0.26 0.32
average 0.280.04 0.300.05
sEPOR2-EMP1 1 0.28 0.31
2 0.33 0.29
3 0.30 0.28
average 0.300.06 0.290.04
sEPOR2-EMP33 1 0.27 0.32
2 0.30 0.41
3 0.30 0.61
average 0.290.05 0.440.16
Values are calculated over all the backbone atoms for
the apo and EPO-bound protomers, or from residue
L27 for the EMP-bound protomers, after a least
squares fit to the backbone atoms in the respective
chain of the crystal structure.
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Fං඀ඎඋൾ 3.2: RMSD values for the sEPOR2 dimer calculated over the backbone atoms after first performing a least squares
fit onto the backbone atoms of the chain A. sEPOR2-EPO (A), apo-sEPOR2 (B), sEPOR2-EMP1 (C) and sEPOR2-
EMP33 (D). Independent simulations 1-5 are colored green, red, blue, orange and grey.
led to a large overall RMSD.
3.3.2 Changes in the crystal structures of the apo, EPO-, EMP1- and EMP33-
bound sEPOR dimers in solution
The conformations adopted by the sEPOR2 dimers in solution were examined in terms of the relative
arrangement of the two protomers within each dimer bymonitoring an angle  and a distance d between
the two chains (Figure 3.3A). Each sEPOR chain was represented as a plane defined by the centres
of mass of the D1 and D2 domains and the centre of mass the four linking hinge residues (Val118-
Leu121). The angle between these planes () and the distance (d) between the centres of mass for the
D2 domains were calculated for each trajectory and compared.
In four out of the five simulations of the EPO-bound dimer,  sampled angles between 70-180°
and d varied between 2.0-3.6 nm (Figure 3.3B). Overall there was an increase in  and decrease in
d from the initial values of 105° and 3.0 nm, respectively (indicated by a black dot in the panel). In
the fifth simulation (grey dots in Figure 3.3B), d increased to over 5.6 nm and  fell to between 60-
90°, resulting in a separation of the D2 domains while the D1 domains remained associated. In the
apo dimer (Figure 3.3C), d stayed close to its initial value of 4.5 nm (3.9-4.9 nm) whereas  ranged
from 10 to 100°. In the case of the agonistic EMP1- and antagonistic EMP33-bound sEPOR2 dimers
(Figure 3.3D and E, respectively), the initial values of d in the crystal structures were similar (2.9 nm)
but  differed slightly (140° in sEPOR2-EMP1 and 120° in sEPOR2-EMP33). In the simulations, d
sampled a range of values (1.9-4.1 nm in sEPOR2-EMP1 and 2.1-3.3 nm in sEPOR2-EMP33) and 
varied between 70-180° in both systems.
35
Fං඀ඎඋൾ 3.3: (A) The overall conformations of the sEPOR chains within the dimer were determined in terms of an angle
between the chains () and the distance between the centre of mass of the D2 domains (d). (B)-(E) scatter plots of 
against d for simulations of the sEPOR2-EPO (B), sEPOR2 (C), sEPOR2-EMP1 (D) and sEPOR2-EMP33 (E) starting
from the crystal structures . Simulations 1-5 are coloured green, red, blue, orange, and grey respectively. The black
dots represent the values of the initial conformations.
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Fං඀ඎඋൾ 3.4: The overall conformation of the sEPOR chains in terms of  and d (see Figure 3.3A) for the systems sEPOR2-
0 (A), sEPOR2-20 (B), sEPOR2-EPO R103A (C), sEPOR2-EMP6 (D), sEPOR2-EMP7 (E), sEPOR2-EMP8 (F) and
sEPOR2-EMP16 (G). Simulations 1-3 are coloured green, red and blue respectively. The black dots represent the
values of the initial conformations.
3.3.3 Changes in the structures of the sEPOR dimers in solution derived from
the crystal structures
The variations in d and  were also examined in a series of simulations involving alternative active
and inactive complexes derived from either crystal structures or previous simulations. Specifically,
two further apo forms of the sEPOR2 were generated by removing the EPO from the EPO-bound
sEPOR2 in either the initial crystal structure (Figure 3.4A) or after 20 ns of simulation (Figure 3.4B).
In addition, sEPOR2 bound to a range of other agonistic and antagonistic ligands was also investigated.
These included the antagonistic R130Amutant of EPO (Figure 3.4C), the antagonistic mimetic EMP6
(Figure 3.4D), and the agonistic EMP7 (Figure 3.4E), EMP8 (Figure 3.4F) and EMP16 (Figure 3.4G).
In the simulations of the apo complexes generated from the holo (EPO-bound) crystal structure
(apo-sEPOR2-0 and apo-sEPOR2-20),  ranged between 20-180° in both cases. In contrast the value
of d varied significantly depending on the origin of the starting structure. In particular, in the apo form
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derived from the EPO-containing complex after the system had been relaxed for 20 ns (apo-sEPOR2-
20), d markedly increased reaching about 4.7 nm after 50 ns. This effectively meant the two sEPOR
chains had disassociated (Figure 3.4B). In the case of the other bound forms,  sampled a similar range
of values in all simulations (60-180°) (Figure 3.4C-G). Likewise, d varied between 2.2 and 3.4 nm in
these simulations except in a simulation of the EPO R130A mutant-bound dimer where d increased
up to 3.8 nm, which again involved the disassociation of chain B from chain A (Figure 3.4C).
3.4 Discussion
The erythropoietin receptor (EPOR) is a primary regulator of erythropoiesis but has also been recently
identified in neurons where it helps protect against brain injury [72]. Its mechanism of activation, in
particular how the binding of a ligand on the extracellular domains is transmitted through the plasma
membrane, has therefore been of prime interest for pharmaceutical development. A critical question in
the activation of EPOR is whether differences in the relative arrangement of the soluble extracellular
domains within the sEPOR dimers observed in the available crystal structures are truly indicative of
the active or inactive states as has been widely assumed [5, 6, 7, 8, 22, 9].
When the crystal structures of the apo and EMP1-bound forms of the soluble extracellular domain
of EPOR (sEPOR) were solved initially, it was proposed that distances between the termini observed
crystallographically were distances that occurred on the cell surface. In this model, ligand binding
would separate the D1 domains and bring the D2 domains close together (Figure 1.3C). This would
then allow interactions between the cytosolic domains of the EPORmolecules and the JAK kinases [8].
However, this model was proposed without any discussion of how the transmembrane domains might
restrain the extracellular domains when embedded in a membrane. Not only has it been claimed that
the precise distance between the terminal regions is crucial to the activity state of the sEPOR dimers,
but also the angle formed between the receptor chains [5, 6, 7, 8]. An overlay of the sEPOR dimers
showing the relative arrangement of the D1 domains is displayed in Figure 1.4E. When the dimers are
fitted onto the first same chain, the second chain in the EMP33-bound dimer is rotated by 15° with
respect to the second chain in the EMP1-bound dimer [6]. The difference in this angle was claimed
to account for the different activity of the ligand despite the distance of the C-termini between the
sEPOR chains being practically identical. This would suggest that not only are the individual domains
rigid but that the binding of either EPOR, EMP1, EMP33 or indeed any of the known agonists or
antagonists would need to hold the two receptor chains in a very precise relative orientation and to
generate sufficient mechanical force to separate (or bring together) the transmembrane helices and the
two associated JAK2 domains that consist of over 1000 amino acids.
In the simulations presented here, the overall structure of the individual sEPOR molecules were
maintained with average backbone RMSD values between 0.29-0.44 nm, in both the EPO-bound and
unbound (apo) sEPOR dimer (Table 3.3). This is in line with the range of RMSD values (average
RMSD of 0.25 nm0.11 nm) between the different structures of the sEPOR obtained crystallograph-
ically, including the apo dimer [8], the dimer bound to EPO [7], EMP1 [5], EMP33 [6], a single
sEPOR molecule bound to an antibody [73] or a diabody [9]. This indicates that the range of motion
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seen within the individual receptor molecules in the simulations is in line with the variations observed
crystallographically. The range of motion observed in the simulations is also consistent with experi-
mental studies that showed that the secondary structure of the receptor molecules in the EPOR dimer
was not changed upon EPO binding using circular dichroism [30].
The simulations were also analysed in terms of the angle  between the chains and the distance d
between the two D2 domains. The aimwas to determine whether the differences considered character-
istic of activity based on the crystal structures were maintained in solution. It was found that the range
of values of  sampled by the dimer was similar across all simulations regardless of the nature (agonist
or antagonist) of the ligand bound to the sEPOR dimer. In general, the D2 domains moved close to-
gether in the simulations, except in three cases (one agonist bound, one apo and one antagonist bound)
where these domains separated (Figures 3.3B, 3.4B and C). As the EPO-binding site is occluded in the
apo sEPOR dimer crystal structure, two further apo systems derived from EPO-bound conformations
were investigated to determine if the structure of the apo dimer as observed in the crystal structure
could spontaneously form in solution. In neither apo systems (apo-sEPOR2-0 or apo-sEPOR2-20) did
the two sEPOR protomers relax to a relative arrangement close to that seen in the crystal structure. In
fact, the states sampled in the simulations were not obviously dependent on the nature or the presence
of the ligand. They were however, heavily influenced by the initial coordinates. This suggests that for
these complexes the energy surface is relatively flat. Certainly it was not possible to determine any
structural differences that would support any of the potential models of receptor activation. Indeed, in
one simulation of the sEPOR2-EPO system, the D2 domains separated, but the complex remained in
contact via the D1 domains. This suggests the membrane, transmembrane domains and intracellular
regions all potentially play essential roles.
3.5 Conclusion
X-ray crystallography remains the primary technique for determining protein structures with almost
90% of the structures deposited with the PDB being solved using crystallographic techniques. The
aim of this study is not to cast aspersion on any specific structure but simply to highlight the diffi-
culty and pitfalls when attempting to infer how a receptor or other protein may operate when only
considering the structure of a protein within a crystal lattice. This is of particular importance in the
case of membrane-associated proteins such as the EPOR and other cytokine receptors, where only the
soluble extracellular domain is considered. In this case differences observed in the crystal were not
maintained in solution. All of the systems examined readily sampled a broad range of structures. In
short the differences observed in the crystals are unlikely to be physiologically significant. Clearly in
the case of the EPOR the influence of the transmembrane domains and the membrane environment
must be considered when attempting to propose a mechanism of activation. Recently, a series of crys-
tal structures were published which suggest alternative arrangements of the sEPOR dimer bound to
diabodies with a range of proliferative activity [9]. Despite not being attached to the transmembrane
domain, much significance was placed on the distances in the domain D2 C-termini of these structure
that were separated over 13 nm. Such large distances are in stark contrast to the values seen with the
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native ligand EPO and the small EMPs and would imply a mechanism of action very different from
that proposed for closely related systems such as the growth hormone receptor. In light of the simu-
lations presented here the physiological significance of the arrangement observed in these complexes
should be treated with due caution.
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Chapter 4
Can the Models of the X-ray Crystal
Structures for the Erythropoietin Receptor
Reproduce the Crystal Lattice?
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4.1 Introduction
Protein X-ray crystallography is an invaluable technique in structural biology with over 90% of the
structures deposited with the Protein Data Bank having been solved using this technique. The method
requires high-quality protein crystals that are able to produce sharp, discrete spots in an X-ray diffrac-
tion pattern from an X-ray beam. From these diffraction patterns structure factors are generated and
used to estimate the electron density [74]. If the resolution of the data is sufficiently high the place-
ment of atoms into the electron density is unambiguous. However, using lower resolution data, which
may be due to intrinsic or static disorder within the crystal lattice, the placement of atoms becomes
less certain. In areas where the electron density cannot be determined atoms are frequently omitted
from the final structure. The quality and reliability of a model produced from X-ray crystallography
is directly related to the confidence with which atoms can be placed within the electron density. In
order to validate the model quality, both global and local structure indicators are required. The global
quality can be inferred from values such as the highest resolution shell, which is the smallest lat-
tice spacing sampled and therefore the smallest distance or detail that can be resolved in the electron
density, and the R-free value which is a statistical method to avoid over-fitting of the model. Local
structure quality indicators check predominantly for geometric outliers from historic knowledge, e. g.
plausibility of backbone torsion angles by checking for Ramachandran outliers as well as bad contacts
(clash scores) [74].
In the case of the crystal structures that contain the soluble erythropoietin receptor (sEPOR) the
models deposited to the Protein Data Bank are of reasonable resolution (1.90-2.80 Å) for protein
complexes containing 3-4 separate protein/peptide chains and totalling between 500-600 amino acids
in the asymmetric unit. However, the validation reports for these structures produced by the Protein
Data Bank have scores in the lower percentiles in regard to the clashscore, Ramachandran outliers and
side chain outliers (Figure 4.1). These reports would suggest that the local geometry of the proteins is
not ideal and could be improved. That is, there may be alternative ways to place the atoms that could
provide a better agreement with the structure factors. Visualisation of why these structures containing
sEPOR have such poor validation reports can be seen when the X-ray crystal structures are coloured
according to the recorded B-factor in the respective PDB entries (Figure 4.2). It becomes clear in
the case of the sEPOR2-EPO complex that a number of surface exposed residues, particularly in loop
regions, have a high atomic displacement indicating these regions are less well defined (Figure 4.2A).
This is less obvious in the sEPOR2-EMP1 complex where the B-factors have been scaled and are
dominated by the modeled loop regions for which no density was observed (Figure 4.2B) [5].
In both the crystal structures of the sEPOR2-EMP1 and sEPOR2-EMP33 complexes (PDB entries
1EBP and 1EBA respectively) the residues of the sEPOR that connect the N-terminal -helix to the
D1 domain (residues 21-23) have been modelled using low or no density [5, 6]. However, the authors
noted that density was observed for these residues in an unpublished structure of the sEPOR with
another EMP [75]. The trace obtained for the unpublished structure was used to model the chain
for these residues in the sEPOR2-EMP1 and sEPOR2-EMP33 complexes. This led in both cases to
the N-terminal -helix being modelled as a domain swapped dimer with a neighbouring asymmetric
unit (Figure 4.3) [75]. In the sEPOR2-EPO complex crystal structure this -helix is folded under the
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D1 domain (see the sEPOR chains in Figure 1.4A). This immediately raises the question on whether
these residues have been appropriately modelled in these complexes. It is essential to know when
using these models for molecular dynamics (MD) that the motions observed in the simulations may
be physiologically relevant and not just a result of spurious forces due to the inappropriate placement
of atoms in the X-ray model.
A method to investigate the quality of these X-ray crystal structures containing the sEPOR, that
simultaneously validates the use of MD simulations to study these proteins, is to recreate the crystal
lattice of these crystal structures. The lattice effect can be achieved by simply creating the unit cell and
combining it with periodic boundary conditions (Figure 1.7). By using this approach the protein con-
formations are effectively kept restrained in the crystalline environment without artificial restraints.
This would allow identification, if any, of regions in the protein that are under strain owing to large
forces; these large forces would be an indication of atoms being inappropriately modelled, for example
from electrostatic interactions that are not considered during structure refinement.
In turn, if the crystal lattice remains stable, it would indicate that the simulation conditions, in-
cluding the force field, are not the predominant driver of the motions observed in MD simulations.
However, in order to validate the approach and rule out any bias or artefacts due to the simulation
conditions, the force field and system of interest and their combinations, an additional, independent
system needs to be tested. As a test case, the protein bovine pancreatic trypsin inhibitor (BPTI) will be
used for this purpose as its available crystal structure (PDB entry 4PTI) has a high resolution (1.5 Å)
and the PDB validation report has favourable scores (Figure 4.1E) [76]. Here we aim to determine the
reliability of the models that contain the sEPOR derived from X-ray crystallography data. In parallel
we will test the ability of the GROMOS54A7 force field to reproduce a protein crystal lattice.
4.2 Methodology
4.2.1 Systems simulated
The X-ray crystal structures of the BPTI (PDB entry 4PTI) and the sEPOR in complex with erythro-
poietin (EPO) (PDB entry 1EER) or EMP1 (PDB entry 1EBP) were simulated within a crystal lattice.
Any missing atoms were modelled using PyMOL [64] to make the protein complete as recorded under
the respective SEQRES entries in the respective PDB files. The sEPOR2-EMP1 was also simulated
with the N-terminal-helixmodelled folded under the D1 domain of the chain to which it is connected,
similar to how it is folded in the sEPOR2-EPO structure. This was achieved by taking the coordinates
of the N-terminal -helix (residues 1-20) from both the neighbouring asymmetric units and modelling
the residues in the loop (residues 21-23) connecting the helix to the D1 domain. The coordinates of
the complete asymmetric unit in conjunction with the recorded crystallographic symmetry operations
were used to generate the unit cell in PyMOL. In all cases the unit cell was duplicated and translated
in one dimension to prevent an asymmetric unit being in contact with its periodic image. For this
set of proteins this resulted in eight copies of the asymmetric unit within a super-unit cell, see for
example Figure 4.4. Side chains and the N- and C-termini were protonated as appropriate for pH 7.
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Fං඀ඎඋൾ 4.1: Validation reports from the Protein Data Bank for entries 1EER (sEPOR2-EPO) (A), 1ERN (apo-sEPOR2)
(B), 1EBP (sEPOR2-EMP1) (C), 1EBA (sEPOR2-EMP33) (D) and 4PTI (BPTI) (E).
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Fං඀ඎඋൾ 4.2: The X-ray crystal structures and average B-factor per residue for the sEPOR chains in the dimers bound
to EPO (A) and EMP1 (B) (PDB entries 1EER and 1EBP respectively). Structures have been coloured according to
B-factors reported in the respective PDB entries. Blue, 0Å2; red, 100Å2.
Fං඀ඎඋൾ 4.3: The N-terminal-helix of the sEPOR is modelled as a domain swapped dimer in the sEPOR2-EMP1 complex
crystal. The loop consisting of residues 21-23 (yellow) did not have observable electron density [5].
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Fං඀ඎඋൾ 4.4: The super-unit cell of the BPTI consisting of eight replicates of the BPTI protein.
Each system was then placed in a box of water and sufficient Na+ and Cl  ions were added to obtain
100ආM and to neutralise the system . The ions were added by selecting water molecules at random
and replacing them by either Na+ or Cl  ions.
4.2.2 Simulation parameters
All simulations were performed using the GROMACS simulation package 4.6 [50] in conjunctionwith
the GROMOS 54A7 united-atom force field [48]. Each systemwas simulated under periodic boundary
conditions in a rectangular box, the initial dimensions of which were obtained from the unit cell data
in the respective PDB file. The temperature of the system was maintained by independently coupling
the protein and, water and ions to an external temperature bath at 298K with a coupling constant T =
0:1 ps using a Berendsen thermostat [53]. Pressure was maintained at 1 bar by weakly coupling the
system to an anisotropic pressure bath [53] for using an isothermal compressibility of 4.610 5 bar 1
and a coupling constant P = 1 ps. All bond lengths within the protein was constrained using the
LINCS algorithm [66]. Water was included explicitly in the simulations using the Simple-Point Charge
model (SPC) [67] and constrained using the SETTLE algorithm [68]. Hydrogen atoms in the protein
were replaced by virtual interaction sites, the positions of which were constructed at each step from
the coordinates of the heavy atoms to which they are attached as described by Feenstra et al. [71].
This allowed a 4-fs time step to be used without affecting the thermodynamic properties of the system
significantly. The Verlet cutoff scheme [52] was used with a minimum cutoff of 1.4 nm for short-
range Lennard-Jones interactions and the real-space contribution to the smooth Particle Mesh Ewald
algorithm using a fast Fourier transform grid spacing of 0.16 and an interpolation order of 6 [77, 78],
which was used to compute long-range electrostatic interactions. A lattice sum method was used to
better represent the crystalline environment.
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4.2.3 System equilibration
Systems were energy-minimised and equilibrated under constant pressure with position restraints on
C atoms that were observed in the electron density. Water molecules were added or removed during
equilibration to obtain between 1-100 bar of pressure along the X , Y and Z-axes. Position restraints
were initially imposed with an energy of 50 kJ  mol 1  nm 2 and gradually removed over a period
of 14 ns for BPTI; 6-8 ns for sEPOR2-EMP1-crystal system or 18 ns for the sEPOR2-EPO-crystal.
In the case of the sEPOR2-EMP1 system with the remodelled N-terminus, after an initial relaxation
with position restraints the modelled atoms in residues 21-23 were gradually grown from soft-core
potentials over a period of 0.2 ns with position restraints of 500 kJmol 1  nm 2 on the non-modelled
atoms. After all position restraints were removed, the system was coupled to an anisotropic pressure
bath. The final 2.5 ns of the unrestrained simulations was used in the analysis.
4.2.4 Analysis
4.2.4.1 Pressure
The pressure tensor P is calculated from the difference between the kinetic energy (Ekin) and the virial
():
P =
2
V
(Ekin   ) (4.1)
where V is the volume of the box. The virial () tensor is defined as:
 =  1
2
X
i<j
rij 
 Fij (4.2)
4.2.4.2 Root mean square deviation
The root mean square deviation (RMSD) of the coordinates of the backbone atoms with respect to a
reference structure was calculated after performing a least-squares fit of the backbone atoms to the
reference structure. Only residues that were modelled in the respective PDB entries and had observed
electron density were considered for the RMSD calculation. To calculate the RMSD per residue the
last 2.5 ns of simulation for each asymmetric unit was first extracted and concatenated into a single
trajectory. Each frame was then aligned by a least-squares fit of the backbone atoms to the reference
structure and the RMSD per residue was calculated and averaged over all frames.
4.2.4.3 B-factors
The B-factors were calculated using Equation 4.3:
B =
82
3
hu2i (4.3)
where u is the mean squared displacement of the atom from the reference structure. In all cases the
displacement was calculated from the position of the atom in the X-ray crystal structure.
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4.2.4.4 Conformations of the sEPOR dimers
The overall relative conformations adopted by the sEPOR2 dimers in the crystals were characterised
by the angle  between the sEPOR protomers and the distance d, between the D2 domains (see Figure
3.3A). The angle  was calculated as the angle between the normals of the planes representing each
of the sEPOR protomers. The planes were defined by the centres of mass of the D1 and D2 domains
and the four-amino acid-hinge region (amino acids Val118-Leu121) at each time point. The distance
d was calculated as the distance between the centres of mass of the D2 domains at each time point.
Analysis was performed over the last 2.5 ns for each asymmetric unit.
4.3 Results
4.3.1 BPTI crystal
Equilibration of the BPTI crystal was monitored via the pressure (Figure 4.5A). Between 0-5 ns the
volume of the system was kept constant and water molecules removed until the average pressure in
each direction was fluctuating between 0-100 bar. The system was allowed to further relax under
isotropic pressure coupling with position restraints before going to fully anisotropic pressure coupling
with no restraints. The dimensions of the unit cell remained constant under anisotropic conditions
(Figure 4.5B), deviating less than 4% of the box dimensions (Figure 4.5C). The average RMSD for
the entire super-unit cell over the backbone atoms for the last 2.5 ns with respect to the initial X-ray
crystal structure was 0.13 nm (Figure 4.5D). This low backbone RMSD is reflected in the RMSD per
residue where only 7 of the 53 residues in BPTI had an average RMSD greater than 0.2 nm from the
initial structure (Figure 4.5E). This can also be seen in average asymmetric unit structure coloured
according to the B-factors, which shows the largest deviations occurred in the side chains of a few
surface-exposed residues and at the termini (Figure 4.5F).
4.3.2 Crystals containing the sEPOR
Similarly to the BPTI crystal simulation, equilibration of the sEPOR containing crystal was monitored
via the pressure (Figures 4.6A, 4.7A and 4.8A). Once the systems had reached between 1-100 bar and
switched from constant volume to constant pressure the box dimensions deviated less than2% of the
unit cell dimensions (panels B and C in Figures 4.6, 4.7 and 4.8). The average RMSD for the entire
super-unit cell over the (non-modelled) backbone atoms for the last 2.5 ns for these crystals ranged
between 0.24-0.32 nm (panels D in Figures 4.6, 4.7 and 4.8). The RMSD averaged for each residue
for both sEPOR chains is shown in Panel F and G respectively in Figures 4.6, 4.7 and 4.8). Overall
these sEPOR chains have relatively large RMSD values in particular at the termini and in the surface
exposed loops. These regions of high deviation are reflected in the average asymmetric unit coloured
according to the B-factors (panel H in Figures 4.6, 4.7 and 4.8).
The conformation of the sEPOR chains within each dimer was also monitored by the distance
between the D2 domains (d) and angle between the chains (), as was done previously in Figure 3.3.
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Fං඀ඎඋൾ 4.5: Results for the BPTI crystal lattice. (A) the total pressure of the unit cell (black) and along the X (blue),
Y (red) and Z(green) axes. (B) fluctuations in the dimensions of the unit cell and deviation from the crystal values
and (C) as a percentage along the X (blue), Y (red) and Z (green) axis. (D) The backbone RMSD (black) over the
entire unit cell and the corresponding position restraint energy (red). (E) The average RMSD per residue from the
initial crystal structure averaged over all asymmetric units within the crystal lattice. (F) The average asymmetric unit
structure coloured according to the B-factor calculated from the simulation; blue, 0Å2; red, 100Å2.
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In all cases d varied only over a small range of up to 0.6 nm across all dimers. The angle  had a larger
range of values between 80-150° in the EPO-bound dimers than the EMP1-bound dimers, which only
ranged between 130-160°. Closer inspection of the EPO-bound dimer complexes revealed that in half
of the dimer complexes  increased while it decreased in the remaining half. This lead to average
values for d and  in the simulation of the EPO-bound dimer crystal (3.1 nm and 103.7°) that were
near identical to the initial values (3.0 nm and 103.4°). In EMP1-bound dimer complexes the average
for  increased from the initial value of 130.1° to 139.6° and 141.2° in the originally submitted crystal
structure and the structure with the swapped N-terminal respectively.
4.4 Discussion
X-ray crystallography not only provides beautiful images of proteins but also important insights into
protein structure. Knowledge of the 3-dimensional structure for a protein is essential to understand
how a protein functions and to explain how it can interact with other proteins or co-factors. Owing
to the very nature of X-ray crystallography in which a crystal is formed from near-identical repeating
units, the conformational space available to the protein is restricted and therefore limits information on
the dynamical behaviour of the protein. Despite this limitation, detailed mechanisms of how proteins
work have often been proposed based on a limited set of X-ray crystal structures. For example this
has been done in the case of the erythropoietin receptor (EPOR) [8, 9]. In light of the work presented
in Chapters 2 and 3, this approach to interpreting protein dynamics is questionable. To overcome the
limits of protein X-ray crystallography MD simulations can be used to provide dynamical information
about the protein. However, the accuracy and relevance of the models obtained in simulation is intrin-
sically limited by the quality of the initial structure employed and the reliability of the molecular force
field. This study aimed to investigate and determine the quality of the protein structures containing the
sEPOR. As a comparison we also examined the ability of the GROMOS54A7 force field to reproduce
a well defined crystal lattice.
The crystal structure of BPTI (PDB entry 4PTI [76]) used in this study had the highest resolution
at 1.5 Å of all the structures considered. It has a relatively small size (53 amino acids, compared to
225 for the sEPOR), and can be considered a high quality X-ray crystal structure given the low clash
score and few Ramachandran and side chain outliers in the PDB validation report (Figure 4.1E). The
quality of this structure is reflected in the ease of simulating the protein in a recreation of the crystal
lattice as demonstrated by the relatively low position-restraint energies required to maintain the crystal
structure (4.5D). The RMSD of 0.13 nm for the entire super-unit cell for BPTI was the lowest out of
all the simulations. This RMSD value is comparable to, if not slightly lower than, the RMSD values
produced from simulation of the protein ubiquitin in a crystal lattice, reported previously using an
earlier version of the GROMOS force field [79, 80]. To give context to this value the distance a
carbon-carbon bond is 0.154 nm. The RMSD observed is would almost entirely be due to thermal
motion given that the simulations were performed at 293K while the crystal structure was solved at
100K. As evident from the B-factors the majority of the motion occurred in the exposed side chains
and terminal regions (Figure 4.5F). Together these results reiterate the PDB validation report that
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Fං඀ඎඋൾ 4.6: Results for the sEPOR2-EPO crystal lattice. (A) the total pressure of the unit cell (black) and along the X
(blue), Y (red) and Z(green) axes. (B) fluctuations in the dimensions of the unit cell and deviation from the crystal
values and (C) as a percentage along the X (blue), Y (red) and Z (green) axis. (D) the backbone RMSD (black)
over the entire unit cell and the corresponding position restraint energy (red). (E) Scatter plot of  against d for the
individual asymmetric units within the super-unit cell. Asymmetric units 1-8 coloured crimson, blue, orange, magenta,
aqua, red, green and purple respectively. The initial crystal structure and average asymmetric unit values are shown
as a black circle and grey square respectively. (F) and (G) the average RMSD per residue from the initial crystal
structure averaged over all asymmetric units within the crystal lattice for the sEPOR chains A and B respectively. (H)
the average asymmetric unit structure coloured according to the B-factor calculated from the simulation; blue, 0Å2;
red, 100Å2.
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Fං඀ඎඋൾ 4.7: Results for the sEPOR2-EMP1 crystal lattice. (A) the total pressure of the unit cell (black) and along the X
(blue), Y (red) and Z(green) axes. (B) fluctuations in the dimensions of the unit cell and deviation from the crystal
values and (C) as a percentage along the X (blue), Y (red) and Z (green) axis. (D) the backbone RMSD (black)
over the entire unit cell and the corresponding position restraint energy (red). (E) Scatter plot of  against d for the
individual asymmetric units within the super-unit cell. Asymmetric units 1-8 coloured crimson, blue, orange, magenta,
aqua, red, green and purple respectively. The initial crystal structure and average asymmetric unit values are shown
as a black circle and grey square respectively. (F) and (G) the average RMSD per residue from the initial crystal
structure averaged over all asymmetric units within the crystal lattice for the sEPOR chains A and B respectively. (H)
the average asymmetric unit structure coloured according to the B-factor calculated from the simulation; blue, 0Å2;
red, 100Å2.
52
Fං඀ඎඋൾ 4.8: Results for the sEPOR2-EMP1 crystal lattice with the swapped N-terminal region in sEPOR. (A) the total
pressure of the unit cell (black) and along theX (blue), Y (red) and Z(green) axes. (B) fluctuations in the dimensions
of the unit cell and deviation from the crystal values and (C) as a percentage along theX (blue), Y (red) and Z (green)
axis. (D) the backbone RMSD (black) over the entire unit cell and the corresponding position restraint energy (red).
(E) Scatter plot of  against d for the individual asymmetric units within the super-unit cell. Asymmetric units 1-8
coloured crimson, blue, orange, magenta, aqua, red, green and purple respectively. The initial crystal structure and
average asymmetric unit values are shown as a black circle and grey square respectively. (F) and (G) the average
RMSD per residue from the initial crystal structure averaged over all asymmetric units within the crystal lattice for
the sEPOR chains A and B respectively. (H) the average asymmetric unit structure coloured according to the B-factor
calculated from the simulation; blue, 0Å2; red, 100Å2.
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this X-ray crystal structure is of a high quality. Furthermore, this simulation proves the ability of the
GROMOS54A7 force field to reproduce a protein crystal lattice. While somewhat crude in the fact that
some of the solutes present experimentally in the crystalline medium were omitted in the simulations,
e. g. missing polyethylene glycol or substituting Ca2+ for Na+, that fact that no detrimental fluctuations
in any of the proteins occurred indicates the methodology is reliable, but opportunities for refinement
may exist.
In the simulations with the sEPOR larger deviations in the RMSD values (0.24-0.32 nm) were
observed over the entire super-unit cell than was seen with the BPTI crystal. Somewhat surprisingly
the largest overall RMSD was calculated for the sEPOR2-EPO crystal, which had the highest reported
resolution of 1.9Å out of the three X-ray crystal structures containing the sEPOR. Intriguingly, this
complex also deviated the greatest in regards to , however on average gave almost the exact value
calculated for the initial structure. Furthermore, these changes in were not associated with significant
deviations in the box dimensions (Figure 4.6C). A possible explanation for this result, is that the orig-
inal authors enforced the symmetry of the average structure of a single sEPOR2-EPO complex as the
asymmetric unit, whereas the asymmetric unit may actually be composed of two complexes (or even
more) with slightly different chain arrangements. Additionally, greater movement in this structure
may be allowed due to a higher solvent content compated to the crystal containing the sEPOR-EMP1
dimers, approximately 1.2 as many water molecules. In regard to the sEPOR-EMP1 crystal com-
plexes, the results do not definitively prove the domain-swapped dimer of the N-terminal -helix as
originally published, or folded under the respective D1 domain, is a more stable form of the model
than the other. The RMSDs from the original domain-swapped dimer gave the lower values, but the
average results for  and d where near identical in both systems, both deviate slightly from the initial
crystal structure values. Only rerefinement of these models against the structure factors would be able
to distinguish whether one model is a better fit than the other. Alternatively, given these structures
were published over 20 years ago, resolving crystal structures of these complexes with modern tech-
niques and equipment may generate models of higher quality without these structural uncertainties.
One unexpected result that emerged from the comparison of the B-factors is the consistently high
fluctuations observed in the lower half of the D2 domain. These loops and residues are proximal to
the C-terminal that would be connected to the transmembrane domain inserted in a membrane. It is
tempting to think that these residues are fluctuating because of missing interactions from either the
transmembrane domain or lipid components of the membrane that would stabilise their positions.
4.5 Conclusion
This chapter aimed to validate a method used to reproduce protein crystals and thereby the use of the
GROMOS54A7 force field in the simulation of systems containing the sEPOR.We believe the method
was affirmed by the successful simulation of a stable BPTI crystal lattice. The same methodology
was used to determine the quality of the X-ray crystal structures that contain the sEPOR molecule.
While these simulations had fluctuations within the individual chains and overall arrangement of the
complexes, on average they maintained the configuration of the asymmetric unit. These simulations
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support the PDB validation reports produced for these structures and that significant improvements
could be made to the X-ray crystal structure. Unfortunately, further comparison of these crystal simu-
lations to the experimental data would require the structure factor amplitudes, which are currently not
publicly available. The authors of the X-ray crystal structures containing the sEPOR were contacted
to request the structure factors, however this data was unable to be retrieved. This prevents the use
of these simulations to further refine the models that could perhaps answer some the questions posed
by these simulations such as, whether the sEPOR2-EPO complex has a larger asymmetric unit, and
whether the domain-swapped dimer occurs in all the EMP-bound sEPOR complexes.
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Chapter 5
Does the Membrane Environment Affect the
Structural Properties of the Type-I Cytokine
Receptor Transmembrane Domains?
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5.1 Introduction
In the previous Chapters 2-4 only the extracellular domain of the erythropoietin receptor (EPOR) has
been considered in detail. However, as illustrated in Figure 1.1, the full-length EPOR, and all other
type-I cytokine receptors, have the extracellular domain linked to an intracellular region via a single
helical transmembrane domain that spans the plasma membrane. As suggested by the simulations
presented in Chapter 3, to understand ligand-induced activation of these receptors, the restraints im-
posed by a transmembrane domain embedded in a membrane must also be considered. Further to
this, it would also appear that the composition of the membrane, in particular the presence of choles-
terol and membrane rafts, is critical to the activation of at least the growth hormone receptor (GHR),
interleukin-7 receptor subunit  (IL-7R) and EPOR [81, 28, 38]. What remains to be determined
is whether the receptors are merely co-localising with the cholesterol-rich rafts because that is where
target kinases, for example Lyn kinase, are located [38], or whether the types of lipids within the rafts
have a regulatory effect on the structure of the receptor transmembrane domains.
The transmembrane domain of the type-I cytokine receptors is predicted to be helical. This has
been confirmed experimentally for the human and mouse EPOR [10, 11] and human prolactin receptor
(PRLR) [12] in micelles by NMR spectroscopy. The helical nature of the transmembrane domain has
been exploited in chimeric constructs in which the mouse erythropoietin receptor (mEpoR) and human
GHR transmembrane domains are attached to leucine zippers from transcription factors [21, 17, 18].
These constructs suggested a critical role of the transmembrane domain in controlling the activation
state of the receptor by orientating the intracellular domain. Despite knowing the secondary structure
of the transmembrane domains, relatively little atomic resolution structural information is actually
available on how these domains interact as a dimer, let alone with the lipids in the membrane. This
has led some to employ computational techniques to find likely dimer conformations for the mEpoR
and GHR [21, 82, 18]. Active and inactive conformations of the hGHR transmembrane dimer were
proposed using a coarse-grained model of the transmembrane domain in a pure 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC). Both studies that employed computational methods to determine
low-energy dimer conformations of the mEpoR transmembrane domain were performed in vacuo [21,
82], that is there was no explicit treatment of the lipid molecules and water. This raises the question of
whether these structures are physiologicallymeaningful conformations as different conformationsmay
be obtained with lipid molecules interacting with the protein side chains. Indeed, it has been reported
that depletion of cholesterol from a membrane can inhibit activation of the hGHR [81]. Whether
this corresponds with a change in structure of the transmembrane domain in the different membrane
environments has not been determined.
In order to better understand the behaviour and structure of the type-I cytokine receptor transmem-
brane domains we have investigated the transmembrane domains from several receptors as a monomer
in a pure 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayer and a mixed bilayer of
POPC and cholesterol. We explored several structural features of the transmembrane domains and
asked whether it is appropriate to ignore the effects of the membrane. Furthermore, we examined a
range of receptors in order to verify whether the type-I cytokine receptors behave consistently across
the family so that a single receptor could be used as a representative model for the whole family.
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5.2 Methodology
5.2.1 Systems simulated
The transmembrane domains from the type-I cytokine receptors were investigated embedded in two
types of model membrane: (i) a pure POPC bilayer and (ii) a POPC:Cholesterol bilayer. The type-
I cytokine receptor sequences chosen for study were based on the availability of a corresponding
X-ray crystal structure for the extracellular domain. The receptors examined and the corresponding
UniProt sequence used were the human erythropoietin receptor (EPOR) P19235; the human growth
hormone receptor (GHR) P10912; the rat prolactin receptor (rPRLR) P05710; the human granulocyte-
macrophage colony-stimulating factor receptor subunit  (CSF2R) P15509; the human thrombopoi-
etin receptor (TPOR) P40238; the human interleukin-4 receptor subunit  (IL-4R) P24394; the hu-
man interleukin-5 receptor subunit  (IL-5R) Q01344 and the human IL-7R P16871. The se-
quences were taken from the terminal residue observed in the corresponding X-ray crystal structure
and included the Box-1 motif on the intracellular side of the transmembrane domain. Specifically the
sequences and PDB entries were; GHR: P234-K287 (3HHR); IL-4R: H196-A244 (5E4E); IL-7R:
N212-K260 (3UP1); rPRLR: N204-K251 (3NPZ); CSF2R: F296-K344(4RS1); IL-5R: H316-
K359 (3VA2); EPOR: T220-E266 (1EER); and TPOR: T460-H511. An alignment of the sequences
used that also includes the WSXWS motif is shown in Figure 5.1. The transmembrane domains were
built with the N-terminal sequence up until the beginning of the transmembrane domain (as defined
in the corresponding UniProt entry) as an unstructured loop, with the transmembrane domain and the
remaining C-terminal sequence modelled as an ideal -helix using PyMOL [64]. In one set of simula-
tions of the EPOR the available nuclear magnetic resonance (NMR) spectroscopy structure was used
for the initial structure [10]. The peptides were embedded into a membrane using the GROMACS
program g_embed [83]. The peptides were first aligned with the -helix of the transmembrane do-
main perpendicular to the plane of the membrane with the first residue after the end of the predicted
transmembrane domain aligned to the average Z-coordinate of the phosphorus atom from POPC in
the lower leaflet. The proteins were then resized in the XY directions (corresponding to the plane
of the membrane) to 10% of their original size and to insert the -helix any overlapping lipid and
water molecules were deleted. The peptides were then grown stepwise to the original size [83]. An
overview of the systems simulated is presented in Table 5.1
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Fං඀ඎඋൾ 5.1: Protein sequence alignment of the type-I cytokine receptors from the WSXWS motif (blue) to the Box-1
motif (red) that includes the predicted transmembrane domain sequence (bold). The underlined residues indicates the
beginning of the sequence used in the simulations. Alignment was performed using the Multiple Sequence Alignment
Tool available at www.ebi.ac.uk/Tools/msa/.
Tൺൻඅൾ 5.1: Overview of the type-I cytokine receptor transmembrane domains systems simulated.
System Membrane Composition (ratio) Copies of peptide Simulation time (ns)
mEpoR1 POPC 1 100
mEpoR1C POPC:Cholesterol (1:1) 1 100
GHR1 POPC 1 100
GHR1C POPC:Cholesterol (1:1) 1 100
rPRLR1 POPC 1 100
rPRLR1C POPC:Cholesterol (1:1) 1 100
EPOR4 POPC 4 180
EPOR4C POPC:Cholesterol (1:1) 4 180
GHR4 POPC 4 180
GHR4C POPC:Cholesterol (1:1) 4 180
TPOR4 POPC 4 180
TPOR4C POPC:Cholesterol (1:1) 4 180
rPRLR4 POPC 4 180
rPRLR4C POPC:Cholesterol (1:1) 4 180
CSF2R4 POPC 4 180
CSF2R4C POPC:Cholesterol (1:1) 4 180
IL-4R4 POPC 4 180
IL-4R4C POPC:Cholesterol (1:1) 4 180
IL-5R4 POPC 4 180
IL-5R4C POPC:Cholesterol (1:1) 4 180
IL-7R4 POPC 4 180
IL-7R4C POPC:Cholesterol (1:1) 4 180
aPOPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
5.2.2 Simulation parameters
All simulations were performed using the GROMACS simulation package 4.6.5 [50] in conjunction
with the GROMOS 54A7 united-atom force field [48]. Each system was simulated under periodic
boundary conditions in a rectangular box. The pressure wasmaintained at 1 bar byweakly coupling the
system to a semi-isotropic pressure bath [53] using an isothermal compressibility of 4.610 5 bar 1
and a coupling constant P = 1 ps in the XY and Z directions, corresponding to the plane and nor-
mal directions of the bilayer respectively. The temperature of the system was maintained at 298K by
independently coupling the protein, lipids and water to an external temperature bath with a coupling
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constant T = 0:1 ps using a Berendsen thermostat [53]. All bond lengths within the protein and lipids
were constrained using the LINCS algorithm [66]. Water was included explicitly in the simulations
using the Simple-Point Charge (SPC) model [67] and constrained using the SETTLE algorithm [68].
Explicit polar hydrogen atoms in the protein and lipids were replaced by virtual interaction sites, the
positions of which were constructed at each step from the coordinates of the heavy atoms to which they
are attached [71]. This allowed a 4-fs time step to be used without affecting the thermodynamic prop-
erties of the system significantly. Nonbonded interactions within the cutoff of 1.4 nm were calculated
every step and the pair list was updated every three steps. A reaction-field correction was applied to
the electrostatic interactions beyond the cutoff of 1.4 nm [69], using a relative dielectric permittivity
constant of RF = 62 as appropriate for SPC water [70]. All systems were energy-minimised after
embedding the peptides into the membrane. The temperature of each system was then gradually in-
creased from 50K to 298K in 50-K steps over 120 ps to further relax the system and obtain the starting
configurations used in the simulations.
5.2.3 Analysis
5.2.3.1 Residue helicity
The GROMACS program g_helix [50] was used to examine the percentage of time each residue was
in a helix over the final 50 ns of simulation using the criteria of Hirst and Brooks [84]. A residue was
deemed to be in a helix if: p
(  c)2 + (    c)2 < 8 (5.1)
where c and  c are any of the 12 pairs of (,  ) helix angles examined by Manning and Woody [85].
5.2.3.2 Helix length
Again, the GROMACS program g_helix [50] was used to obtain the total length of the helix by fitting
the longest helical part to an ideal -helix around theZ-axis. The total length was then calculated over
the final 50 ns of simulation from the average distance between the C atoms times the total number
of residues in the helix.
5.2.3.3 Helix vector angle
The overall tilt of the helix was calculated over the final 50 ns of simulation between the normal of the
bilayer (Z-axis) and the vector formed from the centroids of the C atoms in the first and last turns in
the transmembrane region of the helix. A schematic is provided in Figure 5.2A.
5.2.3.4 Local helix bending
The GROMACS program g_helixorient [50] was used to examine the local helical bending for each
residue in the helix over the final 50 ns of simulation. The local residue helix bending for the ith
residues is defined as the angle calculated between local axis for the i-2 and i-1 at each time point.
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The local residue helix axis is obtained from the axis of the helix (X-axis), the C vector (Y -axis)
and the XY cross-product (Z-axis). A schematic is provided in Figure 5.2B.
5.2.3.5 Local helix tilt
The GROMACS program g_helixorient [50] was used to examine the local residue helix tilt over the
final 50 ns of simulation. Again, the local residue helix axis is obtained from the axis of the helix
(X-axis), the C vector (Y -axis) and the XY cross-product (Z-axis). The local residue helix tilt is
the angle required to rotate the XY -axes to the initial reference frame. A schematic is provided in
Figure 5.2C.
Fං඀ඎඋൾ 5.2: Schematics of the analysis performed on the transmembrane domains helices. (A) The overall helix tilt was
calculated between the centroids of the C atoms in the first and last helix turn of the transmembrane domain. (B)
The local residue bending was the angle calculated between the local axis for the preceding two residues. (C) The
local residue tilt was calculated between the axis defined for each helix at each time point in the simulation with the
corresponding helix in the initial structure.
5.3 Results
5.3.1 Overall behaviour of the transmembrane domains in different lipid bi-
layers
Initially, a single transmembrane domain from the mEpoR, rPRLR and GHR were examined in both
a pure POPC or a mixed POPC and cholesterol bilayer to determine if there were obvious differences
in the behaviour of the transmembrane domains in different bilayers that could be investigated further.
For each system, the membrane used, as well as the starting (0 ns) and final (100 ns) configurations,
is shown in Figure 5.3. For the mEpoR and rPRLR the transmembrane domains had an overall tilt
in the pure POPC bilayer substantially larger than in the respective mixed POPC:cholesterol bilayer
simulations. For GHR the difference in tilt between the two lipid compositions was less severe, but
after visual inspection it appears some bending was present in the mixed POPC and cholesterol bilayer,
whereas in the pure POPC bilayer the transmembrane domain remained virtually straight throughout
the whole simulation. These simulations prompted a systematic investigation into the structural and
behavioural differences of the transmembrane domains in the type-I cytokine receptor family between
different membrane compositions.
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Fං඀ඎඋൾ 5.3: (A) The receptor transmembrane domains were simulated in either a pure POPC or POPC:cholesterol mixture
bilayer. The coordinates of the peptide sequence were obtained either from NMR data in the case of the mEpoR (B)
or built using PyMOL for the rPRLR and GHR (C-D). The orientation of the transmembrane domain from mEpoR
(B) , rPRLR (C) and GHR (D) in the initial (orange helices) and final (purple, green and blue helices respectively)
frames of the simulations are shown as a trace of the backbone atoms. The coordinates of the POPC phosphate atoms
are represented as spheres in the initial (orange) and final (purple, green or blue) frames. The residue predicted to
be the start of the transmembrane domain as well as the charge residues immediately after the C-terminal end of the
transmembrane domain are represented as spheres. The head group and acyl chains of POPC (grey) and cholesterol
molecules (pink) have been omitted from (B-D) for clarity.
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5.3.2 Transmembrane domain helicity, helix length and overall helix tilt
A range of type-I cytokine receptor transmembrane domains were then examined by embedding four
copies of the peptide into a single bilayer. Note, the simulation of four copies of the transmembrane
domain embedded in a single lipid bilayer allowed us to improve the sampling statistics. The rela-
tive position of the transmembrane domains was such that there was no interaction between different
copies of the transmembrane domains. The transmembrane domains were analysed for percentage of
time each residue in the sequence was considered in a helical fold (Figure 5.4). Overall the residues
predicted to be the transmembrane domain from these receptors corresponded to the longest con-
tinuous sequence of residues that remained predominantly helical in both bilayers. For most of the
receptors the helix extended 3-5 residues (up to two turns) into the intracellular juxtamembrane do-
main sequence. In the case of the TPOR the helix finished at the end of the transmembrane domain
sequence but another helix formed starting around 7 residues downstream (residue 496) in both bilay-
ers (Figure 5.4E). In regard to the helicity of the N-terminal (extracellular-domain-proximal) region
of the transmembrane domain, in the majority of cases, the membrane composition did not appear to
affect the helicity of the residues. In the case of the TPOR the addition of cholesterol decreased the
helicity of the first seven residues of the transmembrane domain (residues 468-474) (Figure 5.4E).
The length of the longest continual helix was calculated for each of the receptors in the two
membranes (Figure 5.5). The average length of the helix of the EPOR, TPOR, rPRLR, CSF2R,
IL-5R and IL-7R all decreased between 5-13% in the bilayer containing cholesterol compared
with the pure POPC bilayer (Table 5.2). The TPOR had the greatest percent change (13%) decreas-
ing from 3.90.4 nm to 3.40.2 nm, while the rPRLR had the greatest value change of 5.10.2 nm
to 4.50.1 nm. The IL-4R and GHR were the only sequences to have an average increase in helix
length in the cholesterol containing bilayer, increasing by 2% and 10% respectively.
The helix vector angle, which describes the overall tilt of the transmembrane domain, was cal-
culated for each of the receptors from the centroids of the C atoms in the first and last turns in the
transmembrane region (Figure 5.6). The vectors used to calculate the angle were defined so that 180°
is perpendicular to the plane of the membrane. Overall the receptor transmembrane domains could be
grouped into two distinct populations (Table 5.2). In the first group that comprised the EPOR, GHR,
CSF2R, IL-4R, IL-5R and IL-7R the transmembrane domains were above an average angle of
160° in the pure POPC and had very similar angles in the bilayer with cholesterol, within 2-6°. The
second group consists of the rPRLR and TPOR (Figure 5.6C and E respectively), for which the av-
erage helix vector angle increased by over 18° when cholesterol is present in the bilayer. The TPOR
had the lowest average angles for both bilayers of 131.3°2.0° 151.8°1.1° in the pure POPC and
mixed POPC and cholesterol bilayers.
5.3.3 Transmembrane domain local bending and tilt
The TPOR, rPRLR and GHR transmembrane domains were examined in further detail for the local
bending and tilt of the helices (Figure 5.7). The TPOR displayed the largest average local bending and
greatest variation in both the POPC and mixed POPC and cholesterol bilayer of 20°17° and 13°10
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Fං඀ඎඋൾ 5.4: Average residue helicity in a POPC (red) or POPC:Cholesterol (blue) bilayer for the EPOR (A), GHR (B),
rPRLR (C), CSF2R (D), TPOR (E), IL-4R (F), IL-5R (G) and IL-7R (H) transmembrane domains. Values are
the average over all four peptide copies  the standard deviation.
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Fං඀ඎඋൾ 5.5: Average length of the transmembrane domain helix in a POPC (red) or POPC:Cholesterol (blue) bilayer for
the EPOR (A), GHR (B), rPRLR (C), CSF2R (D), TPOR (E), IL-4R (F), IL-5R (G) and IL-7R (H). Values are
the average over all four peptide copies. The pink and light blue shading is  the standard deviation.
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Fං඀ඎඋൾ 5.6: Average overall tilt angle in a POPC (red) or POPC:Cholesterol (blue) bilayer for the EPOR (A), GHR (B),
rPRLR (C), CSF2R (D), TPOR (E), IL-4R (F), IL-5R (G) and IL-7R (H) transmembrane domains. Values are
the average over all four peptide copies. The pink and light blue shading is  the standard deviation.
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Tൺൻඅൾ 5.2: Total helix length and vector, and local helix bending and tilt. Values are mean and SD.
Total helix Local helix
System Length (nm) Vector angle (°) Bending (°) Tilt (°)
EPOR4 4.80.1 168.32.2 3.61.1 12.84.0
EPOR4C 4.60.1 170.50.8 4.11.5 12.63.9
GHR4 4.30.2 169.91.6 4.51.2 14.13.6
GHR4C 4.70.1 169.21.0 4.51.3 16.03.1
TPOR4 3.90.4 131.32.0 2017 4721
TPOR4C 3.40.2 151.81.1 1310 2815
rPRLR4 5.10.2 151.71.4 4.01.0 24.98.1
rPRLR4C 4.50.1 170.61.0 3.81.1 11.62.4
CSF2R4 5.20.1 166.81.4 4.01.1 14.85.2
CSF2R4C 4.90.1 168.30.9 4.11.1 12.72.8
IL-4R4 4.20.2 168.90.9 7.52.9 16.53.5
IL-4R4C 4.30.1 172.11.2 5.11.6 12.02.7
IL-5R4 4.30.1 163.31.5 3.61.2 17.15.8
IL-5R4C 3.80.2 164.32.2 3.71.3 14.96.0
IL-7R4 4.60.2 168.41.3 5.21.4 16.23.3
IL-7R4C 4.20.2 174.30.8 5.41.6 17.85.0
(Figure 5.7A). This bending can be seen in the average structure of the TPOR to occur predominantly in
the C-terminal residues of the helix as it exits the bilayers. The rPRLR and GHR had a negligible local
average bending (approximately 4°) (Figures 5.7B and C). The rPRLR decreases the average local tilt
from 25°8° to 11.6°2.4° in the presence of cholesterol, whereas the GHR remains relatively stable
at approximately 15° (Table 5.2).
5.4 Discussion
Transmembrane domains provide a physical link through the plasma membrane between the interior
of a cell and its environment. In some proteins, for example the G-protein coupled receptors, the trans-
membrane domain spans several helices that enter and exit the membrane multiple times. However, in
the case of the type-I cytokine receptors each chain has a single helical transmembrane domain linking
the extracellular and intracellular domains (Figure 1.1). This structural similarity between the type-I
cytokine receptors allows for the extracellular domain from one receptor to be grafted onto that of an-
other with the resulting complex capable of activating respective JAK/STAT signalling pathway. For
example, a chimeric construct consisting of the EPOR extracellular domain and the gp130 transmem-
brane and cytosolic domains could activate STAT1 and STAT3 in the presence of EPO [86]. Given
this and the fact that there are only four JAK and seven STAT proteins, it is reasonable to suggest
that type-I cytokine receptors likely act via a shared mechanism. It would therefore be expected that
the helix that links the extracellular and intracellular domain would have similar behaviour across the
family. However, these simulations showed a range of behaviour across the family both between the
family members and when comparing the same receptor in different lipid environments.
A comparison of the time each residue is considered to be in a helical fold (as a percentage of
the total time) did not reveal any residues that had different structural behaviour in the receptor trans-
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Fං඀ඎඋൾ 5.7: The local bending and tilt of the TPOR (A), rPRLR (B) and GHR (C) transmembrane domains. The average
structure of the transmembrane domain from the final 50 ns of simulation are shown for each system from the POPC and
POPC:cholesterol bilayers. The peptide sequence is coloured blue to red from the N- to C-termini. The phosphorus
atoms of the POPC molecules are represented as orange spheres and are indicative only. The average bending is
calculated over all residues in the helix for all four peptide copies for the POPC (red) and POPC:cholesterol (blue)
bilayers. The average tilt is calculated over all local helices in the helix for all four peptide copies for the POPC (red)
and POPC:cholesterol (blue) bilayers. The pink and light blue shading is  the standard deviation.
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membrane domain in the two lipid bilayers (Figure 5.4). Interestingly, the helix extended past the end
of the proposed transmembrane domain into the intracellular juxtamembrane domain by around four
residues, approximately another complete turn of the helix. This has been seen in the NMR struc-
tures of the EPOR [10, 11] and is important to note as alanine insertion mutants immediately after
the final residue in the transmembrane domain sequence of the mEpoR could constitutively activate
the receptor. From these data it was proposed that the orientation of the intracellular juxtamembrane
domain was critical to the activation of the receptor [87]. Using the NMR structure of the mEpoR
as the starting coordinates, the transmembrane domain tilted substantially more in the POPC bilayer
compared to the mixed POPC and cholesterol bilayer (Figure 5.3B). This tilting was not observed in
the modelled sequence of the human EPOR that was extended past the corresponding residues in the
NMR sequence to include the Box 1 motif (Figure 5.6A). These extra intracellular juxtamembrane
residues may have restricted the orientations that the transmembrane domain could adopt. Indeed, the
tilt of the transmembrane domain in the case of the rPRLR appeared to influence the orientation of the
intracellular juxtamembrane domain (Figure 5.7B). The rPRLR is intriguing at it was one of two re-
ceptors that had a large difference (18°) in the overall tilt between the two bilayers as well as the largest
decrease in the helix length (Table 5.2). This tilt and change in length however did not correspond
with any significant bending of the helix, or noticeable loss of residues involved in the helix. This
is consistent with the NMR structure of the human PRLR transmembrane domain, which only bent
as much as 6° [12]. The authors of this NMR structure also noted the PRLR transmembrane domain
was embedded from residues 211 to 234 in 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC), a
short chain lipid, which is in agreement with what was observed in these simulations. Both the hu-
man and rat PRLR therefore appear to have a similar structure across multiple types of bilayer, but
shortened and more perpendicular to the membrane when cholesterol is present, this suggests the pro-
lactin transmembrane domain responds to the hydrophobic mismatch by tilting rather than a structural
change. This is important to know as the authors of the human PRLR transmembrane domain NMR
structure have presented the model of the full-length PRLR with the transmembrane domain modelled
orthogonal to the membrane [12]. In light of these simulations presented here, the full-length model
of the PRLR would need to be investigated in membranes with different compositions in order to val-
idate the model as presented or determine other potential arrangements of the transmembrane domain
connected to the extracellular and intracellular domains.
The structures adopted by the TPOR transmembrane domain would be an interesting case to have
validated experimentally, potentially by NMR as has been done for the EPOR and PRLR transmem-
brane domains [10, 11, 12]. This receptor transmembrane domain displayed large variations in the
helix length, overall tilt, bending and local tilt when in the pure POPC bilayer that were somewhat
dampened when in the presence of cholesterol (Table 5.2). The change in average secondary structure
that occurred in the C-terminal region of this receptor is in contrast to all other receptors examined
(Figure 5.7A). The GHR however was one case where there was an extension of the helix length in the
presence of cholesterol corresponded to a residue at the C-terminal end of transmembrane domain be-
coming part of the helix (Figure 5.7C). Whether the type-I cytokine receptor transmembrane domains
have cholesterol-binding motifs, such as those reported for the human nicotinic acetylcholine receptor
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that have been suggested to have important structural and/or functional roles [88], or a cholesterol-
binding pocket formed upon dimerisation, has not been examined. These simulations may suggest,
that themembrane could have a critical regulatory role in receptor activation, in particular controlling a
conformational change within the transmembrane or intracellular juxtamembrane domain. This would
be a novel aspect of the mechanism of activation for the type-I cytokine receptors that has not been
investigated previously. Furthermore, if a conformational change was involved this would support
the idea that the dimerisation of the receptor chains alone is insufficient for receptor activation. What
would need to be tested is whether as a dimer these transmembrane domains had similar structural
changes. This would require the use of highly-technical cryo-electron microscopy that could preserve
the arrangements of the dimers in a membrane environment as has been done to study the structure of
nuclear pore complex [89].
More generally these simulations demonstrate some of the difficulties in modelling proteins in a
membrane environment. Large studies have been performed investigating dimer interfaces and ori-
entation of helices based using only a pure lipid bilayer in both coarse-grained and full-atomistic
molecular dynamics (MD) simulations in order to draw mechanistic conclusions [90, 91]. Indeed,
particular crossed and parallel orientations of the GHR transmembrane dimer generated from simula-
tion in a DPPC bilayer were suggested to be the active and inactive conformations respectively [18].
However, as shown previously for the epidermal growth factor receptor transmembrane domain, in-
creasing the acyl chain length of lipids in the bilayer from 12 to 20 carbons can affect the dynamics
of a transmembrane domain in simulations [92]. Indeed, changes in the tilt angle of a transmembrane
domain as well as changes in the NMR structure between pure lipid and raft-like bilayers have been
reported for other membrane receptors [93, 94]. The simulations presented here support the studies
that suggest the membrane composition heavily influences the structure and behaviour of proteins em-
bedded in the membrane. It would be a mistake however, in light of the results presented in Chapter 3,
to interpret or propose a detailed mechanism of how membrane-embedded proteins function without
considering the restrictions imposed by the extracellular and intracellular domains in these cases.
5.5 Conclusion
Here we asked whether it was important in the case of the type-I cytokine receptors to consider the
membrane composition when constructing a model of the receptor embedded in the membrane. By
considering a range of family members in bilayers with and without cholesterol we demonstrated vari-
ations in both the structure and behaviour of the transmembrane domains. While it would be improper
to extrapolate any mechanistic details from these simulations owing to the lack of the extracellular
domain, there does exist the possibility of a regulatory role for the membrane during the activation of
the receptor. Further studies into whether this role is due to the presence of cholesterol itself or the
generally more ordered and thicker structure of the raft-like bilayer that cholesterol promotes would
be of interest in pursuing this idea. The diverse behaviour of the receptor transmembrane domains
would also oppose using any single receptor as a model for the entire family.
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Chapter 6
Generation and Validation of Palmitoyl
Sphingomyelin Parameters and Lipid
Raft-Like Bilayers
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6.1 Introduction
The plasma membrane is a lipid matrix that physically separates the interior of cells from the external
environment. Associated with and embedded in this structure are a wide range of membrane proteins.
Some of these proteins are responsible for the transfer of chemical signals across the membrane, for
example the type-I cytokine receptors. Others are transporters that facilitate the transfer of metabolites
through themembrane, such as P-glycoprotein. The fluid mosaic model of the membrane proposed the
lipids and membrane proteins were essentially randomly distributed throughout the membrane [95].
However, the proposal of membrane rafts within membranes challenged this idea and suggested the
membrane is able to organise and compartmentalise cellular processes [40]. Early concepts of mem-
brane rafts suggested that these domains had a regulatory role on membrane proteins including cell
surface receptors [39]. Indeed, it has been suggested that the activation of some of the type-I cytokine
receptors requires the co-localisation of the receptor with membrane rafts [38]. What is unclear how-
ever, is how the lipid components are able to regulate receptor behaviour. The spatial organisation and
ordered nature of rafts suggests two potential mechanisms by which they could regulate receptors: (i)
that they cause a spatial separation of a receptor from its secondary-messenger target molecule; or (ii)
they induce a conformational change in the protein as it moves between the ordered and disordered
phases of the membrane. Spatial separation of target proteins within a signalling pathway has been
demonstrated in the case of the erythropoietin receptor (EPOR) and the Lyn kinase signalling pathway
[38]. While the Lyn kinase was observed to be constitutively located within lipid rafts, the EPOR co-
localises with lipid rafts upon stimulation with erythropoietin (EPO). What has yet to be determined
is whether the type-I cytokine receptors adopt a different conformation when in a raft compared to the
bulk membrane. Understanding how lipids can regulate proteins could provide new avenues to pursue
in drug targeting of membrane proteins. These questions are difficult to probe experimentally but can
be examined in atomic detail using molecular dynamics (MD) simulations. In order to be able to study
the receptors in a raft-like membrane force field parameters are needed for the lipid molecules as well
as the generation of the membrane structure.
The three major lipid families found in mammalian membranes are the glycerophospholipids, sph-
ingolipids and sterols, e. g. phosphatidylcholines (PCs), sphingomyelins and cholesterol respectively
(Figure 1.5). These lipids are found in varying ratios depending on the cell surface, e. g. the basolateral
or apical surfaces [96, 97], the inner or outer leaflet [98], life cycle, cell type and organism. Membrane
rafts are the result of further segregation of these lipids via lateral organisationwithin amembrane. The
rafts are small domains (10-200 nm) that generally have a higher degree of order than the bulk mem-
brane and are enriched in sterols and sphingolipids and can compartmentalise cellular processes [40].
Mammalian sphingolipids are based on the molecule sphingosine ((4E)-ൽ-erythro-2-aminooctadec-4-
ene-1,3-diol). N-acylation of sphingosine generates a ceramide. Sphingomyelin is a common sph-
ingolipid found in membranes and is derived from a ceramide by the addition of a phosphocholine
headgroup through an ester linkage. The overall structure is reminiscent of that of a phosphatidyl-
choline (Figure 1.5). An example of a sphingomyelin, N-palmitoyl-ൽ-erythro-sphingomyelin (PSM),
is shown in Figure 6.1. The length of the acyl chain of sphingomyelins varies with tissue expression.
For example palmitoyl is predominantly found in erythrocytes [43], while stearoyl is more common
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in nervous tissue [44, 45]. With regard to the lateral distribution of sphingomyelin experimental anal-
ysis of the lipid composition of detergent-resistant membranes (often considered to be representative
of the membrane raft in vivo) from rat neurons gave the molar ratio of sphingomyelins, cholesterol
and glycerophospholipids of a raft as 1:3:6 compared to the cell homogenate of 1:5:32 [99]. The
raft-like membrane of the human immunodeficiency virus (HIV) is also enriched in sphingomyelins
by a factor of 3 compared to a T-cell leukaemia membrane [100]. The locally increased amounts of
sphingomyelins and cholesterol give rise to the raft domains that are in a liquid-ordered phase (Lo)
within a bulk membrane in the liquid-disordered phase (Ld) (also referred to as the liquid-crystalline
phase).
The lateral segregation and generation of rafts is driven in part through the different properties
of phosphatidylcholine (PC)s and sphingomyelins. Compared to the glycerophospholipids, for ex-
ample 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) or 1,2-dioleoyl-sn-glycero-3-phos-
phocholine (DOPC), sphingomyelins tend to have a higher degree of acyl chain saturation. Sphin-
gomyelins are also able to form a larger number of hydrogen bonds through the H-bond donor (hy-
droxyl and amide) and H-bond acceptor (amide) groups compared with the PCs that only contain H-
bond acceptor (ester) groups at pH 7. These features give different gel-to-liquid crystalline transition
temperatures of glycerophospholipids and sphingomyelins. For example, the transition temperatures
for POPC and DOPC, both of which have unsaturated acyl chains are 269K (-4°C) and 254K (-
19°C) respectively [44], whereas the transition temperature for PSM is between 311K-314.5K (38°C-
41.5°C)[101, 44, 102, 103, 104]. Experimentally cholesterol is observed to preferentially co-localise
with sphingomyelins over phosphatidylcholines [105]. Together these properties are suggested to ac-
count for the phase separation of the lipids in the rafts from the surrounding membrane resulting in
these microdomains having tighter packed and more ordered lipids. While parameters for PC lipids
have been extensively tested in MD simulations using the GROMOS 54A7 force field, parameters
for sphingomyelins have not been widely used. In order to generate raft-like membranes, reliable
parameters for sphingomyelins need to be generated and validated against the available experimental
data.
Fං඀ඎඋൾ 6.1: Molecular structure of N-palmitoyl-ൽ-erythro-sphingomyelin (PSM). PSM consists of a sphingosine back-
bone linked to a phosphocholine headgroup and a palmitoyl acyl chain
Experimental data on the structural properties of PSM and other sphingomyelins are available
but relatively scarce compared to the wealth of data available on glycerophospholipids. Specifically,
properties such as the area per lipid, bilayer thickness and the degree of ordering of acyl chains have
been investigated in a few of sphingomyelin bilayers in the gel and liquid-crystalline phases as well as
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in the presence or absence of cholesterol, see Tables 6.1 and 6.2. Parameters forN-stearoyl-ൽ-erythro-
sphingomyelin (SSM) using the GROMOS force field have been previously developed and examined
in a pure bilayer containing 1,600 lipid molecules for 2 ns [106], with mixtures of cholesterol for 10 ns
[107], or with cholesterol and DOPC for 20 ns or 200 ns [108, 109]. These parameters were derived
from those of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC). The partial charges for the SSM
were obtained based onHartree-Fock calculations, at theHF/6-31G* level, of sphingomyelin truncated
at carbon 6 on the sphingosine tail and carbon 3 on the acyl chain [106]. Two parameter sets for PSM
have also been studied, the first generated from GROMACS and GROMOS building blocks [110]
and the second derived from existing parameters for DPPC, POPC and GROMACS building blocks
[111]. These parameters have been used to study the properties PSM as a single molecule in solution,
as well as in 8 ns and 50 ns simulations of 128 PSM molecules in a bilayer, and also 100 ns simulation
of a ternary mixture of POPC, PSM and cholesterol at different ratios [110, 111, 112]. Overall these
studies demonstrated that the use of these parameters the bilayers were stable with properties such
as the area per lipid (AL), bilayer thickness (dp-p) and chain order parameters (jSCDj) being close to
experimental values (Tables 6.1). For example, the AL and dp-p ranged between 0.52-0.6 nm2 and
3.6-4.3 nm respectively in these simulations that were performed at temperatures between 293-325K
[110, 106, 111]. These simulations also showed a higher degree of ordering in the acyl chains when
compared with PCs and greater propensity to form hydrogen bonds with cholesterol.
While in some instances these studies used relatively large membranes, for example 1,600 lipid
molecules [106], and produced long timescales (3 ns) runs for the size of the systems when initially
presented, these are now relatively short simulations given the computing power of today. Properties
of membranes that result over milliseconds to seconds experimentally are still beyond what can be rea-
sonably expected of today's computers and may never be captured by MD simulations. Nevertheless,
improvements can be made to the force field parameters describing the molecules as well as in the
tools used to generate the parameters. For example, Poger et al. [113] proposed a revised set a param-
eters for glycerophospholipids that modified the Lennard-Jones parameters between the choline atoms
and the non-ester phosphate oxygens. These parameters allowed for a system of DPPC molecules to
spontaneously assemble into a bilayer in a liquid-crystalline phase in solution. Automation in gener-
ating parameters is another important area of force field development and is available via tools such
as the Automated Topology Builder (ATB) [65]. To obtain a set of self-consistent parameters to de-
scribe lipid molecules and to test the ability of the ATB [65] to produce reliable molecular topologies
we aimed to test the quantum mechanics (QM) calculated charges for the sphingosine backbone in
N-palmitoyl-ൽ-erythro-sphingomyelin (PSM) produced by the ATB in conjunction with the phospho-
choline parameters of Poger et al. [113]. In parallel we aim to produce a set of equilibrated bilayers
containing PSM that can be used in future MD studies. In particular for use in understanding what
structural and behavioural effects a raft-like bilayer imposes on a membrane protein, for example the
type-I cytokine receptors.
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Tൺൻඅൾ 6.1: Experimental values of the area per lipid (AL) and bilayer thickness (dp-p) as a function of temperature in pure
and mixed PSM bilayers.
10°C 29°C 37°C 50°C 55°C Ref.
AL (nm2)a 0.55 0.41 - 0.6-0.64 0.47 [101, 114, 115]
dp-p (nm)a 3.8 4.8-5.0 4.52-4.66 3.5-3.7 4.2-4.4 [101, 114, 115, 116]
dp-p (nm) 50:50b - 4.5 - - 4.5 [115]
dp-p (nm) 80:20c - - 4.34-4.56 - - [116]
a 100% PSM
b 50:50 mixture of PSM and cholesterol.
c 80:20 mixture of PSM and cholesterol.
Tൺൻඅൾ 6.2: Experimental values of the palmitoyl chain order parameter (jSCDj) for bilayers containing sphingomyelin.
Bilayer composition hjSplatCD ji hjSCDji Temperature (K) Ref.
PSM-d31 0.21 - 293 [117]
PSM-d31 0.26 0.22 313 [104]
PSM-d31 0.25 - 318 [117]
PSM-d31 0.26 0.22 321 [118]
PSM-d31/Chol (2:1)a 0.35-0.45 - 293-333 [117]
PSM-d31/POPC/Cholb 0.35 0.30 313 [104]
POPC-d31/PSM/Cholb 0.29 0.23 313 [104]
 The average plateau is calculated over the carbon positions 4-6 in the
palmitoyl chain, see Reference [118].
a Molar ratio 2:1.
b Molar ratio 37.5:37.5:25
6.2 Methodology
6.2.1 Systems simulated
The properties of N-palmitoyl-ൽ-erythro-sphingomyelin (PSM) were examined in a pure bilayer con-
sisting only of PSM and in mixed bilayers containing different concentrations of cholesterol (Table
6.3). The starting configuration for the pure PSM bilayer and PSM:cholesterol mixtures were ob-
tained by progressively removing cholesterol molecules from a bilayer containing 720 PSM and 720
cholesterol molecules (PSM50:CHOL50). To generate the PSM50:CHOL50 bilayer initially, a randomly
arranged patch of ten PSM and ten cholesterol molecules was generated and replicated into a 3  3
grid containing 90 PSM and 90 cholesterol molecules. The grid was further replicated three times
with each replicate rotated either 90°, 180° or 270° around the normal to the grid. The four grids were
merged together to create a monolayer of 360 PSM and 360 cholesterol molecules. The monolayer
was duplicated and rotated 180°around an axis orthogonal to the normal of the monolayer and aligned
with the first monolayer to create a bilayer that contained 720 PSM and 720 cholesterol molecules
(Figure 6.2). This system was hydrated and relaxed by a steepest decent energy minimisation fol-
lowed by a further 10 ns MD simulation. To create the PSM60:CHOL40 bilayer an equal number of
cholesterol molecules from each leaflet were deleted by random selection from the final configuration
of theMD simulation. This process of energy minimisation, MD relaxation and deletion of cholesterol
molecules was repeated to successively obtain the PSM70:CHOL30, PSM80:CHOL20, PSM90:CHOL10
and pure PSM bilayers (Table 6.3). A larger pure PSM bilayer containing 1440 PSM molecules was
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generated by merging together the configurations of the pure PSM bilayers simulated at 293K and
333K (PSML and PSMH bilayers respectively) after simulation of the bilayers for 360 ns and 210 ns
respectively (Table 6.3).
A membrane raft-like bilayer was also investigated which consisted of an equimolar ternary mix-
ture of PSM with POPC and cholesterol (POPC:PSM:CHOL) (Table 6.3). The initial coordinates of
the POPC:PSM:CHOL bilayer were obtained by generating a randomly arranged patch of 5 POPC, 5
PSM and 5 cholesterol molecules that was replicated into a 33 grid. The grid was further replicated
three times with each replicate rotated either 90°, 180° or 270° around the normal to the patch. The
four patches were merged together to create a monolayer of 180 POPC, 180 PSM and 180 cholesterol
molecules. The monolayer was duplicated and rotated 180° around an axis orthogonal to the normal
of the monolayer and aligned with the first monolayer to create a bilayer that contained 360 POPC,
360 PSM and 360 cholesterol molecules (Figure 6.2).
Fං඀ඎඋൾ 6.2: The bilayers were generated from a randomly arranged patch of lipids that were replicated into a 3 3 grid
(i.). The grid was further duplicated with each duplicate rotated 90° 180°or 270° (ii.) to create a monolayer. The
monolayer was duplicated, rotated and aligned to create a bilayer (iii.)
Tൺൻඅൾ 6.3: Overview of the PSM containing membranes simulated.
System Lipid species Number of lipids Temperature (K) Simulation time (ns)
PSML PSM 720 293 900
PSMH PSM 720 333 400
PSM90:CHOL10 PSM:Cholesterol 720:80 293 400
PSM80:CHOL20 PSM:Cholesterol 720:180 293 400
PSM70:CHOL30 PSM:Cholesterol 720:310 293 400
PSM60:CHOL40 PSM:Cholesterol 720:500 293 400
PSM50:CHOL50 PSM:Cholesterol 720:720 293 400
POPC:PSM:CHOL POPC:PSM:Cholesterol 360:360:360 293 600
PSM293 PSM 1440 293 25
PSM296 PSM 1440 296 25
PSM299 PSM 1440 299 25
PSM302 PSM 1440 302 25, 25
PSM305 PSM 1440 305 25, 25
PSM308 PSM 1440 308 25, 25
PSM311 PSM 1440 311 25, 25
PSM315 PSM 1440 315 25
PSM318 PSM 1440 318 25
PSM333 PSM 1440 333 25
POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; PSM, N-palmitoyl-ൽ-erythro-sphingomyelin
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6.2.2 Simulation parameters
All simulations were performed using the GROMACS simulation package 4.6.7 [50] in conjunction
with the GROMOS 54A7 united-atom force field [48]. The force field parameters for N-palmitoyl-ൽ-
erythro-sphingomyelin (PSM)were partly based on the parameters for DPPC developed by Poger et al.
[113]. Specifically, the phosphocholine headgroup and the palmitoyl chain were derived from DPPC,
whereas for the sphingosine backbone, the parameters were obtained from the ATB [65] and derived
from themodelmoleculeN-acetylhexasphingosine-O-phosphocholine (ATBmolecule ID: 9232). Par-
tial charges for the N-acetylhexasphingosine-O-phosphocholine were obtained from QM calculations
performed by the ATB using GAMESS-US [119]. The molecule was initially optimised at the PM3
level of theory [120] and further optimised at the B3LYP/6-31G level of theory [121, 122, 123] in an
implicit solvent described using a polarizable continuummodel [124]. All charges from the QM calcu-
lations were rounded to one decimal place. The partial charges for each atom are shown in Figure 6.3
and the complete topology file for PSM can be found in Appendix A. If needed, charge groups were
manually optimised. In particular, carbon 1 in  position of phosphocholine in hexasphingosine was
placed in the same charge group as the amide group in order to ensure compatibility with the charge
groups used to describe PC in the GROMOS 54A7 force field. The resulting excess positive charge
was distributed evenly over the atoms in the charge group. Parameters for POPC and cholesterol were
also obtained from the ATB; molecule IDs: 1506 [125] and 1731 respectively.
Each system was simulated under periodic conditions in a rectangular triclinic box. The pressure
was maintained at 1 bar by weakly coupling the system to a semi-isotropic pressure bath [53] using
an isothermal compressibility of 4.610 5 bar 1 and a coupling constant P = 1 ps in theXY and Z
directions (corresponding to the lateral and normal directions with respect to the bilayer). The tem-
perature of the system was maintained by independently coupling the lipids and water to an external
temperature bath with a temperature (T) (Table 6.3) and a coupling constant T = 0:1 ps using a
Berendsen thermostat [53]. All bond lengths within the lipids were constrained using the LINCS al-
gorithm [66]. Water was included explicitly in the simulations using the Simple-Point Charge (SPC)
model [67] and constrained using the SETTLE algorithm [68]. The explicit hydrogen atom in the
amide group of PSM was replaced by a virtual interaction site, the position of which was constructed
at each step from the coordinates of the nitrogen atom to which it is attached as described by Feenstra
et al.[71]. This allowed a 4-fs time step to be used without affecting the thermodynamic properties
of the system significantly. Nonbonded interactions within the cutoff of 1.4 nm were calculated every
step and the pair list was updated every five steps. A reaction-field correction was applied to the elec-
trostatic interactions beyond the cutoff of 1.4 nm [69], using a relative dielectric permittivity constant
RF = 62 as appropriate for SPC water [70]. All systems, excluding PSMH, were energy-minimised.
The temperature of each system was then gradually increased from 50K to 293K in 50-K steps over
120 ps to further relax the system and obtain the starting configurations used in the simulations.
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Fං඀ඎඋൾ 6.3: The charge groups and the partial charges for each atom in PSM. The charges and atom types for the
phosphocholine groups were taken from Poger et al. [113]. The partial charges and atom types for the sphingosine
head groups were obtained from the QM calculations performed by the ATB [65]. The remaining charges and atom
types were obtained from the GROMOS54A7 force field.
6.2.3 Analysis
6.2.3.1 Area and volume per lipid
The area per lipid (AL) was calculated in two ways. Firstly, for the pure PSM bilayers the AL was
taken as the lateral area of the simulation box divided by the number of lipids per leaflet. Secondly, the
program GridMAT-MD was used for the bilayer mixtures [126]. In this method each lipid molecule
was represented as a reference point and assigned to the upper or lower leaflet. Each leaflet was divided
into a 200 200 grid in the lateral dimension. The resulting grid was then divided into polygons with
each polygon associated to a single lipid reference point. The number of grid cells within each polygon
was then evaluated for each lipid reference point [126]. The atoms taken for the reference points were
the phosphorus atoms in POPC and PSM and the oxygen of the hydroxl group in cholesterol.
The volume per lipid (VL) was calculated using the equation:
VL =
V   nwVw
nL
(6.1)
where V is the volume of the simulation box, nL and nw are the number of lipid and water molecules
respectively. Vw is the volume per water molecule for SPC. At 293K Vw= 3:06  10 2 nm3 and at
333K Vw = 3:16  10 2 nm3 obtained from independent simulations of water. The partial specific
volume is calculated by dividing the volume per lipid by the mass of one PSM molecule and is equal
to 1:167 10 21 nm3g 1.
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6.2.3.2 Bilayer thickness (dp-p)
The bilayer thickness was calculated between the phosphorus atoms in the two leaflets from either the
calculated electron density or from a grid-based nearest neighbour search [126]. The electron density
profiles were calculated by dividing the simulation box into slices along the bilayer normal (Z-axis).
The partial density for each atom in each slice was weighted by the number of electrons and averaged
over the whole simulation. The distance was then calculated between the two maxima corresponding
to the phosphorus atoms. The grid-based method assigned a reference point for each lipid to either the
upper or lower bilayer leaflet. A 20 20 grid was aligned on each leaflet and for each grid point the
nearest reference point in the opposite bilayer in theXY directions was used to calculate the thickness
between the two leaflets for that grid point [126].
6.2.3.3 Lipid bond order parameter
The degree of order within a membrane can be probed experimentally using 2H-NMR spectroscopy.
Specifically, the carbon-deuterium bond order parameter SCD provides a measure of the relative ori-
entation of individual carbon-deuterium (C-D) bonds with respect to the overall magnetic field which
is aligned with the bilayer normal. The order parameter SiCD of a methylene at position i is defined as:
SiCD =
1
2
h3 cos2 i   1i (6.2)
where i is the angle between a C-D vector of the ith methylene in an acyl chain and the normal to the
bilayer (Z-axis) (Figure 6.4). The angular brackets indicate an ensemble average. As the GROMOS
force field uses an united-atom representation in which aliphatic hydrogens are not treated explicitly
but incorporated into the carbons to which they are bound, the positions of the hydrogen atoms bound
to a methylene carbon Ci were constructed based on the positions of the neighbouring carbons (Ci 1
and Ci+1) assuming tetrahedral geometry.
Fං඀ඎඋൾ 6.4: The carbon-deuterium bond order parameter is calculated from the angle formed between the the overall
magnetic field which is aligned with bilayer normal (Z-axis) (blue) and the C-D bond (red) of the ith carbon atom in
the acyl chain (black).
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6.2.3.4 2-Dimensional radial distributions
The 2-dimensional radial distribution function between two atoms A and B is defined as:
gAB(r) =
hB(r)i
hBilocal
=
1
hBilocal
1
NA
NAX
i2A
NBX
j2B
(rij   r)
4r2
(6.3)
where hB(r)i is the particle density of atom B at a distance r around atoms A, and hBilocal is the
particle density of atomB averaged over all circles around atomsAwith radius rmax in theXY plane,
with rmax being half of the lateral box length.
6.2.3.5 Membrane bifurcation
The transitioning of a membrane between the gel and liquid-disordered (Ld) phases is a temperature
dependent property at atmospheric pressure. Bifurcation was monitored by calculating the area per
lipid (AL) for a membrane composed of a 50/50 mixture of PSML and PSMH membrane at a range
of temperatures from 293K to 333K (Table 6.3). Using the numerical analysis package SciPy a 3-
dimensional surface was then interpolated over all data points for time, temperature and AL. The
surface was used to produce curves of AL versus temperature for multiple time points. The transition
temperature was calculated by finding the average intersect between all curves in the range 0-12.5 ns
with all curves in the range 12.5-25 ns.
6.3 Results
6.3.1 Area and volume per lipid of PSM
The pure PSM bilayers at low and high temperatures (systems PSML and PSMH respectively) were
analysed for equilibration by convergence in the area and volume per lipid (Figure 6.5). Over the final
100 ns the two bilayers gave an area and volume per lipid of 0.58 nm2  0.00 nm2 and 1.16 nm3 
0.00 nm2 at 293K, and 0.63 nm2  0.00 nm2 and 1.20 nm3  0.00 nm2 at 333K. These volumes per
lipid equate to partial specific volumes of 0.995mL/g and 1.029mL/g at 293K and 333K respectively.
Upon introduction of cholesterol into the PSM bilayer, the AL of PSM decreased to 0.55 nm2 in the
PSM90:CHOL10 bilayer (Figure 6.6A). Each subsequent addition of cholesterol decreased theAL with
the PSM50:CHOL50 bilayer having the smallest value of 0.43 nm2. Cholesterol followed an inverse
trend by having a higher AL of 0.39 nm2 in the PSM50:CHOL50 bilayer and a lower value of 0.36 nm2
in the PSM90:CHOL10 (Figure 6.6B). The AL values for PSM, POPC and cholesterol in the ternary
mixture are 0.48 nm2, 0.43 nm2 and 0.36 nm2 respectively (Figure 6.6C). The individual values for
each bilayer are summarised in Table 6.4.
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Fං඀ඎඋൾ 6.5: The area (AL) (A) and volume (VL) (B) per lipid from the pure PSM bilayers PSML at 293K (blue) and PSMH
at 333K (red). Note, 0 ns corresponds to the time at 800 ns and 300 ns in the PSML and PSMH simulations respectively.
Fං඀ඎඋൾ 6.6: The area per lipid (AL) for mixed bilayers containing PSM. The AL was calculated for both PSM (A)
and cholesterol (B) for the bilayers PSM90:CHOL10 (green), PSM80:CHOL20 (violet), PSM70:CHOL30 (orange),
PSM60:CHOL40 (cyan) and PSM50:CHOL50 (grey). (C) The AL values for POPC (blue), PSM (red) and cholesterol
(purple) in the ternary mixture (POPC:PSM:CHOL).
6.3.2 Bilayer thickness of membranes containing PSM
The electron density profiles were calculated for all membranes and used to calculate the bilayer
thickness between the peaks corresponding to the phosphate atoms (dp-p). Increasing the temperature
from 293K to 333K resulted in a decrease of dp-p from 3.8 nm to 3.6 nm in the pure PSM bilayers
(Figure 6.7A). The presence of cholesterol increases the thickness of the bilayer to a maximum of
4.2 nm, which is reached after addition of at least 20% cholesterol (Figure 6.7B). The ternary mixture
bilayer (POPC:PSM:CHOL) had the largest thickness of 4.4 nm (Figure 6.7C).
It is noted that the electron density profile for the PSML bilayer is asymmetrical (Figure 6.7A).
Visual inspection of the final configurations for the PSML and bilayer reveals patches of the bilayer
that are thicker than the surrounding bilayer (Figures 6.8A and B), whereas the PSMH has no such
domains of lipids (Figure 6.8C). These visual elements are reflected in the membrane thickness for
these membranes calculated using the grid-based approach [126]. In the PSML the patches of bilayer
could be as thick as 4.8 nm but also had valleys in the membrane with a thickness of 2.6 nm and gave an
average thickness of 3.7 nm (Figure 6.8D). The PSMH bilayer had a narrower range of values between
3.2 nm to 4.0 nm with an average thickness of 3.6 nm (Figure 6.8E). These values are summarised in
Table 6.4.
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Fං඀ඎඋൾ 6.7: Electron density profiles across the hydrated bilayers containing PSM. (A) Pure PSM bilayers at 293K (red)
(PSML) and 333K (blue) (PSMH). (B) PSM bilayers containing increasing amounts of cholesterol: PSM90:CHOL10
(green); PSM80:CHOL20 (violet); PSM70:CHOL30 (orange); PSM60:CHOL40 (cyan); PSM50:CHOL50 (grey). (C)
POPC:PSM:CHOL system.
6.3.3 Influence of temperature and lipid composition on the ordering of acyl
chains in PSM
The jSCDj profiles of the acyl tail in sphingosine andN-palmitoyl chains for the pure PSM bilayers and
with increasing amounts of cholesterol are shown in Figure 6.9. The carbon numbering in Figure 6.9
corresponds to the numbering shown in Figure 6.1, that is from carbon 4 in sphingosine and carbon
2 in palmitoyl. The average jSCDj order parameter for each carbon atom in each lipid is calculated
independently for the sphingosine and palmitoyl chains and each averaged over 100 ns. In the pure
PSM bilayers a similar profile is obtained in the sphingosine chain from carbon 4 to carbon 7 at 293K
and 333K. However, from carbon 8 there is a continual decrease in jSCDj at 333K while a plateau
is maintained from carbon 6 to carbon 13 at 293K. The introduction of 10% cholesterol results in
an increase in the order parameter of carbons 6-14 in the sphingosine chain and 4-13 in the palmitoyl
chain, the effect is not maintained over the final 2-3 carbons with similar values to those obtained in the
PSML bilayer being observed. Amounts of cholesterol over 20% led to an increase of the jSCDj over
the length of both chains. At all concentrations of cholesterol a plateau occurs from carbons 6-13 in the
sphingosine chain (S-SplatCD ). Experimentally the plateau in the palmitoyl chain (P -S
plat
CD ) occurs over
carbons 4-6 [118]. The average values for both plateaus (S-SplatCD and P -S
plat
CD ) are presented in Table
6.5. In the ternary mixture (POPC:PSM:Chol) the jSCDj profiles of the sphingosine chains are similar
to what was observed for the PSM and cholesterol bilayer mixtures (Figures 6.9C and D). S-SplatCD and
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Fං඀ඎඋൾ 6.8: (A-C) Final configurations of the pure PSM bilayers at 293K (PSML) and 333K (PSMH). (A) and (B) show
the same patch of membrane at 293K from different angles. The phosphate atoms of the lipids have been drawn as
gold spheres and the carbon tails as cyan or grey lines. In (A) and (B) the lipids in a thicker region of the bilayer have
been coloured cyan. (D) and (E) heat maps of the bilayer thickness calculated using GridMAT-MD [126]. Plots are
the thickness averaged over the final 5 ns of simulation in the PSML (D) and PSMH (E) systems. In panels (D) and
(E) the X and Y -axes correspond to the plane of the membrane (XY -coordinates), with the corresponding thickness
in the Z-direction coloured according to the colour bar scale.
P -SplatCD are 0.40 and 0.37 respectively (Table 6.5), higher than the values in the PSM70:CLR30 mixture
that would correspond to a similar ratio to cholesterol (Table 6.5). The acyl chains in POPC give a
profile trace that is characteristic for the palmitoyl (Figure 6.9D) [127] and oleoyl (Figure 6.9E) [125]
chains. The SplatCD in the POPC palmitoyl chain is higher at 0.400.02 than the P -SplatCD in PSM of
0.37. However, by the end of both the POPC and PSM palmitoyl chains there is no distinguishable
difference between the jSCDj (Figure 6.9D).
It was noted above that the electron density profile for the PSML bilayer was asymmetric and
there were patches of thicker membrane. To establish if this membrane is still evolving in regard to
the order of the lipid tails, the jSCDj order parameter was calculated over 100 ns intervals for the carbon
6 and carbon 16 atoms of the sphingosine chain. These were selected because of their proximity to
the start and end of the carbon chain respectively. Figure 6.10 shows the evolution of the distribution
of the jSCDj for these atoms over the entire length of the simulation. The average and median values
for carbon 6 stabilise within the first 200-300 ns, however growth of the upper quartile is observed
over each time interval (Figure 6.10A). The distribution of the jSCDj for carbon 16 shows a continual
increase in the average and median values, as well as continual growth of the upper quartile and
reduction in the number of outliers (Figure 6.10B) over the length of the simulation.
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Tൺൻඅൾ 6.4: Area per lipid and bilayer thickness of membranes containing PSM.
Area per lipid (nm2) Bilayer thickness (nm)
System PSM Cholesterol POPC Electron density GridMAT-MD [126]
PSML 0.58  0.00 - - 3.8 3.7 (2.6-4.8)
PSMH 0.63  0.00 - - 3.6 3.6 (3.2-4.0)
PSM90:CHOL10 0.55  0.00 0.36  0.01 - 4.0 -
PSM80:CHOL20 0.50  0.00 0.35  0.00 - 4.2 -
PSM70:CHOL30 0.48  0.00 0.37  0.00 - 4.2 -
PSM60:CHOL40 0.45  0.00 0.38  0.00 - 4.2 -
PSM50:CHOL50 0.43  0.00 0.39  0.00 - 4.2 -
POPC:PSM:CHOL 0.48  0.00 0.36  0.00 0.43  0.00 4.4 -
Fං඀ඎඋൾ 6.9: Carbon deuterium bond order parameter (jSCDj) profiles for bilayer containing PSM. (A) sphingosine
and (B) palmitoyl chains from PSM in pure bilayers and with increasing amounts of cholesterol. PSML (blue);
PSMH (red); PSM90:CHOL10 (green); PSM80:CHOL20 (violet); PSM70:CHOL30 (orange); PSM60:CHOL40 (cyan);
PSM50:CHOL50 (grey). (C-E) the profiles for POPC and PSM in the POPC:PSM:CHOL system. (C) sphingosine,
(D) palmitoyl from POPC (black) and PSM (red) and (E) oleoyl chains. The order parameters were calculated for each
0.5 ns interval and averaged over the final 100 ns. Error bars are 1 standard deviation.
6.3.4 Analysis of the distribution of lipids around cholesterol
The interaction of cholesterol with either PSM or POPC was examined by calculating the 2-D radial
distribution function (g(r)) of the amide oxygen in PSM and the sn-1 or sn-2 carbonyl oxygens in
POPC around the hydroxyl hydrogen from cholesterol as illustrated in Figure 6.11A and B. In bilayers
containing only mixtures of PSM and cholesterol there is a single peak in the 2-D radial distribution
with a height of between 6-7 in all membranes at around 0.15 nm (Figure 6.11C). This corresponds
to a cumulative number of oxygen atoms around the hydroxyl hydrogen of between 0.30-0.52 at a
distance of 0.25 nm (Table 6.6). In the ternary mixture, again there is only a single peak for both
the PSM and either of the two POPC oxygens at 0.15 nm (Figure 6.11B). In this ternary bilayer PSM
has a greater probability, with a distribution height over 9, than either of the two POPC oxygens
with distribution heights of 4.5 and 2 for the oleoyl and palmitoyl chains respectively. These values
correspond to a cumulative number of the oxygen atoms around the hydroxyl hydrogen of 0.29, 0.16
and 0.07 respectively at a distance of 0.25 nm (Table 6.6).
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Fං඀ඎඋൾ 6.10: The order parameter for carbon 6 (A) and carbon 16 (B) in the sphingosine chain of PSM at 293K (PSML).
The order parameter was calculated over a 100 ns interval for the individual molecules in the system. Plotted are the
average (red square), median (red line), upper and lower quartiles (box), and outliers (blue crosses).
Tൺൻඅൾ 6.5: Average carbon-deuterium bond order parameter (jSCDj) of the carbon tail plateau in lipid bilayers containing
PSM.
PSM POPC
System Sphingosinea Palmitoylb Palmitoylb
PSML 0.260.03 0.240.01 -
PSMH 0.210.03 0.210.01 -
PSM90:CHOL10 0.290.02 0.270.01 -
PSM80:CHOL20 0.350.01 0.330.02 -
PSM70:CHOL30 0.380.01 0.360.02 -
PSM60:CHOL40 0.400.01 0.380.02 -
PSM50:CHOL50 0.400.02 0.390.03 -
POPC:PSM:CHOL 0.400.01 0.370.03 0.400.02
a Plateau calculated over carbon positions 6-16.
b Plateau calculated over carbon positions 4-6, see Reference
[118].
6.3.5 Melting temperature of a pure PSM bilayer
The bifurcation of the pure PSM bilayer was examined by monitoring the change in the area per
lipid (AL) of a bilayer composed of a 50/50 mixture of PSM molecules that had been equilibrated at
293K and 333K (Figure 6.12A) (above and below the experimental melting temperature respectively).
This bilayer was simulated at the range of temperatures listed in Table 6.3. The bifurcation of the
AL as a function of time and temperature is shown in Figure 6.12B. As a general statement, these
simulations show a trend of increasing AL with increasing temperature. At temperatures of 311K
and below the AL at later time points (red points) are lower than the earlier time points (blue points).
In simulations performed at and above 315K the later time points give higher AL values than than
the earlier time points. To analyse all time points from the independent simulations performed at the
different temperatures a surface was interpolated over all data points. The surface was used to generate
the lines describing the change in AL as a function of temperature for each time point (Figure 6.12B).
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Fං඀ඎඋൾ 6.11: (A) and (B) the 2-dimensional radial distribution function (g(r)) was calculated between the hydroxyl hy-
drogen of cholesterol and the amide oxygen in PSM (A) and the sn-1 or sn-2 carbonyl oxygens in POPC (B). (C)
g(r) for bilayers containing increasing amounts of cholesterol: PSML (blue); PSMH (red); PSM90:CHOL10 (green);
PSM80:CHOL20 (violet); PSM70:CHOL30 (orange); PSM60:CHOL40 (cyan); PSM50:CHOL50 (grey). (D) g(r) of the
ternary mixture for PSM (red) and the oleoyl (blue) or palmitoyl (black) carbonyl oxygens in POPC.
Tൺൻඅൾ 6.6: Cumulative number of cholesterol hydroxyl hydrogens within 0.25 nm of the PSM and POPC oxygen atoms.
POPC carbonyl oxygen
System PSM amide oxygen sn-1 (palmitoyl) sn-2 (oleoyl)
PSM90:CHOL10 0.51 - -
PSM80:CHOL20 0.52 - -
PSM70:CHOL30 0.44 - -
PSM60:CHOL40 0.37 - -
PSM50:CHOL50 0.30 - -
POPC:PSM:CHOL 0.29 0.07 0.16
The intersect of all the lines for 0-12.5 ns with all the lines for 12.5-25 ns were averaged to calculate
a predicted melting temperature of 311.9K  2.8K (Figure 6.12B).
6.4 Discussion
The biological importance of sphingolipids cannot be understated. Not only are they a key lipid in the
formation of rafts, but the ceramide derivatives are also used in cell signalling [128]. While structurally
similar to PCs the sphingolipids have an amide group, and in general have more saturated carbon tails
[44]. These structural differences are suggested to account for the generally higher gel-to-liquid crys-
talline transition temperatures of sphingomyelins compared to PCs [44] and the preferential packing
of cholesterol with sphingomyelins seen in simulations [109, 129]. It is remarkable that cells have
been able to exploit these physical properties of lipids in their membranes to create rafts that are able
to regulate membrane protein function. Indeed, while the study of lipids and membrane structure is
of itself an interesting and expansive area, an overarching goal of this work is to provide models of
raft-like membranes to be able to study membrane proteins with MD simulations in a physiologically
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Fං඀ඎඋൾ 6.12: (A) The initial configuration of the pure PSMused to determine themelting temperature. A bilayer simulated
at 293K and another simulated at 333K were merged together and placed in a single rectangular simulation box. (B)
Bifurcation of the pure PSM bilayer was monitored by calculating the area per lipid (AL) at a range of temperatures
from 293K to 333K. The transition temperature was calculated from curves describing a 3-dimensional surface fitted
to all the data points. The dashed vertical lines indicate the average intersect of the curves  one standard deviation.
For clarity only the average AL value over 1 ns intervals is shown as points, and the lines correspond to the surface
divided at 2 ns intervals.
relevant environment. These membranes therefore need the development of a set of self-consistent
parameters for a range of lipids that have been validated against experimental data. To generate pa-
rameters for PSM that were self-consistent with existing parameters for POPC and cholesterol, we
generated the parameters using the automated protocol of the ATB [65]. A common goal of force
field development is to have parameters that are transferable between molecules containing similar
functional groups. Here we tested the parameters developed for the phosphocholine headgroup for
PCs with a sphingosine backbone.
Two common properties of lipid bilayers that can be inferred from experimental data such as X-
ray diffraction data are the area per lipid (AL) and bilayer thickness (dp-p). For a pure PSM bilayer
below the experimental melting temperature estimates range between 0.41-0.55 nm2 and 3.8-4.6 nm.
Above the experimental melting temperature these estimates range between 0.38-0.50 nm2 and 3.5-
4.4 nm (Table 6.1). The AL for the PSML and PSMH bilayers obtained in this work were, 0.58 nm2
and 0.63 nm2 respectively. While these fall outside the range of values estimated experimentally they
reproduce the general trend of a lower AL and thicker bilayer below the melting temperature and a
higherAL and thinner bilayer above the transition temperature. The large variation in values proposed
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based on experimental data make it difficult to know how or if these values should compare to the
simulations. It also must be kept in mind that while the dp-p can be derived from X-ray data using a
model of the lipid, the AL is a derived property requiring knowledge of the partial specific volume of
the lipid. In their work Maulik and Shipley [115] assumed values of the partial specific volume for
PSM of 0.945mL/g and 1.012mL/g at 298K and 328K taken from DPPC. These are lower than the
partial specific volumes obtained for the PSML and PSMH simulations of 0.995mL/g and 1.029mL/g
respectively. Further complicating the comparison of these values is the organisation of the bilayer
leaflets. In their work Maulik and Shipley [115] report the PSM bilayers to be in a hexagonal phase,
while the simulations presented here were in a lamellar phase. Care must therefore be taken not to
over interpret differences between the simulations and the experimental values. It should also be noted
that in a previous MD simulation of a pure PSM bilayer below the gel-to-liquid crystalline transition
temperature yielded an AL of 0.49 nm2 [108], closer but still significantly higher than the 0.41 nm2 as
reported by Maulik and Shipley [115]. Together with our simulations this may suggest the AL in the
gel phase for PSM may not be as low as it has been reported experimentally.
The order parameters of the deuterium-carbon bonds in the lipid tails can provide information on
the bilayer phase. Overall the trend in the order parameters for PSM are in agreement with what would
be expected experimentally, with lower values and more disordered chains at high temperatures, and
increased ordered with increasing concentrations of cholesterol. The profile of the order parameters
for the palmitoyl chain in PSM however differ from what has been observed experimentally (see
Figure 6.13). In particular the carbons at positions 2-4 have a lower value and do not form a plateau
that has been observed by NMR [118]. In contrast the palmitoyl chain in POPC, in the ternary mixture
(Figure 6.9D) has a closer profile to the experimental data. This disorder may be due to the difference
in the charges placed on the carbons. While in POPC all the carbons in the palmitoyl chain do not
have a charge, in PSM the QM calculations led to the placement a partial negative charge on carbon
2 (Figure 6.3). However, QM calculations performed by Chiu et al. [106] did not place a charge on
this atom, yet in subsequent simulations using these parameters for PSM a similar curved profile was
obtained over these atoms in the palmitoyl chain [108, 109]. This would suggest that there may be
an inappropriate interaction of the parameters in the amide group causing the decreased order in the
palmitoyl chain.
The preferential interaction of cholesterol with sphingomyelins over PCs is an often reported prop-
erty suggested to play a major role in the segregation of membrane rafts from the bulk membrane. The
interaction of cholesterol with PSM and POPC was examined by calculating the 2-D radial distribu-
tion of the hydroxyl hydrogens around the oxygen atoms in the lipid backbone. Interestingly as the
cholesterol content increased the less cholesterol was found to be interacting with the amide oxygen
in PSM (Table 6.6). A possible explanation for this behaviour may be less competition of cholesterol
molecules for PSM which allows for longer interaction times between the atoms. This may also ex-
plain why the POPC:PSM:CHOL system has a similar cumulative number of cholesterol hydroxyl
hydrogens around the PSM (0.29) to the PSM50:CHOL50 (Table 6.6), but has a similar amount of
cholesterol as the PSM70:CHOL30, as the POPC oxygens provide extra competing oxygens. Deeper
analysis into the H-bonding network between, for example between the amide groups in PSM as well
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Fං඀ඎඋൾ 6.13: The NMR order parameter profile for PSM with a perdeutrerated acyl chain (PSM-d31). Reproduced from
fig. 4A from Mehnert et al. [118].
as the length of time for which the H-bonds exist will be needed to understand how these groups can
promote the lateral separation of the different lipids.
The temperature at which the lipids undergo a phase transition is a property that has not been
previously addressed in simulations of PSM-containing bilayers. The thermodynamic temperature
of a MD simulation is dependent on the force field. To determine if states sampled by the molecule
correspond to the reference temperature set one can determine the temperature at which the system
undergoes a phase transition. For this we used a method that has previously been applied to PC
lipids and estimated the transition by merging bilayers in different phases and simulating the resulting
membrane at a range of temperatures [130]. While the previous method analysed tail dihedrals in a
neighbour search algorithm to determine the fraction of lipids in the gel phase, our analysis simply
used the change in AL as an indicator of whether the two phase bilayer was moving towards a gel or
liquid crystalline phase. By interpolating a surface over all data points wewere able to construct curves
that describe the AL as a function of temperature. We then used the average intersect point of these
curves to provide an estimate of the transition temperature. This method gave a result of 311.92.8K
which is in good agreement of the experimental range of 311K-314.5K (most experiments give the
exact value as 314.5K) [101, 44, 102, 103, 104]. While the system setup here involved over five
times as many lipids as what was used to determine the transition temperatures of PCs, this method
shows that at reasonable accurate estimate of the transition temperature can be obtained using only
25 ns simulations as opposed to 100 ns simulations used in simulations of PCs [130]. Furthermore,
a relatively simple description of the system, in this case the AL is enough, and calculation of more
complex properties such as order parameters or dihedral angles appears unnecessary.
In comparison to PSM described by other force fields, specifcally CHARMM [131, 132] and
SLIPIDS [133], the performance of the parameters for the measured values AL, dp-p and jSCDj com-
pared to the experimental values is somewhat poorer. In particular the CHARMM parameters produce
values for the AL between 0.52-0.57 nm2 and a dp-p thickness of 4.0-4.4 nm at temperatures of 310-
321K and the Slipids parameters gave values of 0.54 nm2 and 4.2 nm at 323K. The higher AL and
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thinner dp-p reported here for PSM may indicate that the density of PSM is incorrect. This may be a
product of the setup where cholesterol was deleted from the bilayer producing holes the PSM filled,
but the bilayer did not compress to an ideal value. This is probably reflected in the jSCDj, where the
CHARMM and Slipids bilayers produced lipids with a higher degree of order, in particular around
carbons 4-6 in the sphingosine chain, and more closely trace the order parameter profile produced
from NMR experiments. It is interesting to note however, that the parameters described here produce
a similar order parameter profile to the previous simulations performed with the GROMOS force field.
Suggesting this may be a artefact from the united atom force field. The density of PSM could be ad-
dressed in two ways to acheive anAL closer to experimental values; firstly the pure PSM system could
be rebuilt at a lower AL, or secondly cycle the bilayer through rounds of compression and relaxation
by increasing and decreasing the reference pressure.
6.5 Conclusions
In this study we proposed new parameters forN-palmitoyl-ൽ-erythro-sphingomyelin (PSM) generated
in part from an automated tool but in part manually curated. Comparison to available experimental
data suggests these parameters can reproduce physical properties of PSM, in particular the estimated
transition temperature (311.92.8K) was very close to the experimental value of 314.5K. These sim-
ulations provide a new set of PSM containing bilayers that have self-consistent parameters with other
lipid molecules developed for the GROMOS force field. Based on these results we have confidence
in the use of these parameters and bilayer systems we have generated for future studies of membrane
proteins in raft-like membranes.
6.6 Disclaimer
During the final write up of the results for this section an error was discovered in the parameters for
sphingomyelin. The improper dihedral for the carbon-carbon double bond was set to 0° instead of
the correct 180°. This resulted in the cis configuration of the double bond rather than the required
trans configuration. Initial tests suggest this error does not alter the properties of sphingomyelin or
the mixed bilayers. The values for the reported properties are being recalculated (Figure 6.14). The
correct trans configuration is used for all simulations containing protein in the remainder of the thesis.
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Fං඀ඎඋൾ 6.14: The recalculated properties of PSM with the trans double bond. (A) The distribution of angles for the
double bond dihedral at 293K and 333K. (B) The evolution of the AL values at 293K and 333K. (C, D) The order
parameter values for the sphingosine and palmitoyl chains respectively over the final 100 ns of simulation: PSML
(blue); PSMH (red); PSM90:CHOL10 (green); PSM80:CHOL20 (violet); PSM70:CHOL30 (orange); PSM60:CHOL40
(cyan); PSM50:CHOL50 (grey). Values are the average  the standard deviation.
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Chapter 7
What are Active Conformations of a Type-I
Cytokine Receptor Transmembrane Domain
Dimer?
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7.1 Introduction
In Chapters 2 and 3 we investigated whether the X-ray crystal structures of the erythropoietin recep-
tor (EPOR) extracellular domain alone, that is without a transmembrane domain, was sufficient to
determine active or inactive conformations of the dimer complex. Our reinterpretation of the avail-
able crystal structures has cast doubt on the physiological significance of the differences between
these structures, and the simulations confirmed that these were not unique conformations of the re-
ceptor extracellular domain dimer. Indeed this work highlighted the need to consider the receptor in
a more physiologically relevant environment, that is with the transmembrane domain embedded in a
membrane environment. We subsequently explored, in Chapter 5, the effects of lipid composition on
the transmembrane region embedded in bilayer for a range of the type-I cytokine receptors. The sim-
ulations indicated that lipid composition was an essential factor to consider in the activation of these
receptors and therefore raft-like bilayer containing N-palmitoyl-ൽ-erythro-sphingomyelin (PSM) and
cholesterol were built and equilibrated in Chapter 6. The current Chapter builds upon this work: in
particular we examine dimers of transmembrane domains from a range of type-I cytokine receptors.
While computational techniques have been employed previously to predict and study possible dimer
interfaces in the transmembrane domains for the EPOR and GHR, neither the effect of the membrane
composition nor restrictions imposed by an extracellular domain have been taken into consideration
[21, 82, 18]. As evident from our work in (Chapters 2-5), these factors will affect the structures ob-
tained and draw into question the physiological significance of any result obtained without them. We
therefore sought to improve upon our understanding of how type-I cytokine receptor transmembrane
domain dimers interact in a membrane environment.
Currently no experimental structure of a dimer of a type-I cytokine receptor transmembrane do-
main exists. Furthermore, the structural details on how the extracellular domains and transmembrane
domains are linked, i. e. whether the extracellular juxtamembrane region has secondary structure or is
an unstructured loop, are not known. We therefore have focused on model systems in which dimers of
the transmembrane domains were naturally conformationally restricted. Previously, the GHR trans-
membrane dimer was modelled in a pure 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) bi-
layer with a disulfide bond in the N-terminal region (proximal to the extracellular domain), associ-
ated with activation of the receptor, to obtain a range of dimer conformations. We also found in the
literature a report of another disulfide-linked dimer associated with an oncogenic mutation in the
interleukin-7 receptor subunit  (IL-7R) due to the insertion of the amino acid sequence CPT in the
the N-terminal region of the transmembrane domain. Several chimeric constructs of a dimerisation
motif from a transcription factor attached to the transmembrane domain of a receptor have also been
studied experimentally. In particular these are the Put3 and mouse EpoR [21], and c-Jun and human
GHR chimeras [18]. The Put3-EpoR chimeras were designed to induce a relative rotation between the
two transmembrane domains by progressively deleting residues from the N-terminus of the transmem-
brane domain sequence. The Jun-GHR chimeras were suggested to affect the proxity of the N-termini
of the transmembrane domains and thereby orientate the intracellular juxtamembrane domains.
Transcription-factor-transmembrane-domain chimeric constructs have been invaluable for under-
standing receptor activation. They demonstrate that dimerisation alone is insufficient for receptor
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activation, and that the orientation of the transmembrane domain also affects the activation of the
downstream signalling domains. These constructs provide a relatively simple system in which the
transmembrane domains of a type-I cytokine receptor are restricted by the presence of an extracel-
lular region, but can change the activation state with the insertion or deletion of a single amino acid
(Table 7.1). They are also informative in that both the transcription factor dimerisation domains and
the transmembrane domains are helical, so it is likely that the full construct (up until the end of the
transmembrane domain) will be helical. While these constructs have provided new insights into the
activation of the receptors, it stills remains to be answered whether these chimeric constructs are ap-
propriate substitutions for the receptor extracellular domain. That is, are the structure of the chimeras
similar to that of the wild-type full-length receptor, or do they provide an alternative mechanism to
activate the kinase domains? In this chapter, we examine the structures of several type-I cytokine
receptor transmembrane domain dimers and ask whether the conformations of the constructs known
to be constitutively active can be distinguished from inactive dimers.
7.2 Methodology
7.2.1 Systems simulated
Three sets of dimeric receptor constructs of alternative receptor transmembrane domains have been
examined: (i) an oncogenic mutation of the IL-7R (referred to as ``P2 clinical mutant'') that allows
for a disulfide-linked dimer and constitutive activation of the receptor [134], (ii) chimeric constructs of
the yeast Put3 transcription factor attached to the mouse EpoR transmembrane domain [21], and (iii) a
chimeric construct of the Jun transcription factor attached to the human GHR transmembrane domain
[18]. Sequences were taken from UniProt database entries P14753 (mEpoR), P10912 (hGHR) and
P16871 (IL-7R) with the amino acid numbering ignoring the signal peptide sequence. In all cases the
transmembrane domains were modelled as ideal -helices using PyMOL [64]. The IL-7R dimer was
created by duplicating the monomer, and rotating and translating the second transmembrane domain
into proximity with the first transmembrane domain so that a disulfide bond could be defined between
the N-terminal cysteines. The Put3-EPOR chimeras were built by extending the Put3 dimer taken
from the crystal structure (PDB entry 1ZME [135]) with the mouse EpoR transmembrane domain
sequence as an ideal -helix. Similarly, the NMR structure of the c-Jun dimer from the (PDB entry
1JUN [136]) was extended with the human GHR transmembrane domain sequence as an ideal -helix.
The initial configurations of these constructrs are illustrated in Figure 7.1. The amino acid sequences
of the peptides and constructs used are presented in Figure 7.2. All systems were simulated with
four copies of the dimer embedded in a raft-like bilayer containing 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine (POPC), PSM and cholesterol (Table 7.1). A second system of the IL-7R dimer
was simulated in a pure POPC bilayer (Table 7.1).
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Fං඀ඎඋൾ 7.1: Illustration of the dimer systems simulated. (A) The il-7ra! P2 clinical mutant linked through a disulfide
bridge. (B) The Put3-mEpoR dimer. (C) and (D) the Jun-GHR dimers with and without the extracellular juxtamem-
brane domain linker.
Tൺൻඅൾ 7.1: Overview of the type-I cytokine receptor transmembrane domains systems simulated.
System Membrane Composition (ratio)a Simulation time (ns) Activityb Reference
IL-7RA_P2-CMpopc POPC 300 n/dc
IL-7RA_P2-CM POPC:PSM:Chol (1:1:1) 260 + [134]
Put3-EpoR-0 POPC:PSM:Chol (1:1:1) 280 +/- [21]
Put3-EpoR-1 POPC:PSM:Chol (1:1:1) 270 - [21]
Put3-EpoR-2 POPC:PSM:Chol (1:1:1) 260 - [21]
Put3-EpoR-3 POPC:PSM:Chol (1:1:1) 260 + [21]
Put3-EpoR-4 POPC:PSM:Chol (1:1:1) 270 - [21]
Put3-EpoR-5 POPC:PSM:Chol (1:1:1) 260 - [21]
Put3-EpoR-6 POPC:PSM:Chol (1:1:1) 260 + [21]
Jun-L-GHR POPC:PSM:Chol (1:1:1) 340 +/- [18]
Jun-GHR POPC:PSM:Chol (1:1:1) 400 + [18]
aPOPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; PSM, N-palmitoyl-ൽ-erythro-
sphingomyelin; Chol, cholesterol
b The activity of the construct is relative to the respective constructs of a receptor and not between the
different receptors.
cNot determined.
7.2.2 Simulation parameters
Simulations of the Put3-EpoR dimers were performed using the GROMACS simulation package 4.6.5
[50], while the simulations of the IL-7R and Jun-GHR dimers were performed using the GROMACS
simulation package 5.0.4 [137]. All simulations were run in conjunction with the GROMOS 54A7
united-atom force field [48]. Each system was simulated under periodic boundary conditions in a
rectangular box. The pressure was maintained at 1 bar by weakly coupling the system to a semi-
isotropic pressure bath [53] using an isothermal compressibility of 4.610 5 bar 1 and a coupling
constant P = 1 ps in the lateral (XY ) and normal (Z) directions of the bilayer. The temperature
of the system was maintained at 298K by independently coupling the protein, lipids and water to an
external temperature bath with a coupling constant T = 0:1 ps using a Berendsen thermostat [53].
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Fං඀ඎඋൾ 7.2: Amino acid sequences of the constructs used to study the transmembrane domain dimer in a raft-like mem-
brane. The human IL-7R P2 clinical mutant (A) was modelled as a dimer through a cysteine-linked disulfide bridge.
The mouse EpoR (B) and human GHR (A) transmembrane domains were dimerised using the Put3 or Jun transcription
factors respectively. The transcription factor and transmembrane domain sequences are highlighted in grey and blue
respectively. The insertion mutation in the IL-7R sequence is underlined.
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All bond lengths within the protein and lipids were constrained using the LINCS algorithm [66].
Water was included explicitly in the simulations using the Simple-Point Charge (SPC) model [67] and
constrained using the SETTLE algorithm [68]. Explicit polar hydrogen atoms in the protein and lipids
were replaced by virtual interaction sites, the positions of which were constructed at each step from
the coordinates of the heavy atoms to which they are attached [71]. This allowed a 4-fs time step
to be used without affecting the thermodynamic properties of the system significantly. Nonbonded
interactions within the cutoff of 1.4 nm were calculated every step and the pair list was updated every
five steps. A reaction-field correction was applied to the electrostatic interactions beyond the cutoff
of 1.4 nm [69], using a relative dielectric permittivity constant of RF = 62 as appropriate for SPC
water [70]. All systems were energy-minimised after embedding the peptides into the membrane.
The temperature of each system was then gradually increased from 50K to 298K in 50-K steps over
120 ps to further relax the system and obtain the starting configurations used in the simulations.
7.2.3 Analysis
7.2.3.1 Residue helicity
The GROMACS program g_helix [50] was used to examine the percentage of time each residue was
in a helix over the final 50 ns of simulation using the criteria of Hirst and Brooks [84]. A residue was
deemed to be in a helix if: p
(  c)2 + (    c)2 < 8 (7.1)
where c and  c are any of the 12 pairs of (,  ) helix dihedral angles examined by Manning and
Woody [85].
7.2.3.2 Helix length
Again, the GROMACS program g_helix [50] was used to obtain the total length of the helix by fitting
the longest helical part to an ideal -helix around theZ-axis. The total length was then calculated over
the final 50 ns of simulation from the average distance between the C atoms times the total number
of residues in the helix.
7.2.3.3 Helix vector angle
Like in Chapter 5 the overall tilt of the helix was calculated between the normal of the bilayer (Z-axis)
and the vector formed from the centroids of the C atoms in the first and last turns in the transmem-
brane region of the helix. A schematic is provided in Figure 5.2A.
7.2.3.4 Calculation of contacts between the transmembrane domains
The GROMACS program g_mindist [50] was used to calculate the number of contacts between the
transmembrane domains in a dimer. An atom in the first transmembrane domain of a dimer was
deemed to be in contact with an atom in the second transmembrane domain if the distance between
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any of the atoms was less than 0.4 nm. Atoms were only counted as being in contact with the second
transmembrane domain once.
7.2.3.5 Relative orientation of the transmembrane domains
The relative orientation of the transmembrane domains within the mEpoR and hGHR transmembrane
domains dimers were calculated from the positions of the leucine residues in the C-terminal region
of the transmembrane domain. For mEpoR these were residues L245, L246, L247, L250, L252 and
L253, and for the hGHR these were residues L264 and L286. In both cases the angle was calculated
from the average vector generated from the vectors from the C to the C atoms for each residue in
the respective transmembrane domain. The vectors were defined such that an angle of 180° would
indicate that the leucine residues in the two transmembrane domains were orientated towards each
other in the dimer.
7.2.3.6 Secondary structure
The GROMACS program do_dssp [50] in conjunction with DSSP version 2.0.4 [138, 139] was used to
assign secondary structure to the receptor protein sequence from the intrabackbone hydrogen-bonds.
7.3 Results
7.3.1 IL-7R P2 clinical mutant transmembrane domain dimer
The IL-7R P2 clinical mutant transmembrane domain (Figure 7.2A) was built as an ideal -helix and
dimerised by linking the N-terminal cysteine residues with a disulfide bond. This provided a relatively
simple, yet novel dimer of an activated type-I cytokine receptor transmembrane domain. This was used
to investigate whether the effects of the membrane composition on the structure and behaviour of the
transmembrane domains observed in Chapter 5 also occur with a dimer construct. To this end, the
same properties examined for the transmembrane domains in Chapter 5 were initially calculated again
for the IL-7R P2 clinical mutant. The overall trace of the average helicity was similar between the
two bilayer compositions (Figures 7.3A and B). However, a noticeable decrease in the helicity was
observed between residues 237-241 (numbering based off the first residue after the signal peptide in
the UniProt entry being residue 1) in the raft-like membrane (Figure 7.3B). This did not substantially
affect the length or angle of the transmembrane domain with both systems averaging around 4 nm and
165° respectively (Figures 7.3C-F). The two systems showed differences between the contacts in the
two halves of the transmembrane domains. The dimers in the pure POPC bilayer formed a number of
contacts in both halves of the transmembrane domain ranging between 0-30 and 0-10 in the top and
bottom halves respectively (Figures 7.3G and I). The number of contacts in the dimers in the raft-like
bilayer ranged between 10-30 and 0-1 for the top and bottom halves (Figures 7.3H and J). Embedding
the transmembrane domain dimer into a raft-like bilayer resulted in a slight increase in the average
distance between the C-termini from between 1.5-2.0 nm, in the POPC bilayer, to 1.7-2.2 nm (Figures
7.3K and L). Visualisation of the average dimer structures for the transmembrane domains in the pure
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POPC and raft-like bilayers showed only the S249 residues are aligned in the POPC bilayer (Figure
7.4A) whereas both serine residues, S246 and S249, orientated towards the corresponding residue in
the raft-like bilayer (Figure 7.4B). Overall the dimer in the raft-like bilayer is more clamped in the top
half and more splayed in the bottom half.
7.3.2 Put3-EpoR chimeras
The Put3-EpoR chimeras of Seubert et al. [21] range in activity from inactive to constitutively active
(Table 7.1). The constructs differed by the length of the transmembrane domain, specifically the
transmembrane domain was shortened at the N-terminus by progressively deleting residues. These
chimeras were modelled by extending the crystal structure of the Put3 transcription factor (PDB entry
1ZME [135]) with the sequences shown in Figure 7.2B. Figure 7.5A illustrates the key features of
these constructs highlighting the Put3 and mEpoR sequences as well as the transmembrane domain
and the residues that were sequentially deleted. As can be seen in Figure 7.5B the conformation of the
dimers were restricted by the Put3 dimer. The overall helicity of these constructs was well maintained
in all simulations with only a slight loss of helicity at the termini (Figures 7.5C-I).
The dimerisation of these constructs was maintained through the Put3 transcription factor. In fact
very few contacts were observed between the residues in the mEpoR transmembrane domains (Figure
7.6). The Put3-EpoR-2 chimera displayed the largest number of contacts typically ranging between 5-
10 per dimer (Figure 7.6G). These contacts in the Put3-EpoR-2 chimera were almost entirely from in-
teractions of the N-terminal leucine and threonine residues. The C-termini in the Put3-EpoR chimeras
never made contacts with each other (Figure 7.5B). Typically the C-termini were separated by around
2.5 nm with the Put3-EpoR-(0,1) chimeras having a slightly larger separation of over 2.8 nm (Figures
7.6B, E, H, K, N, Q and T). The relative orientation of the transmembrane domain adopted by the
chimeras was bimodal averaging around 40° for Put3-EpoR-(0,1,4,5) and 80° for Put3-EpoR-(2,3,6)
(Figures 7.6C, F, I, L, O, R and U).
7.3.3 Jun-GHR chimeras
Two Jun and GHR transmembrane domain chimeras were investigated that were linked either via 12
amino acids from the extracellular juxtamembrane sequence or directly to the Jun sequence, referred
to as Jun-L-GHR and Jun-GHR respectively (Figure 7.7A). Both of these constructs are constitutively
active, with the Jun-GHR being the more potent of the two [18]. Overall, both of these chimeras re-
tained helicity throughout the Jun and hGHR transmembrane sequences, however some of the residues
in the extracellular juxtamembrane domain linker lost helicity (Figures 7.7B and C). The C-termini of
the transmembrane domains were separated by 1.5 nm and 4.5 nm in the Jun-L-GHR and Jun-GHR
dimers respectively (Figures 7.7D and E). The overall tilt of the helix through the membrane was
similar for the two chimeras at 155°, although the Jun-L-GHR did display a greater variation (Figures
7.7F and G). The relative orientation of the transmembrane domains calculated from the leucine face
was 35° and 115° for the Jun-L-GHR and Jun-GHR dimers respectively (Figures 7.7H and I).
As the GHR sequences were observed to interact in the Jun-L-GHR construct these dimers were
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Fං඀ඎඋൾ 7.3: The results for the IL-7R P2 clinical mutant dimer in a pure POPC (red) or raft-like bilayer (blue). (A-B)
The percentage of time the residues within the eight chains from the four dimers were calculated as being helical. (C-D)
The length of the longest continual helix. (E-F) The overall tilt angle of the helices in the dimers. (G-H) and (I-J) are
the number of contacts between the dimers for the top and bottom halves of the transmembrane domain respectively.
(K-L) The distance between the C-terminal end of the transmembrane domains in the dimers. Values are the average
(black line)  the standard deviation (red or blue shading) over the eight chains (A-F) or for the four dimers (G-L) in
each system.
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Fං඀ඎඋൾ 7.4: The average structures of the IL-7R P2 clinical mutant transmembrane domain dimers in (A) a pure POPC
bilayer and (B) a raft-like bilayer. Peptide sequence has been coloured blue to red.
examined further in terms of their relative orientation and distances between the residues. As can
been seen in Figure 7.8A, the GHR sequence formed contacts between the two dimers in the extra-
cellular juxtamembrane linker sequence through to the residues in the GxxG motif. The dimers were
arranged such that only one GxxG motif (red trace in 7.8A) was interacting with the second chain
(blue trace). This orientation of the dimers resulted in corresponding residues pairs (e. g. L250 from
each transmembrane domain), suggested to be orientated towards each other in the inactive dimer
from cysteine-mutagenesis cross-linking studies, to be rotated by 180° (Figure 7.8B). This resulted in
residues that displayed minimal cross-linking (e. g. I252) having a smaller average distance between
the chains than residues that displayed strong cross-linking (I254) (Figure 7.8C). These conforma-
tions also prevented the cysteine residues C241 in the linker region, known to form a disulfide bond
during receptor activation, from coming within 0.4 nm in three of the four dimers (Figure 7.8C). De-
spite loosing the initially modelled helicity, the linker region was observed to partially fold during
the simulations. Indeed, the algorithm DSSP [138] calculated two -helices in this region that were
spaced by residues that could form a bend (Figure 7.8D). Furthermore, the algorithm suggests there
may be a further bend or coil between the extracellular juxtamembrane domain and beginning of the
transmembrane domain.
7.4 Discussion
Undoubtedly the binding of a ligand to the extracellular region of a cell-surface receptor is associated
with the mechanical transmission of the signal via a transmembrane region to the intracellular region
of the cell. In the case of the G-protein coupled receptors (GPCRs) it is suggested that the binding of
an agonist would stabilise the transmembrane regions of the receptor in an active conformation [140].
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Fං඀ඎඋൾ 7.5: The Put3 and mEpoR chimera. (A) The Put3 leucine-zipper was extended as an -helix with the mouse
EpoR transmembrane domain sequence as shown in Figure 7.2B. Indicated on the figure are start and end of the
transmembrane domain (TMD) and intracellular juxtamembrane domain (IJMD), the residues that were progressively
deleted, and the C-terminal leucine residues of the transmembrane domain. (B) The final configuration of a dimer
construct from the Put3-EpoR-0, Put3-EpoR-3 and Put3-EpoR-6. (C-I) The percentage of time the residues within the
Put3-EpoR-(0-6) chimeric constructs were calculated as being helical. The black lines indicate the start and end of the
EpoR transmembrane domain sequence. Values are the average (black line)  the standard deviation over the eight
chains in the four dimers in each system.
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Fං඀ඎඋൾ 7.6: The number of contacts between the first two turns of the EpoR transmembrane domain, the distance between
the C-terminus of the transmembrane domain and the angle between the C-terminal leucine face on the transmembrane
domain for: Put3-EpoR-0 (A-C); Put3-EpoR-1 (D-F); Put3-EpoR-2 (G-I); Put3-EpoR-3 (J-L); Put3-EpoR-4 (M-O);
Put3-EpoR-5 (P-R); Put3-EpoR-6 (S-U). Values are the average (black line)  the standard deviation (blue shading)
over the the four dimers in each system.
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Fං඀ඎඋൾ 7.7: (A) The Jun leucine-zipper was extended as an -helix with either the human GHR extracellular juxtamem-
brane domain as a linker with the transmembrane domain (Jun-Linker-hGHR) or only the transmembrane domain
(Jun-hGHR). The peptide sequence used are shown in Figure 7.2C. Indicated on the figure are the Jun dimer (Jun)
(grey), extracellular juxtamembrane domain (EJMD) (magenta), the start and end of the transmembrane domain (TMD)
(green), intracellular juxtamembrane domain (IJMD) (cyan), and the C-terminal leucine residues of the transmembrane
domain. (B-C) The percentage of time the residues within the Jun-L-GHR and Jun-GHR chimeric constructs were cal-
culated as being helical. The black lines indicate the start and end of the mEpoR extracellular juxtamembrane and
transmembrane domain sequences. Values are the average  the standard deviation over the eight chains in the four
dimers in each system. (D-E) The distance between the C-terminal residues in the transmembrane domain. (F-G) The
overall tilt of the transmembrane domain. (H-I) The relative orientation of the transmembrane domain calculated from
the leucine face. Values are the average (black line)  the standard deviation (green or red shading) over the eight
chains in the four dimers in each system.
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Fං඀ඎඋൾ 7.8: Representative structure of the hGHR sequence from the Jun-L-GHR chimera showing (A) the interactions
occurring in the N-terminal region and (B) the relative orientation of the residues in the transmembrane domain. In (A)
the orange spheres are the glycine residues of the GxxG dimerisation motif. In (B) only the C and C atoms from
residues L250-F267 are shown. Residues have been coloured according to the level of cross-linking reported from
cysteine-scanning mutagenesis; blue-strong, green-weak, and grey-minimal [18]. (C) The average distance of each of
the residues with the second chain in the dimer. (D) A representative secondary structure plot of the two protein chains
within a single dimer.
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However, unlike the GPCRs that have seven transmembrane helices, the type-I cytokine receptors only
have one single-pass transmembrane domain per chain (Figure 1.9). Furthermore, the type-I cytokine
receptors require two receptor chains in order to signal. There is also the suggestion that, at least
for the EPOR, growth hormone receptor (GHR) and IL-7R, these receptors can exist as preformed
homo- (GHR, EPOR) or heterodimers (IL-7R with the -common chain) on the cell surface [27,
17, 28]. It would appear therefore, that binding of an agonistic ligand would not only stabilise an
active conformation, but also drive a change in the relative orientation of the two receptor chains
within the dimer. Indeed, studies that investigated mutations in the EPOR and GHR transmembrane
and juxtamembrane domains suggest the activation of the receptor can be modulated by changing
the relative orientation of the receptor chains [87, 21, 17, 18]. The suggestion that the membrane
environment is essential in the activation of the receptors adds further complexity. Not only have
the IL-7R and EPOR been observed to colocalise with rafts upon stimulation with the respective
cytokines, but removal of cholesterol or sphingomyelins from themembrane can prevent the signalling
of the IL-7R, EPOR and GHR [81, 38, 141]. Using this information we built upon our previous
work to investigate several dimers of the type-I cytokine receptor transmembrane domains that had a
restricted conformational space in order to shed light on potential active and inactive conformations
of the transmembrane domain.
The IL-7R P2 clinical mutant was the simplest transmembrane dimer that we investigated. The
transmembrane domain was built as an ideal -helix and the dimer restricted by the presence of a
disulfide bond at the N-terminus (the end proximal to the extracellular domain). In the case of the
IL-7R dimer there was noticeably different behaviour in the upper-half of the transmembrane do-
main depending on the membrane composition. In particular, more contacts were maintained, which
resulted in two transmembrane domains being in closer contact within this region with the serine
residues (S246 and S249) aligned between the transmembrane domains in the raft-like bilayer. This
gave the IL-7R dimer in the raft-like bilayer a splayed appearance at the C-termini. However, this
did not translate into a significantly larger distance between the two termini of the transmembrane do-
mains, with an average difference of 0.5 nm. It is not possible to conclude whether the conformation
observed corresponded to the activated state of the transmembrane domain as the extracellular and
intracellular domains were not included in the simulations. Further work may be required to examine
the effect of removing the disulfide bond in the dimer embedded in the pure POPC, as in both cases
the system simulated may represent an `active' dimer. They do indicate however, that raft-like bilayer
does affect the conformation of the transmembrane domain dimer.
The lack of structural data on the transmembrane dimers and the extracellular juxtamembrane do-
main sequencemeans that anymodelling of the coupling between the extracellular and transmembrane
domains would need to be extensively validated. We therefore investigated the Put3-mEpoR and Jun-
hGHR chimeras, for which experimental data is available, for information on how the transmembrane
domains could potentially be coupled to the extracellular domains for these receptors. A noticeable
feature of these constructs was that the transcription factor clearly had a large influence in the con-
formation of the receptor transmembrane domains. For all the Put3-EpoR chimeras and the Jun-GHR
chimera (lacking the linker), the constructs were a continuous helix stretching several residues into the
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intracelluar juxtamembrane domain. The conformations that were generated were very stable in the
simulations with the distance between the splayed C-termini, and relative orientation of the transmem-
brane domains remaining constant despite relatively few contacts between the receptor sequences. In
contrast the Jun-L-GHR construct (containing the linker), was partially folded in parts of the linker
region. The suggestion from the simulations that this region is largely structured draws into question
the model of the human GHR presented by Brooks et al. [18] where the extracellular domain is linked
by an extended loop to a dimer of the transmembrane domains. The secondary structure analysis in-
dicates this linker region may fold as a helix-turn/bend-helix motif that could be stablised by contacts
with the extracellular domain. In this case, this could suggest that the GHR chain is well structured
from the extracellular domain down through to the intracellular juxtamembrane domain. This model
would support a mechanism whereby a change in the orientation in the extracellular region could
transfer as a mechanical signal to change the relative orientation of the intracellular domains. From
a purely mechanical perspective this would be sensible as it would be easier to transfer a mechanical
force through a rigid/structured body rather than through a loop or unstructured region.
It was not possible to directly compare the dimer conformations obtained with the Put3-EpoR
chimeras with the previously suggested dimer interfaces generated from MD simulations performed
in vacuo [21] given the lack of contacts between the mEpoR sequences. However, in both the Put3
and Jun chimeras the relative orientation of the transmembrane domains could be influenced by the
removal of residues in the N-terminal or extracellular juxtamembrane regions. Interestingly, in the
case of the Put3-EpoR chimeras, not every deletion resulted in a change in the relative orientation of
the transmembrane domains which has been assumed in the interpretation of the experimental data
using these constructs. In the case of the Jun-hGHR chimeras the structure of the constructs followed
the trend deduced experimentally from FRET analysis where the more active construct Jun-GHR was
suggested to have a greater distance between the C-termini than the Jun-L-GHR construct [18]. In
addition the contacts between the GHR chains in the Jun-L-GHR chimera did not correspond with
what would be expected for the inactive dimer nor the active dimer from cysteine mutagenesis cross-
linking studies, suggesting an intermediary alignment of the transmembrane domain whichmay reflect
its partial activity seen experimentally [18]. It is possible that the results reflect the choice of starting
structures. In order to identify potential artefacts due to the structure of the transcription factors,
simulations in which the transcription factor chains are aligned in parallel, as in the PDB entry 1AJY,
will need to be performed in the future [142].
In concert with the simulations of the transmembrane dimers, several attempts were made at con-
necting the extracellular and transmembrane domains for the EPOR and GHR (Figure 7.9). These
include relatively simple constructs consisting of a single D2 sub-domain connected to the transmem-
brane domain through the extracellular juxtamembrane regionmodelled as an-helix or a loop (Figure
7.9A), as well as larger complexes of the two receptor chains bound to a cytokine (Figure 7.9B and
C). Not only were these systems computationally expensive to run, the setup and interpretation of the
structures obtained were difficult. For example, given that the X-ray crystal structures observed are
unlikely to be the exact conformation observed on the cell surface, it must be questioned whether it
is appropriate to use the dimer as seen in the crystal structures. Furthermore, directly building the
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Fං඀ඎඋൾ 7.9: The extracellular domain of the EPOR was modelled linked to the transmembrane domain via a loop (A)
or an -helix (B). The extracellular domain residues 221-225 are shown as spheres. (C) The extracellular domain of
the GHR was modelled linked to transmembrane domain via an -helix. In (A) the angle was calculated between the
plane defining the D2 domain and the normal to the membrane (Z-axis). In (A) and (C) the phosphorus atom of the
lipid headgroup is represented as gold sphere. In (B) the lipids are coloured blue-POPC, green-PSM and magenta-
cholesterol.
transmembrane domains as a continuation of a given crystal structure led to nonphysical structures
within the transmembrane domains. This raises the question of whether the orientation of the trans-
membrane domain should be adjusted to match the extracellular domain or vice versa. This problem
is exemplified by the heavy tilt of the D2 domain of 35° from normal of the bilayer observed in Fig-
ure 7.9A . Given the limitation in resources and time, further production and investigation of these
systems was halted. The setup of these extracellular-transmembrane domain systems is critical given
the starting conditions heavily influence the outcomes of the simulations. How these models can be
reconciled with experimental and structural data, and whether they are physiologically relevant, will
need to be considered in any future work. It has become apparent from these simulations that the
interactions between the D2 sub-domain and the membrane may be crucial. Indeed, the simulations
ruled out consistently that these receptors float proud above the membrane. Instead the simulations
suggest the extracellular domain sits on, if not partially in, the plasma membrane.
7.5 Conclusion
This work aimed to understand how the transmembrane domain in a dimeric conformation could influ-
ence the activation of the receptor. In part this work supports the model in which the transmembrane
domains could move apart during the activation of the GHR and that the orientation of the dimer is
also important. Alternatively, the simulations of the chimeric constructs could support a mechanism of
activation of the receptors that would consist in widely separating the transmembrane domains. Given
the similarities in the structures of the Put3-EpoR chimeras as well as those between the IL-7R dimers
it is not possible to assign particular conformations to active or inactive structures. Future work will
address the orientation of the intracellular region that may need to be extended past the Box 1 motif to
improve the resolution of how this region behaves. Overall, these simulations indicate that care needs
to be taken when interpreting different models of a system and that mechanisms need to be drawn
from known structural data, for example the chimeric constructs were not observed to have a parallel
arrangement of the transmembrane domains as quite often represented in the literature. Finally, the
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chimeric constructs questions the utility in interpreting the fine details in studies that examine only
a part of a system, for example a single transmembrane domain, which neglect contributions to the
structure from the extra and intracellular regions.
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Chapter 8
Conclusions and perspectives
The ability of a cell to sense its environment is a hallmark of life. Indeed, even viruses that are in
general considered non-living biological entities, still require the ability to recognise their target host
cell through surface receptor molecules. How signals are transferred through cell membranes is a
fundamental question in biology, and a problem that has been solved by evolution in numerous ways
including two-component regulatory systems, voltage-gated ion channels, receptor tyrosine kinases,
G-protein-coupled receptors and cytokine receptors. The cytokine receptors are a medically impor-
tant group of receptors. In particular, the type-I cytokine receptor family regulate a diverse range of
functions including inflammation and immune responses, growth and development, and tissue main-
tenance. With continued research on these receptors, exciting new roles in health and disease are being
discovered. For example, the EPOR was initially only reported in the bone marrow but in recent years
has been found in neuronal tissue and suggested to have a role in protecting the brain during ischaemia
and reperfusion [72]. These new roles greatly expand the potential of the EPOR as a drug target, for
example in the treatment of stroke injury. However, understanding how receptor ligands and drugs
modulate the activity of a receptor is critical as agonism for one disease (e. g. anaemia) would be detri-
mental in others (e. g. blood cancers). This thesis was dedicated to improving our understanding of
how the type-I cytokine receptors transfer signals across the plasma membrane. In particular, how the
event of a ligand binding to the extracellular domain of these receptors is mechanically coupled to the
activation of the intracellular region.
The type-I cytokine receptors are a widely studied family of receptors. This is reflected in the
numerous X-ray crystal structures of the extracellular domains both with and without ligands that are
publicly available. When they were first solved, these structures provided novel insights into how
a single cytokine activated two receptors by binding in between the two receptor chains [33]. The
conformations of the receptor complex within different crystals have widely been assumed to be phys-
iologically relevant. In the case of the EPOR, differences between alternative structures were used
to propose a detailed mechanism of action, essentially linearly interpolating between the structures to
infer dynamic behaviour. In Chapter 2 we reviewed the available experimental data in the literature
for the EPOR and provided a reinterpretation of the crystal structures used to propose the cross-action
scissor-like mechanism of activation. We found that this mechanism of action is not supported with
currently available literature and the motions assumed by the model were incompatible with the struc-
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tures originally used to propose the mechanism. This prompted us to ask in Chapter 3 whether it is
appropriate to use the X-ray crystal structures, that only consider a portion of the receptor, as con-
formations that represent active and inactive conformations. It became apparent from the simulations
that the conformations observed crystallographically could not be maintained in solution. This is a
significant finding not only for the type-I cytokine receptors, but more widely to the structural biology
community. It highlights the importance of also considering the environment in which the structure is
observed or used to measure an activity of the protein. In cases where only a single, small, globular,
stable protein like BPTI is being considered, conclusions on structural elements may be drawn with
confidence from these X-ray crystal structures. However, in crystal structures involving truncated
proteins in larger complexes where the influence of the local environment on the conformation of the
complexes is unknown, the potential physiological relevance of the conformations diminishes. Criti-
cal questions must therefore be asked; such as: does it make physiological sense to have a preformed
receptor dimer that occludes the ligand-binding sites lying flat on the surface of the cell [29]? Or, when
proposing an alternative mechanism of activation that separates the receptor chains over 13 nm, is it
appropriate to interpret a difference of 1--2 nm between an agonist or antagonist-bound crystal struc-
ture as physiologically significant [9]? Far from criticising the models of the X-ray crystal structures
themselves, or belittling the effort to solve the crystal structures, this work serves to raise awareness
of how to maximise the utility of X-ray crystal structures when addressing mechanistic questions.
Indeed, in Chapter 4 we investigated how reliable were the models of the X-ray crystal structures
containing the EPOR were by replicating the crystal lattice. If anything the simulations demonstrated
the models themselves were reasonable despite the unfavorable scores in the PDB validation reports
for these structures. Unfortunately the structure factors for these crystal structures are unavailable
and so it was not possible to see whether the MD simulations could have aided in the refinement of
the models. In the future it would be beneficial to see reports on new X-ray crystal structures with
dynamic information produced from MD simulations to advance structural biology from the mindset
of interpreting a single model as the physiologically relevant form, to appreciating that these models
are one amongst many possible arrangements or conformations.
To validate our claims that it is essential these receptor proteins be considered in a membrane
environment, in Chapter 5 we investigated the effect of raft-like bilayers on the transmembrane do-
mains compared to a bulk membrane-like bilayer. These results showed a surprising variation in
the behaviour across the family, ranging from a negligible effects in the case of the GHR, to large
changes in the tilt of the transmembrane domain in the case of the rPRLR. In the case of the TPOR
the differences observed could almost be considered a conformational change. If these changes in
the transmembrane domain were to happen in the case of the full-length receptors where the N- and
C-termini of the transmembrane domains are more restricted, then not only is the presence of the mem-
brane essential to consider when proposing a model of activation but also the membrane composition.
Furthermore, the effect of the raft-like domain in the case of the rPRLR and TPO could suggest a novel
point of regulation of these receptors that has not previously been appreciated. While it is known rafts
are required in the activation of the receptors, it has not been previously reported that the rafts could
influence the structure of these receptors. This is where interdisciplinary studies will be necessary to
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fully elucidate how these receptors signal. While NMR spectroscopy techniques have provided some
insight into the structure of the transmembrane domains in a pure phosphocholinemicelle, the structure
of the transmembrane domain in the presence of cholesterol is not known. Also lacking is a structure
of the extracellular domain coupled to the transmembrane domain. Cryo-electron microscopy (Cryo-
EM) is one experimental technique that could solve this problem and provide structural data of the
receptors in a membrane environment. We attempted in Chapter 7 to generate conformations of a
transmembrane domain dimer for several receptors, the intention eventually being these could be cou-
pled to the extracellular domains. While we tried to restrict the search for active orientations of the
mEpoR and GHR by using the chimeric constructs, the orientation of the transmembrane domains in
these constructs was not compatible with the extracellular domains from the crystal structures, and
could represent an alternative mechanism to activate these receptors. It was also difficult to reconcile
experimental data, such as the cross-linking studies with the GHR, of the full-length receptor with the
chimeric constructs. While a somewhat unexpected result, it reinforces the point made earlier with
the simulations of the extracellular domain in solution, in that full consideration should be given to
what the model actually is before extrapolating mechanistic details, especially when structural data is
absent. This point illustrates a difficulty in molecular modelling in terms of which data can be trusted
and relatively weighing the different pieces of information available that can be used in building a
system. Small errors can have a profound impact on the results obtained. Indeed, modelling the at-
tachment of the extracellular and transmembrane domains proved to be difficult and computationally
expensive. Several simulations were performed but it was not possible to validate that the confor-
mations obtained were physiologically meaningful. In particular, it was not clear on which domain
to orientate, either the transmembrane or extracellular domain of the protein, or how to enforce the
dimer, whether through the transmembrane domains or maintain the configuration of the crystal struc-
ture. This may be a problem unsuitable for MD simulations and require an initial structure produced
experimentally from, for example, Cryo-EM before further simulations of such a large complex are
investigated.
Validation remains an important aspect of molecular modelling and to know the reliability and the
limits of a model are essential. In Chapter 6 we produced parameters for the molecule PSM and built
several bilayers containing this lipid. These bilayers were used to examine several properties of PSM
and compare themwith experimental values. Although while writing the thesis an error was found (cis
rather than trans of the carbon-carbon double bond in the sphingosine backbone) in the parameters of
PSM, given how well the bilayers with the cis configuration compared well to experimental values,
especially the predicted melting temperature, the correct trans configuration of the double bond is not
expected to vary significantly from these results and is currently being run. These cis bond containing
bilayers present us with an opportunity to explore what are the effects of the double-bond configu-
ration. Bilayers are particularly suitable for study with MD simulations as atomic detail can be seen
that cannot be obtained experimentally due to the averaging that occurs over time and through space
frommeasurements. Of particular interest in the PSM bilayers is whether there is an extensive H-bond
network that corresponds with the packing or ordering of the lipids. Furthermore, what influence does
cholesterol have in promoting or disrupting an H-bond network between the PSM molecules? In re-
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gard to cholesterol, it would be interesting to pursue whether the receptor transmembrane domains
had a cholesterol-binding motif. If so, does it exist in the single transmembrane domain sequence or
does receptor-ligand binding promote a dimer conformation of the transmembrane domains that pref-
erentially interacts with cholesterol resulting in the co-localisation of the receptors with rafts. These
questions would require the use of complementary computational techniques such as molecular dock-
ing and bioinformatic analysis of the transmembrane domain sequences. If such cholesterol-binding
sites could be found it would open up new avenues in which to target drugs that could modulate the
activity of these receptors.
The success and utility of MD simulations in the future depends on three points: (i) reliability of
predictions, (ii) speed of generating the predictions, and (iii) integration of experimental and theoret-
ical data. The reliability of MD simulations depends almost entirely on the force field used. While
proteins are on the whole generally well described by current force fields, the description of small
heteromolecular molecules that are substrates, co-factors or potential drugs are less robust and are an
area of focused research in order to improve these shortcomings [143]. The improvement to the speed
of the algorithms running the calculations over the past years has exploded, especially with the de-
velopment and implementation of code that exploits GPU-acceleration [144, 145, 137]. Indeed, these
improvements dramatically reduce the cost in both computing hardware and time needed to achieve
microsecond simulations. These savings make MD simulations more accessible to many researchers
and will render hardware specifically designed to run MD simulations comparatively expensive and
obsolete. The most critical point however is the continual need to successfully integrate experimental
and theoretical data not only for MD, but also the advancement of structural biology as a whole. Not
only do the theoretical scientists need to be able trust the structures produced by the experimental-
ists, the experimentalists in turn need to be able to trust the computational predictions. This requires
computational techniques being promoted as a tool that can help establish models, rather than as a
supplement to purely structural interpretations. It would be a shame to see larger, more detailed pro-
tein complexes solved by new experimental techniques again be treated as snapshots of the system
with non-physical linear interpolations proposed as dynamical properties. We will able to see further
if we can stand on each others shoulders.
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Appendix A
Sphingomyelin Parameters
;
; Parameters fo r sphingomylein
; To be used in conjunction with the GROMOS 54a7 force f i e l d
;
;
; CG1 OP1 H01  O1 H1B
; | | | | |
; CG2  N  CB  CA  OA  P  O3  C3  C2  C1  C1A==C1B  C1C  C1D  ..  C1O
; | | | |
; CG3 OP2( ) N2  HN2 H1A
; |
; C2A==O2A
; |
; C2B  C2C  ...  C2P
;
; ###HOW ITP FILE WAS CONSTRUCTED###
;
; The charges , bond terms , bond angle and dihedra ls fo r phosphocholine were
; taken from POPC. i tp see :
; Poger D. , van Gunsteren W.F. & Mark A.E. (2010) J . Comput . Chem. 31(6) ,
; 1117 1125 Poger D. & Mark A.E. (2010) J . Chem. Theory Comput . 6(1) , 325 336
;
; The charges fo r the backbone carbons C3 C2 C1, the amide bond , the hydroxyl
; group and the double bond were taken from ATB re su l t s fo r
; ceramide 1 phosphocholine (molecule ID 9232) , see a l so r e su l t s fo r
; Molecule ID 9319 and 9318.
;
; The excess pos i t ive charge of 0.209 generated from taking POPC
; phosphocholine and exlcuding C3 from the phosphocholine charge group
; generated by the ATB was subtracted from C3, C2, N2, HN2, C2A, O2A
; and C2B (0.209 / 7 = 0.0299) and rounded to 3 decimal places . C3,
; C2, N2, HN2, C2A, O2A and C2B were placed into a s ing l e charge group as
; per the ATB re su l t s fo r molecule ID 9319.
;
; Charges over atoms were rounded to 1 decimal place .
;
; ### END ###
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[ moleculetype ]
; Name nrexcl
PSM 3
[ atoms ]
; nr type resnr re s id atom cgnr charge mass total_charge
1 CH3p 1 PSM CG1 1 0.400 15.0350
2 CH3p 1 PSM CG2 1 0.400 15.0350
3 CH3p 1 PSM CG3 1 0.400 15.0350
4 NL 1 PSM N 1  0.500 14.0067
5 CH2 1 PSM CB 1 0.300 14.0270 ; 1.000
6 CH2 1 PSM CA 2 0.400 14.0270
7 OA 1 PSM OA 2  0.800 15.9994
8 P 1 PSM P 2 1.700 30.9738
9 OM 1 PSM OP1 2  0.800 15.9994
10 OM 1 PSM OP2 2  0.800 15.9994
11 OA 1 PSM O3 2  0.700 15.9994 ;  1.000
12 CH2 1 PSM C3 3 0.300 14.0270
13 CH1 1 PSM C2 3 0.300 13.0190
14 N 1 PSM N2 3  0.800 14.0067
15 H 1 PSM HN2 3 0.300 1.0080
16 C 1 PSM C2A 3 0.700 12.0110
17 O 1 PSM O2A 3  0.700 15.9994
18 CH2 1 PSM C2B 3  0.100 14.0270 ; 0.000
19 CH2 1 PSM C2C 5 0.000 14.0270 ; 0.000
20 CH2 1 PSM C2D 6 0.000 14.0270 ; 0.000
21 CH2 1 PSM C2E 7 0.000 14.0270 ; 0.000
22 CH2 1 PSM C2F 8 0.000 14.0270 ; 0.000
23 CH2 1 PSM C2G 9 0.000 14.0270 ; 0.000
24 CH2 1 PSM C2H 10 0.000 14.0270 ; 0.000
25 CH2 1 PSM C2I 11 0.000 14.0270 ; 0.000
26 CH2 1 PSM C2J 12 0.000 14.0270 ; 0.000
27 CH2 1 PSM C2K 13 0.000 14.0270 ; 0.000
28 CH2 1 PSM C2L 14 0.000 14.0270 ; 0.000
29 CH2 1 PSM C2M 15 0.000 14.0270 ; 0.000
30 CH2 1 PSM C2N 16 0.000 14.0270 ; 0.000
31 CH2 1 PSM C2O 17 0.000 14.0270 ; 0.000
32 CH3 1 PSM C2P 18 0.000 15.0350 ; 0.000
33 CH1 1 PSM C1 19 0.200 13.0190
34 OA 1 PSM O1 19  0.600 15.9994
35 H 1 PSM HO1 19 0.400 1.0080 ; 0.000
36 CH1 1 PSM C1A 20  0.100 13.0190
37 CH1 1 PSM C1B 20 0.100 13.0190 ; 0.000
38 CH2 1 PSM C1C 21 0.000 14.0270 ; 0.000
39 CH2 1 PSM C1D 22 0.000 14.0270 ; 0.000
40 CH2 1 PSM C1E 23 0.000 14.0270 ; 0.000
41 CH2 1 PSM C1F 24 0.000 14.0270 ; 0.000
42 CH2 1 PSM C1G 25 0.000 14.0270 ; 0.000
43 CH2 1 PSM C1H 26 0.000 14.0270 ; 0.000
44 CH2 1 PSM C1I 27 0.000 14.0270 ; 0.000
45 CH2 1 PSM C1J 28 0.000 14.0270 ; 0.000
46 CH2 1 PSM C1K 29 0.000 14.0270 ; 0.000
47 CH2 1 PSM C1L 30 0.000 14.0270 ; 0.000
48 CH2 1 PSM C1M 31 0.000 14.0270 ; 0.000
49 CH2 1 PSM C1N 32 0.000 14.0270 ; 0.000
50 CH3 1 PSM C1O 33 0.000 15.0350 ; 0.000
; to ta l charge of the molecule : 0.000
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[ bonds ]
; a i aj funct c0 c1
1 4 2 gb_21
2 4 2 gb_21
3 4 2 gb_21
4 5 2 gb_21
5 6 2 gb_27
6 7 2 gb_18
7 8 2 gb_28
8 9 2 gb_24
8 10 2 gb_24
8 11 2 gb_28
11 12 2 gb_18
13 12 2 0.1530 7.1500 e+06
13 33 2 0.1530 7.1500 e+06
14 13 2 0.1470 8.7100 e+06
14 16 2 0.1350 1.0300 e+07
15 14 2 0.1000 1.8700 e+07
17 16 2 0.1230 1.6600 e+07
18 16 2 0.1520 5.4300 e+06
18 19 2 0.1530 7.1500 e+06
19 20 2 0.1530 7.1500 e+06
20 21 2 0.1530 7.1500 e+06
21 22 2 0.1530 7.1500 e+06
22 23 2 0.1530 7.1500 e+06
23 24 2 0.1530 7.1500 e+06
24 25 2 0.1530 7.1500 e+06
25 26 2 0.1530 7.1500 e+06
26 27 2 0.1530 7.1500 e+06
27 28 2 0.1530 7.1500 e+06
28 29 2 0.1530 7.1500 e+06
29 30 2 0.1530 7.1500 e+06
30 31 2 0.1530 7.1500 e+06
31 32 2 0.1530 7.1500 e+06
33 36 2 0.1520 5.4300 e+06
34 33 2 0.1435 6.1000 e+06
35 34 2 0.1000 1.5700 e+07
36 37 2 0.1330 1.1800 e+07
38 37 2 0.1520 5.4300 e+06
38 39 2 0.1530 7.1500 e+06
39 40 2 0.1530 7.1500 e+06
40 41 2 0.1530 7.1500 e+06
41 42 2 0.1530 7.1500 e+06
42 43 2 0.1530 7.1500 e+06
43 44 2 0.1530 7.1500 e+06
44 45 2 0.1530 7.1500 e+06
45 46 2 0.1530 7.1500 e+06
46 47 2 0.1530 7.1500 e+06
47 48 2 0.1530 7.1500 e+06
48 49 2 0.1530 7.1500 e+06
49 50 2 0.1530 7.1500 e+06
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[ pairs ]
; a i aj funct ; a l l 1 4 pairs but the ones excluded in GROMOS itp
1 6 1
5 8 1
6 2 1
6 3 1
6 9 1
6 10 1
6 11 1
7 4 1
7 12 1
8 13 1
9 12 1
10 12 1
11 14 1
11 33 1
12 16 1
12 34 1
12 36 1
13 17 1
13 18 1
13 35 1
13 37 1
14 34 1
14 36 1
15 12 1
15 17 1
15 18 1
15 33 1
16 33 1
14 19 1
17 19 1
16 20 1
18 21 1
19 22 1
20 23 1
21 24 1
22 25 1
23 26 1
24 27 1
25 28 1
26 29 1
27 30 1
28 31 1
29 32 1
33 38 1
34 37 1
35 36 1
36 39 1
37 40 1
38 41 1
39 42 1
40 43 1
41 44 1
42 45 1
43 46 1
44 47 1
45 48 1
46 49 1
47 50 1
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[ angles ]
; a i aj ak funct angle f c
1 4 2 2 ga_13
1 4 3 2 ga_13
1 4 5 2 ga_13
2 4 3 2 ga_13
2 4 5 2 ga_13
3 4 5 2 ga_13
4 5 6 2 ga_15
5 6 7 2 ga_15
6 7 8 2 ga_26
7 8 9 2 ga_14
7 8 10 2 ga_14
7 8 11 2 ga_5
8 11 12 2 ga_26
9 8 10 2 ga_29
9 8 11 2 ga_14
10 8 11 2 ga_14
11 12 13 2 110.30 524.00
12 13 33 2 111.00 530.00
13 14 16 2 125.00 750.00
13 33 34 2 109.50 320.00
13 33 36 2 111.00 530.00
14 13 12 2 111.00 530.00
14 13 33 2 111.00 530.00
14 16 17 2 121.40 690.00
14 16 18 2 120.00 560.00
15 14 13 2 116.00 465.00
15 14 16 2 115.00 460.00
17 16 18 2 121.00 685.00
16 18 19 2 111.00 530.00
18 19 20 2 111.00 530.00
19 20 21 2 111.00 530.00
20 21 22 2 111.00 530.00
21 22 23 2 111.00 530.00
22 23 24 2 111.00 530.00
23 24 25 2 111.00 530.00
24 25 26 2 111.00 530.00
25 26 27 2 111.00 530.00
26 27 28 2 111.00 530.00
27 28 29 2 111.00 530.00
28 29 30 2 111.00 530.00
29 30 31 2 111.00 530.00
30 31 32 2 111.00 530.00
33 36 37 2 125.00 750.00
34 33 36 2 111.00 530.00
35 34 33 2 108.53 443.00
38 37 36 2 125.00 750.00
37 38 39 2 111.00 530.00
38 39 40 2 111.00 530.00
39 40 41 2 111.00 530.00
40 41 42 2 111.00 530.00
41 42 43 2 111.00 530.00
42 43 44 2 111.00 530.00
43 44 45 2 111.00 530.00
44 45 46 2 111.00 530.00
45 46 47 2 111.00 530.00
46 47 48 2 111.00 530.00
47 48 49 2 111.00 530.00
48 49 50 2 111.00 530.00
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[ dihedrals ]
; a i aj ak a l funct ph0 cp mult
1 4 5 6 1 gd_29
4 5 6 7 1 gd_4
4 5 6 7 1 gd_36
5 6 7 8 1 gd_29
6 7 8 11 1 gd_20
6 7 8 11 1 gd_27
7 8 11 12 1 gd_20
7 8 11 12 1 gd_27
8 11 12 13 1 gd_29
12 13 33 34 1 0.00 3.77 3
13 14 16 18 1 180.00 33.50 2
13 33 36 37 1 180.00 1.00 6
16 14 13 12 1 0.00 3.77 6
14 16 18 19 1 0.00 3.77 3
16 18 19 20 1 0.00 3.77 3
18 19 20 21 1 0.00 3.77 3
19 20 21 22 1 0.00 3.77 3
20 21 22 23 1 0.00 3.77 3
21 22 23 24 1 0.00 3.77 3
22 23 24 25 1 0.00 3.77 3
23 24 25 26 1 0.00 3.77 3
24 25 26 27 1 0.00 3.77 3
25 26 27 28 1 0.00 3.77 3
26 27 28 29 1 0.00 3.77 3
27 28 29 30 1 0.00 3.77 3
28 29 30 31 1 0.00 3.77 3
29 30 31 32 1 0.00 3.77 3
33 13 12 11 1 0.00 3.77 3
35 34 33 13 1 0.00 1.26 3
38 37 36 33 1 180.00 1.53 2
36 37 38 39 1 0.00 3.77 3
37 38 39 40 1 0.00 3.77 3
38 39 40 41 1 0.00 3.77 3
39 40 41 42 1 0.00 3.77 3
40 41 42 43 1 0.00 3.77 3
41 42 43 44 1 0.00 3.77 3
42 43 44 45 1 0.00 3.77 3
43 44 45 46 1 0.00 3.77 3
44 45 46 47 1 0.00 3.77 3
45 46 47 48 1 0.00 3.77 3
46 47 48 49 1 0.00 3.77 3
47 48 49 50 1 0.00 3.77 3
[ dihedrals ]
; GROMOS improper dihedra ls
; a i aj ak a l funct angle f c
13 12 33 14 2 35.26 334.72
14 15 13 16 2 0.00 167.36
16 14 17 18 2 0.00 167.36
33 34 13 36 2 35.26 334.72
33 36 37 38 2 gi_4
[ exclusions ]
; a i aj funct ; GROMOS 1 4 exc lus ions
[ virtual_sites3 ]
; a i aj ak a l funct c0 c1
15 14 16 13 2
132
